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Abstract 
Evidence suggests that the walking ability of people with cerebral palsy (CP) often 
deteriorates in early adulthood. This is especially problematic as the health care for 
young people with disabilities changes considerably over the course of the transition 
from paediatric to adult health care services. This suggests the importance of 
providing young people with the appropriate tools for managing their disability on a 
largely independent basis if they hope to reduce or delay this physical decline. One 
such strategy is the introduction of young people to an exercise programme which 
may be carried out independently of the health care system. Therefore, the main 
aim of this thesis was to investigate the feasibility and effectiveness of an 18-week 
pragmatic community exercise programme in adolescents and young adults with 
CP. Acknowledging the importance of assessing the effects of exercise studies 
using outcome measures (OMs) which are reliable, valid and responsive to change, 
a secondary aim of this thesis was to synthesise the psychometric evidence for the 
measures of gait quality and walking performance currently used for adolescents 
and young people with CP through a systematic review. Additional psychometric 
evidence for measures commonly used to assess the efficacy of exercise 
interventions was provided by a test-retest reliability study as part of this thesis. 
 
A standardised quality checklist (COSMIN) was used in the systematic review 
(Study 1) to measure methodological quality. The strength of the evidence was rated 
using standardised guidelines. The synthesis of best evidence was scored 
according to the Cochrane criteria, which indicated that the reliability (inter-rater) of 
the Functional Mobility Scale was characterised by a ‘strong’ level of evidence. The 
evidence for the responsiveness for all OMs included in this review was rated as 
‘unknown’. Only one study reported on measurement error when reporting on 
reliability. In Study 2, test-retest reliability (Intraclass Correlation Coefficient (ICC) 
and Minimal Detectable Change) was calculated for physical function, habitual 
physical activity (HPA), quality of life (QoL) and self-esteem measures in a group of 
adolescents and young adults with CP (n=8) and their age-matched peers (n=14). 
The ICCs for physical function and HPA OMs ranged from moderate to good but 
were poor for the measures of QoL and self-esteem. The RCT (Study 3) showed no 
statistically significant improvement following the exercise programme in any of the 
OMs at 6 weeks (experimental n=9, control n=7). A small effect size (d=0.54) in 
favour of the experimental group was found for the Canadian Occupational 
Performance Measure (COPM). Considering the experimental group only, a 
statistically significant improvement was found for the COPM at 12 weeks (n=7, 
p=0.02) compared to the baseline. Feasibility issues were also identified. This study 
was limited by its small sample size. 
 
This thesis contributes to the evidence base on pragmatic community exercise 
programmes for adolescents and young adults with CP and confirms the test-retest 
reliability (consistency) of physical function and HPA OMs commonly used to assess 
the efficacy of exercise interventions in CP. 
 
Key words: adolescents, young adults, cerebral palsy, exercise, reliability, minimal 
detectable change, measurement error, psychometric properties physical activity, 
isometric strength, 3D gait analysis, Quality of Life, Self-esteem 
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CHAPTER 1 INTRODUCTION 
 
Cerebral palsy (CP) occurs as a result of developmental brain injuries during 
foetal development, birth or shortly after birth (Baxter et al. 2007). CP is a 
non-progressive neurological condition, but it often results in secondary 
musculoskeletal conditions including pain, fatigue, muscle weakness and 
decreased mobility, which can lead to diminished independence. Some of 
these secondary conditions are likely to worsen during early adulthood (Tosi 
et al. 2009). The incidence of CP in the UK is reported to be two in every 
1000 live births, and there is an increased likelihood of CP in children with 
low birth weights (Surman et al. 2009). With advancement in medical 
technologies and effective management, more than 90% of the CP 
population survive to adolescence and adulthood (Cathels and Reddihough 
1993, Cooley and American Academy of Paediatrics Committee on Children 
With Disabilities 2004b). 
 
Adolescence is an important time in terms of the care of young people with a 
long-term health condition, and those with CP are no exception. Paediatric 
care for people with CP is generally quite comprehensive and involves 
multidisciplinary treatment; however, once patients reach a certain age, 
generally around 16–21 years (Binks et al. 2007, Wright et al. 2016), they are 
discharged from child health care. Since CP was traditionally viewed as a 
childhood ailment, health care for adults with CP is typically not as well 
established and services similar to those available to CP patients during 
childhood are lacking (Field et al. 2010, Horsman et al. 2010b, Ng et al. 
2003, Zaffuto-Sforza 2005). This likely contributes to the reported decrease 
in utilisation and exposure to health care services after patients reach 
adolescence, leave school and enter adulthood (Ng et al. 2003, Hilberink et 
al. 2007, Stevenson et al. 1997). This type of situation is common despite 
adults with CP experiencing problems such as decreased mobility (Jahnsen 
et al. 2004a, Liptak 2008), loss of walking ability (Bottos et al. 2001, Murphy 
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et al. 1995) and a high prevalence of pain and join deformities (Hilberink et 
al. 2007). This suggests the importance of providing patients with the right 
tools to self-manage their condition if they hope to reduce or delay the 
physical decline which occurs with ageing and which also occurs earlier in 
patients with CP than in the population without CP (Jahnsen et al. 2004a, 
Horsman et al. 2010a). Thus, strategies to help young people with CP to self-
manage this decline in function are warranted. One such strategy is to 
introduce young people to an exercise programme, which can be followed 
without the health care system that is often lacking in resources.  
 
A number of studies have examined the implementation of exercise 
programmes for people with CP in an attempt to improve muscle strength 
and other outcomes of physical fitness. Many have hypothesised that an 
increase in the physical fitness (International Classification of Function (ICF) 
(World Health Organisation 2008) – body structures and function level) of 
people with CP could lead to an improvement in their gait quality, walking 
performance, mobility (the ability of an individual to move about in the 
environment), gross motor function, habitual physical activity, self-esteem or 
quality of life (Dodd et al. 2003, Engsberg et al. 2006, Fowler et al. 2010, 
McNee et al. 2009, Lee et al. 2008, Morton et al. 2005, Liao et al. 2007, 
Patikas et al. 2006, Unger et al. 2006, Salem and Godwin 2009, Unnithan et 
al. 2007, Verschuren et al. 2007, Andersson et al. 2003, Debuse et al. 2009, 
Ballaz et al. 2010, Eek et al. 2008, Slaman et al. 2015, Bania et al. 2016). 
Most review articles in this area seem to support the idea of increased 
muscle strength and, in some cases, gross motor function, as a result of 
exercise interventions (Darrah et al. 1998, Dodd et al. 2002, Jeglinsky et al. 
2010, Martin et al. 2010, Mockford and Caulton 2008, Verschuren et al. 
2008a, Park and Kim 2014). However, closer evaluation reveals a number of 
uncertainties. These systematic reviews report a limited number of studies, 
which are often of low-quality study design, particularly those studies 
focusing on adolescents and young adults (Jeglinsky et al. 2010). In addition, 
Scianni et al. (2009) performed a meta-analysis of strength training in 
children and adolescents with CP that included only randomised control trials 
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(RCTs). Based on the available data, they concluded that strengthening 
interventions had no effect on strength or walking speed and only a small 
statistically significant, but not clinically meaningful, effect on Gross Motor 
Function Measure (GMFM). Only five studies were available for inclusion in 
the meta-analysis, and the authors acknowledged that factors such as 
insufficient intensity or duration of strength training may have contributed to 
these results. Only two of those five studies included only adolescents; Unger 
et al. (2006), which included participants aged 13–19 years, and Unnithan et 
al. (2007), which included participants aged 14–18 years.  
 
In order to evaluate the efficacy of an exercise intervention, the clinician or 
researcher needs to select outcome measures (OMs) which are valid, 
reliable and responsive to change as well as practical and appropriate for the 
research question(s) to be answered. As a result, there has been also 
growing interest in exploring the level of evidence of psychometric properties 
of OMs used in the population with CP, as evidenced by the number of 
systematic reviews published recently. Thus far, however, no clear 
consensus has been reached within clinical groups in terms of which OM(s) 
to use when working on exercise prescription for individuals with CP. Further, 
the evidence of psychometric properties of these OMs is conflicting and, in 
some cases, remains unknown. 
 
To summarise, there is ambiguity in the literature regarding the feasibility and 
effectiveness of exercise programmes in adolescents and young adults with 
CP, which may be attributable to the low-quality design and inappropriate 
exercise programme characteristics (e.g. insufficient frequency of the 
exercise sessions and/or duration of exercise programme) applied in the 
previous studies. Secondly, considering the importance of using 
psychometrically sound OMs to evaluate the effectiveness of a given 
exercise programme, it is important to explore the psychometric properties of 
the OMs in this population. Therefore, the overall aims of this thesis are: 
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1) To examine the level of psychometric evidence for measures of gait 
quality and walking performance used for adolescents and young 
adults with CP (Study 1). 
 
2) To investigate the reliability (i.e. consistency and agreement) of 
measures of physical function, habitual physical activity, quality of life 
and self-esteem used for adolescents and young adults with CP 
(Study 2). 
 
3) To investigate the physical function, habitual physical activity, quality 
of life and self-esteem in young people with CP and healthy controls 
(Cohort study). 
 
4) To investigate the feasibility and effectiveness of an 18-week 
pragmatic community exercise programme in adolescents and young 
adults with CP (Study 3). 
 
1.1 Contribution to knowledge 
In undertaking the studies in this thesis, additional knowledge will be added 
to the growing body of literature surrounding exercise interventions for young 
people with CP. The impact of a pragmatic community exercise programme 
for adolescents and young adults with CP will be established using 
quantitative analysis, and the feasibility of this programme will be explored. In 
addition, the reliability (consistency) and measurement error (agreement) of 
the OMs used to evaluate the effects of an exercise programme involving 
adolescents and young adults with CP will be established.  
 
1.2 Overview of the thesis 
An illustration of the overview of the thesis is shown in Figure 1.1. The next 
chapter (Chapter 2) critically evaluates the available literature on the efficacy 
and effectiveness of exercise programmes for young people with CP through 
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a narrative review. Secondly, this chapter describes the OMs chosen for the 
evaluation of the exercise intervention, in particular with regard to their 
psychometric properties and feasibility/practicality. Chapter 3 outlines the 
details regarding the methodology of Study 2 and Study 3, in particular the 
OMs used in these studies. Chapter 4 attempts to synthesise the evidence 
for the psychometric properties of measures of gait quality and walking 
performance for young people with CP (Study 1). In this systematic review, 
the methodological quality of the studies assessing the psychometric 
properties of gait quality and walking performance in adolescents and young 
adults with CP will be rated using a standardised checklist (COSMIN). The 
strength of the evidence presented in these studies will also be assessed 
using standard criteria, and the overall level of evidence will be scored 
according to the Cochrane criteria.  
 
Study 2, Chapter 5 aims to investigate the test-retest reliability of physical 
function, habitual physical activity, quality of life and self-esteem OMs in 
adolescents and young adults with CP and age-matched peers. Chapter 6 
will compare the OMs of physical function, habitual physical activity, quality of 
life and self-esteem in the young people with CP and age-matched peers 
who took part in Studies 2 and 3. Study 3, Chapter 7 aims to investigate the 
feasibility and effects of an 18-week pragmatic community exercise 
programme on physical function, gait quality, habitual physical activity 
patterns, quality of life and self-esteem in a pilot RCT. Lastly, Chapter 8 
synthesises and discusses the outcomes and limitations of the three studies 
in this thesis and provides recommendations for future studies.  
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Figure 1.1 Overview of the thesis 
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CHAPTER 2 LITERATURE REVIEW 
2.1 Introduction 
This chapter will commence with an overview of CP in terms of its clinical 
definition, incidence, manifestation, management and therapeutic exercises 
for young people with CP. It will then explore the current evidence available 
on exercise interventions in young people with CP with a focus on exercise 
programmes such as aerobic training, strength training and a combination of 
the two. As such, this part of the literature review provides a background to 
the choice of the type and content of the exercise intervention evaluated as 
part of this thesis (Chapter 7). Next, the second part of the literature review 
will describe the OMs used to evaluate the effects of exercise studies and will 
justify the choice of the OMs used in this thesis. This literature review will 
then highlight the gaps identified in the evidence and explain the rationale for 
the studies which form part of this thesis. 
 
2.2 Cerebral Palsy: An overview 
2.2.1 Definition  
Rosenbaum et al. (2006) defined CP as a ‘group of permanent disorders of 
development of movement and posture, causing activity limitation, that are 
attributed to non-progressive disturbances that occurred in the developing 
foetal or infant brain’. The motor disorders of CP are often accompanied by 
disturbances of sensation, perception, cognition, communication and 
behaviour caused by epilepsy, and by secondary musculoskeletal problems 
caused by muscle contractures, bony torsion, hip displacement and spinal 
deformity.  
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2.2.2 Incidence and prevalence 
CP is the most common cause of motor disability in childhood (Cans et al. 
2007). A systematic review of CP incidence was conducted in 2013 and 
revealed the prevalence of CP to be 2.11 per 1000 live births (95% CI 1.98–
2.25) worldwide (Oskoui et al. 2013). The prevalence was highest among 
children born prior to 28 weeks’ gestation, at 111.80 per 1000 births (95% CI 
69.53–179.78), whereas it was lowest, at 1.35 (95% CI 1.15–1.59), for 
children born after 36 weeks. In terms of birth weight, the prevalence was 
highest in children weighing 1000–1499 g (59.18 per 1000 live births; 95% CI 
43.38–73.95) and lowest in children weighing over 2500 g (1.33 per 1000 live 
births; 95% CI 1.19–1.49) (Oskoui et al. 2013). In developed countries, the 
prevalence of CP stands at approximately 2–2.5 per 1000 live births (Odding 
et al. 2006, Andersen et al. 2008). In the UK, the incidence is approximately 
2 in every 1000 live births, although this rises with low birth weights (Surman 
et al. 2009). Dependent on the subgroup of CP, 25–80% of people with CP 
have additional impairments such as cognitive, speech, visual and hearing 
(Odding et al. 2006). 
 
2.2.3 Classification and main clinical features of cerebral palsy 
In 1893, Rosenberg categorised CP as generalised rigidity, paraplegic 
rigidity, bilateral spastic hemiplegia, bilateral athethosis, chorioform diplegia 
and atypical forms. This classification was largely used for understanding and 
describing CP during that time (Scherzer 2001). Later, in 1950, Fay classified 
CP according to anatomical location and pathophysiology, and this had a 
strong influence on the subsequent classification by the American Academy 
for Cerebral Palsy (Scherzer 2001). CP has a modern-era classification that 
considers its early developing signs and identifies the type of motor 
involvement, distribution and degree of involvement and the extent of 
treatment required, as well as motor types (Baxter et al. 2007). The 
topography (which parts of the body are involved), nature of the impairments 
and severity are all commonly used in clinical settings when categorising 
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people with CP (Cans et al. 2007). Figure 2.1 displays a flow chart illustrating 
the classification of CP. 
 
Figure 2.1 Classification of Cerebral Palsy – Adapted from the SCPE Collaborative Group 
 
With regard to functional aspects, the Gross Motor Function Classification 
System (GMFCS) was introduced in the 1990s (Palisano et al. 2008a, 
Palisano et al. 2008b, Palisano et al. 2008c). The GMFCS provides families 
and clinicians with a clear description of a child’s current motor function and 
can provide some guidance as to the type of equipment or mobility aids a 
child may need in the future, e.g. crutches, a walking frame or wheelchair. 
The GMFCS has five levels that describe the gross motor function within two 
age bands; 0–12 years (for children), and 12–18 years (for adolescents). The 
GMFCS classification for young people with CP aged 12–18 years is shown 
in Table 2.1. 
 
Is there persisting increased  
muscle tone in one or more  
limbs?  
Yes No 
Are both sides of the body 
involved?  
 
Is the tone varying?  
Yes Yes  No No  
Spastic  
bilateral  
Spastic  
unilateral  
Dyskinetic  
CP  
Non - 
classifiable  
Is there generalized  
hypotonia with signs of  
ataxia?  
Yes  No 
Ataxic CP  Non - 
classifiable  
Reduced activity  
- tone tends to be  
increased  
Increased activity  
- tone tends to be  
decreased  
Dystonic CP  Choreo - 
Athetotic CP  
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Table 2.1 Gross Motor Classification Score (Palisano et al. 1997) 
GMFCS  Description 
Level I Youth walk at home, school, outdoor and in the community. 
Youth are able to walk up and down curbs without physical 
assistance and stairs without the use of railing. Youth 
perform gross motor skills such as running and jumping but 
speed balance and coordination are limited. Youth may 
participate in physical activity and sports depending on 
personal choices and environmental factors. 
Level II Youth walk in most settings. Environmental factors (such as 
uneven terrain) and personal preference influence mobility 
choices. At school or work, youth walk using a handheld 
mobility device for safety. Outdoors and in the community, 
youth may use wheeled mobility when travelling long 
distances. Youth walk up and down stairs holding a railing 
or with physical assistance if there is no railing. Limitations 
in performance of gross motor skills may necessitate 
adaptations to enable participation in physical activity and 
sports. 
Level III Youth are capable of walking using a handheld mobility 
device. Compared to individuals in other levels, youth in 
Level III demonstrate more variability in methods of mobility 
depending on physical activity, environmental and personal 
factors. When seated, youth may require a seat belt for 
pelvic alignment and balance. Sit-to-stand and floor-to-stand 
transfers require physical assistance from a person or 
support surface. At school, youth may self-propel a manual 
wheelchair or use powered mobility outdoors and in the 
community, youth are transported in a wheelchair or use 
powered mobility. Youth may walk up and down stairs 
holding onto a railing with supervision or physical 
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assistance. Limitations in walking may necessitate 
adaptations to enable participation in physical activity and 
sports including self-propelling a manual wheelchair or 
powered mobility. 
Level IV Youth use wheeled mobility in most settings. Youth require 
adaptive seating for pelvic and trunk control. Physical 
assistance from 1 or 2 persons is required for transfers. 
Youth may support weight with their legs to assist with 
standing transfers. Indoors, youth may walk short distances 
with physical assistance, use wheeled mobility, or, when 
positioned, use a body support walker. Youth are physically 
capable of operating a powered wheelchair. When a 
powered wheelchair is not feasible or available, youth are 
transported in a manual wheelchair. Limitations in mobility 
necessitate adaptations to enable participation in physical 
activities and sports, including physical assistance and/or 
powered mobility. 
Level V Youth are transported in a manual wheelchair in all settings. 
Youth are limited in their ability to maintain antigravity head 
and trunk postures and control arm and leg movements. 
Assistive technology is used to improve head alignment, 
seating, standing, and mobility but limitations are not fully 
compensated by equipment. Physical assistance from 1 or 2 
persons or a mechanical lift is required for transfers. Youth 
may achieve self-mobility using powered mobility with 
extensive adaptations for seating and control access. 
Limitations in mobility necessitate adaptations to enable 
participation in physical activities and sports including 
physical assistance and using powered mobility. 
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2.2.4 Management for people with cerebral palsy 
The management of CP is not aimed at curing or achieving normalcy but 
rather at increasing functionality, improving capabilities and maintaining 
optimum health in terms of mobility, cognitive and social skills and 
independence (Krigger 2006). This requires a team approach that is focused 
on overall individual progress and not solely on the improvement of a single 
symptom. Treatment programmes encompass physical and behavioural 
therapy, pharmacological and surgical treatments, mechanical aids and the 
management of associated medical conditions. The goals for physical, 
occupational, speech and behavioural therapies include enhancing patient 
and caregiver interactions at the same time as providing family support. 
Aisen et al. (2011) suggested that the optimum team should include a 
neurologist, orthopaedic surgeon, psychologist, physiotherapist, occupational 
therapist, speech therapist and social worker. Multidisciplinary team 
approaches and evidence-based practice thus aim to achieve the best 
outcomes for individuals with CP (Aisen et al. 2011).  
 
2.2.5 Exercise and physical activity in young people with cerebral palsy 
Exercise refers to a wide range of physical activities that focus on restoring 
and maintaining strength, endurance, flexibility, stability and balance (Taylor 
et al. 2007); hence, it is important in the rehabilitation or habilitation of 
patients with CP (Tecklin 2008), which is recommended by health 
professionals such as physiotherapists. Physiotherapy is a science-based 
profession which helps people affected by injury, illness or disability through 
movement, manual therapy, education and advice, as well as exercise (The 
Chartered Society of Physiotherapy 2013). The aims of exercise in CP are to 
improve and maintain motor abilities that have been decreased through 
disuse, learning to adopt a healthy lifestyle and to develop appropriate 
community mobility (Levitt 2010).  
 
The term ‘exercise’ is often used interchangeably with ‘physical activity’. 
However, there are differences in their respective definitions. Exercise is 
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defined as physical activity that is planned, structured, repetitive and 
purposive in the sense that the improvement or maintenance of one or more 
components of physical fitness is an objective. Physical activity is defined as 
any bodily movement produced by skeletal muscles that results in energy 
expenditure (World Health Organization 2008). However, both have a 
number of common elements, and in fact ‘exercise’ is a subcategory of 
physical activity (Caspersen and Merritt 1995).  
 
The life expectancy of people with CP has increased dramatically over the 
course of the last two decades (Rosenbaum et al. 2002, Cooley and 
American Academy of Paediatrics Committee on Children with Disabilities 
2004a). Studies have shown that if a child with CP lives to the age of 18, then 
they are more likely to live beyond the age of 40 (Hemming et al. 2005). The 
increasing number of adolescents and young adults with CP provides new 
challenges for the patients themselves, as well as for their families, health 
care teams and communities. Adolescence is the period in human growth 
and development that occurs after childhood and before adulthood, from the 
ages of 10 to 19. It is one of the important phases of shifts that occur during 
the life of an individual. It involves biological processes, such as the onset of 
puberty (World Health Organization 2008). Adolescence is also critical as a 
developmental period in that it has an impact on an individual’s social 
integration and behaviour in adulthood. Change and adjustment may be 
more difficult for adolescents with a physical disability (Michelsen et al. 
2006). In terms of medical needs, they will also experience the process of 
transition from childhood to adulthood services. Transition to adult-oriented 
health care, as defined by Blum et al. (1993), is a planned and purposeful 
movement of adolescents with chronic physical or medical conditions from 
child-oriented to adult-oriented health care systems and often occurs 
between the ages of 16 and 21 (Wright et al. 2016, Bjorquist et al. 2015). A 
recent study in Scotland looking at the transition from paediatric to adult 
health services for young people with CP showed that currently, coordination 
and communication within health services is lacking, in addition to between 
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the health services and educational, social services and adult health services 
to which young people are transitioning (Wright et al. 2016). Although Wright 
et al. (2016) did not provide any evidence that this problematic transition 
process was having a direct adverse effect on the health and well-being of 
patients, other previous studies have shown that people with a disability who 
are neglected between paediatric and adult health care are more likely to 
face high-cost emergency medical care and increasing disabilities (American 
Academy of Paediatrics et al. 2002). 
 
Apart from the often problematic transition from child to adult medical 
services that mostly affects those between 16 and 21 years of age (Wright et 
al. 2015, Bjorquist et al. 2016), the evidence shows that adolescents with 
physical disabilities are less physically active than their peers (Carlon et al. 
2013, Maher et al. 2007, Rimmer and Rowland 2008, Bloemen et al. 2015, 
Pitetti et al. 2013). A recent systematic review revealed that young people 
with CP between the ages of 5 and 18 have a lower rate (13% to 53%) of 
habitual physical activity than their non-disabled peers (Carlon et al. 2013). 
Maher et al. (2007) conducted a cross-sectional study on young people with 
CP aged between 11 and 17 years and found that adolescents with CP 
scored lower for all items in the Physical Activity Questionnaire for 
Adolescents in comparison with their age-matched peers; hence, this showed 
adolescents with CP as being less physically active than their healthy peers. 
Maher et al. (2007), in their study, also revealed that physical activity 
decreased with increasing age, as the participants with CP aged 14–17 had 
lower physical activity scores than the participants with CP aged 11–14 
years.  
 
Many studies have reported that people with CP show a decline in their 
quality of life, functional mobility, walking and overall well-being in early 
adulthood (Day et al. 2007, Morgan and McGinley 2014, Andersson and 
Mattsson 2001, Livingston and Rosenbaum 2008, Rimmer 2005). Day et al. 
(2007) reported the onset of a decline in ambulatory individuals with CP from 
the age of 25 years. This onset of functional decline may signal the start of a 
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downward cycle (Rimmer 2005), whereby disability, or increased disability, 
results in the experiencing of greater difficulty engaging in physical activity, 
thus leading to its avoidance. Over time, this can contribute to secondary 
conditions (such as pain, weight gain, reduced fitness and impaired balance) 
and greater functional decline, thereby exacerbating the cycle of increased 
disability and barriers to physical activity. The factors that contribute to this 
trend are beyond the scope of this report; however, some clinicians report 
that many individuals with CP stop exercising (i.e. physiotherapy exercise) 
after they have been discharged from paediatric physiotherapy services, due 
to them being tired of having ‘physiotherapy’ since childhood (Andersson and 
Mattsson 2001).  
 
Physical activity in adolescents without disability may contribute to the 
development of healthy adult lifestyles and help in reducing chronic disease 
incidence in the long term (Hallal et al. 2006). The review by Hallal and 
colleagues also highlighted that the short-term benefits for those youth who 
exercise or are physically active include improvements in bone density and 
social interaction. A systematic review of children and adolescents (age <20) 
with a disability looking at the benefits of physical activity found strong 
evidence that activities such as group exercise programmes, treadmill 
training or hippotherapy have a positive impact on aerobic capacity, gross 
motor function and parent or participant satisfaction (Johnson 2009). 
 
To date, there have been no physical activity guidelines that are specific to 
CP; however the, UK Government Department of Health has published a set 
of physical activity guidelines for children and adults (Davies et al. 2011), as 
shown in Table 2.2. These physical activity guidelines can be applied to 
disabled children and adult groups, including those with CP, while 
emphasising that these groups’ physical activity (i.e. type, intensity) needs to 
be adjusted for each individual, based on that person’s exercise capacity 
(fitness level) and any special health or risk issues. 
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Table 2.2 Guidelines for physical activity for children (5–18) and adults (19–64) (Davies et al. 
2011) 
Guidelines for children (5–18 years old) Guidelines for adults (19–64 years old) 
1. All children and young people should 
engage in moderate to vigorous 
intensity physical activity for at least 
60 minutes and up to several hours 
every day. 
2. Vigorous intensity activities, including 
those that strengthen muscle and 
bone, should be incorporated at least 
three days/week. 
3. All children and young people should 
minimise the amount of time spent 
being sedentary (sitting) for extended 
periods. 
1. Adults should aim to be active daily. 
Over a week, activity should add up 
to at least 150 mins (2½ hours) of 
moderate intensity activity in bouts of 
10 mins or more. One way to 
approach this is to do 30 mins at 
least 5 days/week. 
2. Alternatively, comparable benefits 
can be achieved through 75 mins of 
vigorous intensity activity spread 
across the week or a combination of 
moderate and vigorous intensity 
activity. 
3. Adults should also undertake 
physical activity to improve muscle 
strength on at least two days/week. 
4. All adults should minimise the 
amount of time spent being 
sedentary (sitting) for extended 
periods. 
mins; minutes 
 
A related behaviour, but one that is distinct from physical activity, is the 
amount of time spent being sedentary. Sedentary behaviour is defined as 
any waking behaviour characterised by an energy expenditure ≤1.5 
metabolic equivalents (METs) while in a sitting or reclining posture (Barnes et 
al. 2012). In general, this means that any time a person is sitting or lying 
down, they are engaging in sedentary behaviour. Common sedentary 
behaviours include watching television, playing video games, using a 
computer and reading. Sedentary behaviour has been reported to adversely 
affect metabolism and cardiovascular health (Hamilton et al. 2008). 
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In conclusion, the evidence suggests a problematic transition process to 
adult health services at the same time as a decrease in physical activity 
around the ages of 16 to 21 and reduced mobility starting in early adulthood 
(around approximately 25 years of age). All of these factors can adversely 
impact the well-being and quality of life of young people with CP. This is very 
alarming and therefore proactive and sustainable management to keep 
adolescents and young adults with CP physically active and less engaged in 
sedentary behaviour is crucial.  
 
The next section in this chapter comprises a narrative systematic review of 
the characteristics and results of studies investigating the effects of exercise 
programmes for young people (12–20 years of age) with CP. 
 
2.3 Exercise programmes in young people with CP, a narrative 
systematic review of the literature 
Approximately twenty years ago, strength or resistance exercise for people 
with CP was often avoided as it was speculated to increase their muscle 
spasticity. However, studies carried out in the last twenty years have shown 
no adverse effect on patterns of movement (Damiano et al. 1995), flexibility 
(Holland and Steadward 1990) or spasticity (Fowler et al. 2001) following 
resistance training. As a result, there has been growing interest in exercise 
programmes that improve lower limb muscle strength and/or aerobic capacity 
in people with CP. Two narrative systematic reviews (Dodd et al. 2002, 
Darrah et al. 1997), one systematic review (Mockford and Caulton 2008) and 
one meta-analysis (Park and Kim 2014) have been published reviewing the 
evidence regarding the effects of strength training in children with CP. 
Regarding aerobic training and a combination of both strength and aerobic 
training, the two systematic reviews have been published by Rogers et al. 
(2008) and Verschuren et al. (2008a), respectively (Table 2.3). 
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Table 2.3 Summary of systematic review and meta-analysis articles in CP exercise 
studies 
Author Aim Reviewed studies Main conclusion/ 
Recommendation 
Dodd et al. 
2002 
Determine 
whether strength 
training produces 
beneficial 
outcomes for 
people with CP: A 
systematic review 
Darrah et al. 
1999 
Damiano & Abel 
1998 
Toner et al. 
1998 
Tweedy 1997 
Damiano et al. 
1995 
MacPhail & 
Kramer 1995 
O’Connell & 
Barnhart 1995 
Lockwood 1993 
McCubbin & 
Shasby 1985 
Healy 1958 
Strengthening exercises 
for individual muscle 
groups increases muscle 
strength of young people 
with mild CP with no 
adverse effect on 
spasticity. 
Darrah et al. 
1997 
Critically appraise 
the effects of 
progressive 
resisted muscle 
strengthening for 
children and 
adolescents with 
CP: A review 
Damiano et al. 
1995a 
Damiano et al. 
1995b 
MacPhail and 
Kramer 1995 
Holland and 
Steadward 1990 
Horvat 1987 
McCubbin and 
Shasby 1985 
Healy 1958 
The relationship between 
strength training and 
functional abilities is 
scarce. 
Park and 
Kim 2014 
Synthesise the 
effects of 
strengthening on 
individuals with 
CP : A meta-
analysis 
Scholtes et al. 
2012 
Chen et al. 
2012 
Fowler et al. 
2010 
Maeland et al. 
2009 
Unnithan et al. 
2007 
Lee et al. 2007 
Unger et al. 2006 
Kerr et al. 2006 
Engsberg et al. 
2006 
Van der Linden 
et al. 2003 
Doss et al. 2003 
Optimal duration of 
exercise of 40 to 50 
minutes per session 
performed three times per 
week for increasing 
muscle strength in people 
with CP. 
Mockford 
and Caulton 
2008 
Determine the 
evidence 
regarding 
progressive 
strength training 
for children and 
adolescents with 
CP who are 
ambulatory: A 
systematic review  
Liao et al. 2007 
Ensberg et al. 
2006 
Jiang et al. 
2006 
Unger et al. 
2006 
Morton et al. 
2005 
Eagleton et al. 
2004 
Dodd et al. 
2003 
Blundell et al. 
2003 
Damiano and 
Abel 1998 
Tweedy 1997 
Damiano et al. 
1995a 
Damiano et al. 
1995b 
MacPhail & 
Kramer 1995 
Function and gait 
improvement were greater 
in pre-adolescents in 
comparison to 
adolescents. 
Rogers et 
al. 2008 
Evaluate the 
evidence for the 
effectiveness of 
aerobic exercise 
intervention for 
children with CP 
Fragala-
Pinkham et al. 
2005 
Schlough et al. 
2005 
Mulligan et al. 
2004 
Shinohara et al. 
2002 
Van den Berg-
Emons et al. 
1998 
Wiepert & Lewis 
1998 
Darrah et al. 
1998 
Rintala et al. 
1990 
Dresen et al. 
1985 
Bar-Or et al. 
1976 
Berg 1970 
Lunderberg & 
Pernow 1970 
Lunderberg et al. 
1967 
More research with 
rigorous methods is 
required to determine a 
specific set of exercise 
guidelines and safety 
considerations. 
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Author Aim Reviewed studies Main conclusion/ 
Recommendation 
Verschuren 
et al. 2008a 
Investigate the 
effects of all types 
of exercise 
programmes 
focusing on 
cardiovascular 
fitness (aerobic 
and aerobic 
capacity) and/or 
lower-extremity 
muscle strength in 
children with CP: 
A systematic 
review 
Patikas et al. 
2006 
Unger et al. 
2006 
Morton et al. 
2005 
Schlough et al. 
2005 
Eagleton et al. 
2004 
Dodd et al. 
2004 
Dodd et al. 
2003 
McBurney et al. 
2003 
Blundell et al. 
2003 
Shinohara et al. 
2002 
Damiano et al. 
1998 
Van den Berg-
Emons et al. 
1998 
Rintala et al. 
1998 
Hutzler et al. 
1998 
Darrah et al. 
1997 
Damiano et al. 
1995 
MacPhail 
&Kramer 1995 
Berg et al. 1970 
Lunderberg et al. 
1967 
Healy 1958 
More studies are 
warranted to investigate 
the efficacy of exercise 
programmes on daily 
activity, participation level 
and quality of life in 
children with CP. 
 
 
The aims of exercise programmes designed recently for people with CP are 
not just to prevent secondary complications and/or impairments, i.e. lack of 
range of motion, muscle weakness and spasticity, from getting worse 
(Damiano et al. 2002) but also to maximise the individual’s overall health 
(Katsimanis et al. 2002, Damiano and Abel 1998) and quality of life (Groff et 
al. 2009). According to the World Health Organization (2008), health is 
regarded as a state of complete physical, mental and social well-being and 
not merely the absence of disease or infirmity. 
 
A recent cross-sectional study of 70 young people (11–17 years) with CP 
(GMFCS levels I–V) revealed that the level of physical activity significantly 
predicted their health-related quality of life (R2=0.64, p<0.01), social quality of 
life (R2=0.28, p<0.01) and happiness (R2=0.08, p<0.01). The authors 
concluded that there is a need for clinical services and intervention studies 
aimed specifically at increasing physical activity in young people with CP 
(Maher et al. 2007).  
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2.3.1 Methods:  Identification of studies in the literature review 
A systematic search of the literature was performed to identify the exercise 
studies discussed in this literature review using the online databases 
MEDLINE, CINAHL, PubMed and Scopus up to December 2016. Search 
terms included subject headings and text words based on (I) cerebral palsy; 
and (II) exercise, strength, resistance, fitness, working capacity, aerobic 
power, anaerobic power, endurance and cardiorespiratory physical training. 
In this review, the term young people is used in reference to adolescents, 
and the term young adults refers to those between 12 and 20 years of age 
(World Health Organisation 2008). 
 
The studies had to meet the following inclusion criteria to be included in this 
review: 1) any experimental, pre-post and case studies involving at least one 
participant aged 12–20 with CP; 2) any land-based exercise intervention 
aimed at strengthening lower-limb muscles and/ or improved aerobic 
capacity; 3) any measure of strength, body function, activity, participation, 
self-esteem and quality of life; and 4) full-text original articles in English.  
 
2.3.2 Results 
The search strategy resulted in the identification of 272 articles. Initial 
screening based on the tittle resulted in the exclusion of 166 articles. A 
further 42 and 35 articles were omitted based on the review of abstracts and 
full text, respectively. Based on the inclusion criteria regarding age, a further 
ten articles were excluded. Three articles were added as a result of scanning 
the reference lists of the primary studies. This gave a final number of 30 
articles published between 1958 and 2016. The types of exercise 
programmes investigated are categorised as follows: strength training 
(n=16), aerobic training (n=4) and combined training (n=5). The details of the 
studies are shown in three different tables: exercise interventions focusing on 
strength training (Table 2.4), aerobic training (Table 2.5) and those 
incorporating a combination of both strength and aerobic training (Table 2.6).  
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The specific results obtained for each of these types of exercise training are 
described separately in the next three sections with regard to the 
demographics of the participants, the duration of the exercise and the results 
of the studies, followed by a summary. 
2.3.2.1 Strength training 
 
a. Demographics of the participants, study design and intervention 
characteristics   
The number of participants included in the studies ranged from 7 to 49, with 
only four studies with a sample size of more than 30 participants (Patikas et 
al. 2006, Unger et al. 2006, Taylor et al. 2013, Scholtes et al. 2010). Given 
that the sample size tends to be rather small in CP studies, especially in 
RCTs, multi-centre trials would be an alternative to overcome the small 
sample size.    
 
The age of the participants ranged from 6 to 22 years. Nine studies described 
their participants’ GMFCS level (Dodd et al. 2003, McNee et al. 2009, Eek et 
al. 2008, Bania et al. 2016, Taylor et al. 2013, Scholtes et al. 2010, Chen et 
al. 2012, McBurney et al. 2003, Auld and Johnston 2014). Dodd et al. (2003) 
included a majority of participants who were classified as GMFCS level III 
(n=9). The majority of the participants in the study by Taylor et al. (2013) 
were classified as GMFCS II. Overall, the majority of the participants 
comprised those less severely affected, with no studies including people with 
CP classified as GMFCS levels IV–V. Hence, identifying the effect of strength 
training across the GMFCS levels is essential. 
 
Ten studies conducted pre- and post-test design with no control group, with 
the remainder (n=9) being RCTs, none of which adopted a double-blind 
design. Double-blinding is where neither the participants nor the assessors 
are aware of the experimental groups until after the data have been collected 
(Portney and Watkins 2000). To blind participants, the control group should 
be offered a placebo. However, for many rehabilitation research studies, this 
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is not always possible; hence, a single-blind design may be employed 
instead, whereby only the assessor is blind. Only two studies (Taylor et al. 
2013, Scholtes et al. 2010) used a single-blind design. Blinding will 
substantially strengthen the study as it will reduce the risk of bias when 
assessing the participants. 
 
The type of strength training varies throughout the literature, with many 
studies using dumb-bells, backpacks, body weight or TheraBands/resistance 
bands; further details can be seen in Table 2.2. Six of the exercise 
programmes (n=6) in this review were home-based training (Dodd et al. 
2003, Damiano et al. 1995, Damiano and Abel 1998, Chen et al. 2012, 
McBurney et al. 2003, Dodd et al. 2004). Four studies (n=4) utilised the 
community gymnasium (Taylor et al. 2013, Auld and Johnston 2014, Tweedy 
1997, Eagleton et al. 2004). Other studies were conducted at special schools 
(n=2) (Unger et al. 2006, Scholtes et al. 2010), hospital (n=1) (Patikas et al. 
2006) and a university laboratory (n=1) (MacPhail and Kramer 1995). The 
remaining studies were carried out at both home and hospital (McNee et al. 
2009, Eek et al. 2004). Whilst the implementation of a programme at a 
community gymnasium might not always be possible, this type of venue does 
have the benefit of providing a conducive, welcoming and inclusive 
community environment. It has also been shown that a community setting is 
an important element that contributes to the success of an exercise 
programme in adults with CP (Allen et al. 2004). 
 
The duration of exercise programmes reported in the literature ranges from 6 
weeks to 40 weeks. The majority of the studies conducted programmes for 6 
(n=5) and 8 weeks (n=5), with the remainder being for durations of 10 weeks 
(n=2) and 12 weeks (n=4). It was recommended that longer interventions 
with progressive intensities (i.e. 12–16 weeks) were essential in order to 
experience any significant strength improvement in people with CP 
(Verschuren et al. 2008a). The frequencies of exercise per week varied 
across the studies, with the majority (n=10) implementing twice- or thrice-
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weekly sessions, and these were conducted in accordance with the 
guidelines stated by (American College of Sports Medicine 1980, 
Faigenbaum et al. 2009).  
 
b. Results and discussion of the studies 
A randomised clinical trial evaluated the effects of a home-based, six-week 
strength-training programme aimed at increasing the lower limb strength of 
21 people with CP aged between 8 and 18 years (GMFCS I–III) (Dodd et al. 
2003). There were significant improvements in the strength of the ankle 
plantarflexors and knee extensors of the experimental group compared to the 
control group from baseline to week six. No significant improvements were 
found in terms of the ICF ‘activity’ domain as measured by GMFM dimension 
E over the first six weeks between the experimental and control group. 
However, the authors noted that there was a trend of improvement in the 
experimental group compared to the control group, and power analysis 
revealed that if the effect size were maintained and the sample size 
increased to n=26 in each group, there was an 80% chance that the 
comparison would reach statistical significance. The levels of participation 
and adherence to the training programme were reported to be excellent; 
however, none of the participants continued to exercise after the study had 
ended. The study did not provide information on whether the participants did 
any other form of exercise or physical activity after the end of the 
programme. Thus, the study in question reveals that although there was 
excellent adherence to the home-based exercise programme during the 
course of the study, the intervention did not prove sustainable after its 
completion.  
 
A previous RCT investigating the effect of eight weeks’ resistance training 
(one to three times per week) on young people with CP aged 13–18 years 
found no significant improvement with regard to gait velocity, cadence and 
stride length. In addition, Unger et al. (2006) reported that no significant 
improvement was found in the participants’ kinematics following the 
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programme (Unger et al. 2006). Interestingly, there was a significant 
difference in terms of the participants’ perception of their ability to walk 
between the classroom and managing stairs without support. 
 
A gymnasium-based strength-training programme was conducted by Taylor 
et al. (2013). This trial by Taylor et al. (2013) involved 48 participants aged 
between 14 and 22 years. The participants performed 12 weeks’ progressive 
resistance training twice weekly and showed an increment in muscle 
strength. However, this effect did not carry over into any objectively 
measured improvements in mobility, such as the six-minute walk test 
(6MWT), gait kinematics and GMFM. These authors also emphasised the 
importance of the safety and feasibility of any exercise programme aimed at 
helping young people with CP become stronger and achieve physical activity 
guidelines (Taylor et al. 2013). 
 
A study comprising 17 participants with CP aged 12 to 20 years revealed that 
there was a statistically significant increase in the peak torque (Nm/kg) of 
knee extensor and flexor muscles, as well as of the GMFM score following 
strength training three times per week for a total of eight weeks (MacPhail 
and Kramer 1995). However, the study’s authors did not find any significant 
changes in spasticity and gait parameters such as walking velocity and 
energy efficiency during walking.  
 
In contrast to previous results (MacPhail and Kramer 1995, Unger et al. 
2006), Eagleton et al. (2004) found statistically significant improvements in 
spatial-temporal gait parameters (step length, velocity, cadence and energy 
expenditure index) following strength training conducted three times per 
week for six weeks involving seven young people with CP aged 12 to 20 
years. Of note, this study was the first strength-training programme to be 
conducted in a community gymnasium since strength training for young 
people with CP was first reported by Healy in 1958. Eagleton et al. (2004) 
acknowledged that all the participants reported that they enjoyed the training 
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in the gymnasium. Safety is a vitally important element for a successful 
exercise programme as it contributes to a further increase in the confidence 
of the participant to continue the programme once the study is finished. 
Ploughman et al. (2014) suggested that people with disabilities need 
education, professional support, appropriate programming and accessible 
space to participate in a community-based exercise programme. People with 
disabilities often feel insecure if the exercise programmes are not specially 
designed to meet their needs or they lack support from physiotherapists 
and/or fitness instructors (Lennon et al. 2013, Simpson et al. 2011).   
 
Early studies (Healy 1958, Horvat 1987) showed the positive effects of 
strength training. The strength training conducted by Healy (1958) compared 
isometric (static contraction) and isotonic (dynamic resistance) techniques in 
five participants aged 8 to 16 who exercised three times per week for eight 
weeks and who showed improvement in knee extensor strength at an eight-
week assessment. The study also found improvement in the range of motion 
of knee extension but no significant difference between the isometric and 
isotonic techniques. A single case study involving a 21-year-old participant 
with spastic hemiplegia also demonstrated an improvement in knee extensor 
strength after eight weeks of strength training (Hovart 1987). Neither study 
(Healy 1958, Horvat 1987) reported other outcomes, however, such as 
walking speed and gross motor function.  
 
The first systematic review by Darrah et al. (1997) identified six strength 
exercise studies. Later, Dodd et al. (2002) carried out a systematic review 
and included the same studies as those reviewed by Darrah et al. (1997), 
with the inclusion of an additional five strength exercise studies. Both reviews 
revealed that strengthening exercises for individual muscle groups increased 
the muscle strength of young people with mild CP with no adverse effect on 
spasticity. However, evidence pertaining to the relationship between 
improved muscle strength and improved functional ability is scarce. The third 
systematic review by Mockford et al. (2008) on progressive strength training 
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in children and youths with CP who are ambulatory suggested such training 
may improve motor development in younger children; however, this may not 
be the case in youth as deterioration may occur. Mockford et al. (2008) 
acknowledged that improvement in some aspects of gait (i.e. cadence, 
walking speed) may occur. A recent meta-analysis by Park et al. (2014) on 
the effect of strengthening interventions in individuals with CP identified 13 
RCT studies published between 2001 and 2012. The results of this meta-
analysis suggested an optimal exercise duration of 40 to 50 minutes per 
session performed three times per week for increasing muscle strength in 
people with CP. Previous systematic reviews and meta-analyses 
recommended higher-quality studies (i.e. RCT) to investigate the effects of 
strength training in relation to mobility (Park et al. 2014, Darrah et al. 1997, 
Dodd et al. 2002), function (Darrah et al. 1997, Dodd et al. 2002) and 
participation (Darrah et al. 1997, Dodd et al. 2002). 
 
c. Summary of evidence on the effects of strength training 
As discussed earlier, strength training can result in an improvement in 
muscle strength (MacPhail and Kramer 1995, Taylor et al. 2013, McNee et al. 
2009, Eek et al. 2008, Chen et al. 2012, Scholtes et al. 2010, Auld et al. 
2014, Damiano et al. 1995, Damiano et al. 1998, Tweedy et al. 1997), gross 
motor function (MacPhail and Kramer 1995, Dodd et al. 2003, Patikas et al. 
2006, Eek et al. 2008, Damiano et al. 1998), gait parameters (Eagleton et al. 
2004, Eek et al. 2008, Damiano et al. 1998) and quality of life (McBurney et 
al. 2003). However, there is a need for further exploration in this area, as 
discussed in section 2.3.3. 
 
2.3.2.2 Aerobic training 
a. Demographics of the participants, study design and intervention 
characteristics 
The number of participants across the studies ranged from 3 to 22. The age 
of the participants ranged from 6 to 25 years. GMFCS was reported in only 
27 
 
one study, with one participant classified as GMFCS I and two as GMFCS III 
(Schlough et al. 2005).  
 
The majority (n=3) of the studies were pre-posttest design with no control 
group, and one study was a case series with three participants. The type of 
exercise varied, with two studies utilising a cycle ergometer (Shinohara et al. 
2002, Berg 1970), one study using several different modalities, i.e. treadmill, 
elliptical and recumbent stepper (Schlough et al. 2005), and the remaining 
study (n=1) including activities such as running and jumping (i.e. Lundberg et 
al. 1967) to achieve the desired aerobic effect in their participants. In terms of 
the venue of the programmes, community gymnasiums and university 
laboratories were utilised for the training.  
 
The duration of the exercise programmes in all of the studies was between 6 
and 20 weeks. The frequencies with which they were carried out were 
between two or three times per week, for a duration of 20 to 30 minutes per 
session. 
 
b. Results and discussion of the studies 
Lunderberg (1967) and Berg (1970), in their respective studies, found that 
participants with CP had improved their aerobic capacity at the end of the 
training. Lunderberg (1967), in a study of 14 participants with CP aged 15–20 
years, reported increases in the participants’ maximal oxygen uptake 
(VO2max) after aerobic training (i.e. running, jumping) twice a week for a 
period of six weeks. Similarly, Berg (1970) reported improvement in the 22 
participants with CP aged 12 to 25 years who carried out exercise with a 
bicycle ergometer three times per week for between 1.5 and 6 months. The 
VO2max of the participants was reported to increase by between 10 and 25 
per cent following the total training periods that varied between 1.5 and 16 
months (Berg 1970). Whilst early studies of aerobic training (Lunderberg 
1967, Berg 1970) showed improvement in the participants’ VO2max following 
the training, both studies reported only the pre- and post-intervention means; 
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however, they provided no evidence in terms of statistical analysis to support 
their claims and the results should thus be interpreted with caution. 
 
Shinohara et al. (2002) investigated 11 participants with CP aged between 13 
and 16 years who were randomly divided into two groups. Six of the 11 
participants exercised using a cycle ergometer, with the other five 
participants carrying out training using an arm cranking ergometer twice a 
week. They found that the VO2max of the adolescents who exercised on a 
cycle ergometer showed significant improvement in comparison to the group 
that trained with the arm cranking ergometer, for which no change in VO2max 
was reported. The training period for both groups ranged from 6 to 20 weeks. 
Both the study by Shinohara et al. (2002) and previous studies (Lunderberg 
1967, Berg 1970) appeared to examine only one outcome. In contrast, in a 
report of three case studies, Schlough (2005) evaluated the outcomes of 
aerobic exercise on participants with CP aged between 17 and 20 years 
across a much wider range of aspects, i.e. energy expenditure index (EEI), 
strength, GMFM and self-perception. The participants exercised three times 
per week for six weeks using an elliptical trainer, treadmill or recumbent 
stepper. This study revealed a significant improvement in the participants’ 
EEI, muscle strength and velocity in the individual cases (participants) 
following the programme.  
 
Rogers et al. (2008) undertook a systematic review that aimed to evaluate 
the effect of aerobic exercise for children with CP. The review included land-
based and non-land-based (i.e. hydrotherapy) exercise programmes. The 
authors concluded that more research involving rigorous methods was 
required to determine a specific set of exercise guidelines and safety 
considerations. 
 
c. Summary of evidence on the effects of aerobic training 
A number of researchers have examined the effects of aerobic training in 
young people with CP. Of four studies (Lunderberg 1967, Berg 1970, 
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Shinohara et al. 2002, Schlough 2005), the majority (n=3) examined the 
effects of VO2max. It was shown that, in general, aerobic training benefits 
aerobic capacity. Only one study (Schlough 2005) investigated other aspects 
and reported improvements in strength, walking efficiency, gross motor 
function and self-perception. However, this study appeared to employ poor 
methodologies (i.e. a very low number of participants, non-RCT). There is a 
need for further research in this area, and this will be discussed in section 
2.3.3. 
 
2.3.2.3 Combined training 
a. Demographics of the participants, study design and intervention 
characteristics 
The number of participants included in the studies ranged from 13 to 65, with 
only two studies recruiting less than 30 participants. The age of the 
participants ranged from 7 to 24 years. Four out of the five studies reported 
the GMFCS level of the participants in the individual studies. Three of these 
four studies reporting GMFCS levels had the largest number of participants 
with CP classified as GMFCS level I, followed by participants with CP 
classified as GMFCS level II.  
 
Four of the studies were RCTs with the assessors being blind to the 
participants’ group allocation. Only one study adopted a pre-test/post-test 
design. The venues used in the combined training studies were either 
community gymnasiums or rehabilitation centres. 
 
The durations of the exercise programmes carried out were between 10 and 
32 weeks. Similar to the strength and aerobic studies, the frequency of 
combined training was either two or three times per week.  
 
b. Results and discussion of the studies 
A previous RCT aimed at exploring the effectiveness of a 12-week exercise 
programme on submaximal exercise intensity during arm cranking without 
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resistance at 4 minutes, VO2max and gross motor function (Unnithan et al. 
2007). Thirteen participants with CP aged between 14 and 18 years took part 
in this programme. The experimental group took part in 70 minutes’ training 
that consisted of a warm-up, 20 minutes’ strength training and 20 minutes’ 
aerobic training and stretching, three times per week for 12 weeks. The 
control group continued with their normal physiotherapy session. The results 
showed that submaximal exercise intensity and aerobic capacity were 
significantly improved in the exercise group relative to the control group at 
week 12. They also reported a significant increase in GMFM scores 
(dimensions D and E) in the exercise group compared to the control group. 
This study showed that a combined strengthening and aerobic training 
programme of 12 weeks’ duration had the ability to positively impact on the 
participants’ fitness and gross motor function. 
 
Another RCT was conducted with 68 participants with CP aged between 16 
and 24 years (Verschuren et al. 2007). The participants in the exercise group 
followed a programme that consisted of functional aerobic, anaerobic training 
and muscle strengthening twice weekly for a period of eight months, in 
addition to their usual care. The participants in the control group received 
their usual rehabilitation care. The results of the study revealed that there 
were significant improvements in aerobic capacity measured by the 10 m 
shuttle run test and anaerobic capacity measured using the Muscle Power 
Sprint Test at 4-month and 8-month assessments in the experimental group. 
Moreover, the participants’ muscle strength of lower extremities was found to 
have increased by 20 per cent in comparison to the control group at 8 
months. The number of participants in the study was higher compared with 
the previous RCT study (i.e. Unnithan et al. 2007) as the participants were 
recruited from different centres. 
 
Fowler et al. (2010) conducted a multi-centre RCT that investigated the 
effects of a cycling intervention on 55 participants with CP aged between 7 
and 18 years. The cycling intervention known as PEDALS was performed in 
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a community gymnasium three times per week for a duration of 12 weeks. It 
utilised stationary bicycles which provided resistance. The results showed 
statistically significant improvements in the 600-Yard Walk-Run Test and 
GMFM 66 (dimensions D & E) scores, knee extensor moments (Nm/Kg) at 
1200/s and knee flexor moments (Nm/Kg) at 300/s in the exercise group 
following 12 weeks’ training compared to the baseline. However, this study 
found no significant differences between the exercise and control groups. 
 
A Dutch multi-centre RCT known as LEARN2MOVE was conducted aimed at 
increasing physical activity and improving the physical fitness of people with 
CP aged between 16 and 24 years (Slaman et al. 2010). The LEARN2MOVE 
programme consisted of the following three parts: 1) counselling on daily 
physical activity by a physiotherapist once a month for 6 months; 2) physical 
fitness training that included aerobic and strength training for 24 weeks (12 
weekly supervised sessions in the gymnasium plus 12 sessions at home); 
and 3) counselling on sports participation for approximately 2 to 4 sessions, 
each of 30 minutes’ duration. The results showed a statistically significant 
difference in VO2max at anaerobic threshold between the exercise and 
control groups. The programme was effective in decreasing fatigue (p=0.02) 
and increasing quality of life with regard to bodily pain (p=0.01) and mental 
health (p=0.03) assessed during follow-up (Slaman et al. 2014a). However, 
no significant difference was reported in the strength of hip flexors, abductors 
and knee extensors between the groups following the exercise programme 
(Slaman et al. 2014b) nor in the objectively measured outcomes of physical 
activity or sedentary behaviour (Slaman et al. 2015).  
 
Darrah et al. (1999) conducted a community-based exercise programme 
combining aerobic, flexibility and strength training for adolescents with 23 
participants with CP aged 11–20 years. The participants trained three times 
per week for 10 weeks. According to Darrah et al. (1999), the training 
frequency and duration of the programme was based on recommendations 
as outlined by the American College of Sports Medicine (1991). The training, 
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inclusive of a warm-up, consisted of progressive aerobic training (10–30 
minutes), progressive strengthening of upper-limb and lower-limb muscles 
and stretching. The results showed statistically significant improvements in 
the strength of the participants’ knee extensors, hip extensors and hip 
abductors post training at the 10-week follow-up. However, no significant 
changes were found in EEI and submaximal heart rate. The authors 
commented that a possible reason for the lack of changes in the 
cardiorespiratory endurance of the participants could be related to the 
relatively short duration of the exercise programme (i.e. 10 weeks).  
 
c. Summary of evidence on the effects of combined training 
Combined or mixed training studies enable participants to benefit from 
strength, aerobic and other forms of exercise i.e. stretching. Previous 
combined exercise studies have reported improvements in aerobic capacity 
(Verschuren et al. 2007), anaerobic capacity (Unnithan et al. 2007, 
Verschuren et al. 2007, Slaman et al. 2014a), muscle strength (Darrah et al. 
1999, Fowler et al. 2010, Verschuren et al. 2007), self-perception 
(Verschuren et al. 2007), gross motor function (Unnithan et al. 2007, Fowler 
et al 2010), fatigue (Slaman et al. 2014a) and quality of life (Demuth et al. 
2012, Slaman et al. 2014a). However, further investigation is warranted to 
strengthen the present evidence, and this will be outlined in the next section. 
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Table 2.4 Studies of strength training in young people (12–20 years) with cerebral palsy 
Study 
(Author 
and Year) 
Design Participants (n, 
age, GMFCS) 
Programme details (Time and number of 
measurements, programme duration, 
frequency of the exercise, supervision, 
venue, training programme and exercises, 
other details) 
Outcome measures used Result for each outcome measure 
MacPhail 
and Kramer 
(1995) 
Pre-post 
test 
n=17, 12–20 
years (mean 15.8 
years), 
GMFCS-not 
specified 
1) Before 2) After 3) 3-month f/up, 8 weeks’ 
strength training, 3x/week, supervision: not 
specified, research laboratory, training 
programme: 3 sets of 5 max effort at 90%; knee 
flexors and extensors  
 
1) Isokinetic (dynamometer) 
2) GMFM D & E 
3) EEI at free and fast walk 
speed, 
4) Velocity over 3 mins, free and 
fast speeds 
5) MAS 
1) Peak torque increased 25% at 8w, 
17% at f/up. Work increased 21% at 
8w, 15% at f/up (p<0.001) 
2) 9 participants increased scores 
(p=0.011), no change in 7 participants, 
decreased in one participant 
3) no sig change 
4) no sig change 
5) no sig change 
Dodd et al. 
(2003) 
RCT n=21, 8–18 years 
(mean 
13.1),GMFCS 
(I=7, II =5, III=9) 
1) Start 2) 6w 3) 18w f/up, 6-week strength 
training, 3x/week, supervision: physio & parent, 
home, training programme: 3 sets of 8–10 reps 
of ankle plantar flexor, knee extensor, hip 
extensor, exercises loaded with backpack, 
weight increased gradually, Logbook to record 
weight used (backpack), number of sets and 
repetition, Control group: continue normal 
routines such as sports, school and 
physiotherapy session 
1) Isometric (handheld 
dynamometer) 
2) GMFM D&E 
3) Timed stair test 
4) Self-selected walk speed 
 
1) sig increased in combined knee ext 
&PFat 6w & 18w (p<0.05) 
2) non-sig change   
3) non-sig change 
4) non-sig change 
 
34 
 
Study 
(Author 
and Year) 
Design Participants (n, 
age, GMFCS) 
Programme details (Time and number of 
measurements, programme duration, 
frequency of the exercise, supervision, 
venue, training programme and exercises, 
other details) 
Outcome measures used Result for each outcome measure 
Dodd et al. 
(2004) 
RCT n=17, 8–16 years 
(mean 
12.1),GMFCS 
(I=6, II-4, III-7) 
As above 1) Self-concept (Self-Perception 
Profile for Children) 
1) Sig improve in scholastic 
competence and social acceptance 
(p<0.05) 
Eagleton et 
al. (2004) 
 
 
 
Pre-post 
test  
 
n=7, 12–20 years 
(mean not 
specified), 
GMFCS level not 
specified 
1) Before 2) After, 6 weeks’ strength training, 
3x/week, physio, local & school gym, training 
programme: 80% of 1RM of trunk and lower 
limbs muscle 
 
 
 
1) Isometric (handheld 
dynamometer) 
2) Distance walked in 3 mins 
3) Visual gait analysis 
4) EEI (HR before & after 2-min 
walk 
 
1) No result (due to equipment failure) 
2) sig increase in 6 of 7 participants 
(p=0.05) 
3) sig improvement in velocity, step 
length, cadence (p=0.05) 
4) sig decrease in 4 of 7 participants 
(p=0.05) 
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Study 
(Author 
and Year) 
Design Participants (n, 
age, GMFCS) 
Programme details (Time and number of 
measurements, programme duration, 
frequency of the exercise, supervision, 
venue, training programme and exercises, 
other details) 
Outcome measures used Result for each outcome measure 
Unger et al. 
(2006) 
RCT 
single-
blind 
n=31, 13–18 
years (mean 
16.1),GMFCS-not 
specified 
1) Before 2) After 3) 4w f/up, 8-week strength 
training,1-3x/week, research assistant, special 
school, training programme: 1–3 set of reps, 8–
12 individual selection of a 28-station circuit 
upper and lower limb, trunk, exercise inclusive of 
a 5-min warm-up and stationary bicycle; 
Exercise progressively increased as outlined by 
McArdle et al. (1996); Equipment used was 
dumbbells, ankle and wrist cuff weights and bar-
with disc weights, elastic-rubber band and 
gymball 
1) 3DGA 
2) Self-perception questionnaire 
1) sig improved sum of hip/knee/ankle 
angles at midstance for exs group 
compared to controls (p=0.05).no sig 
change in gait parameters 
2) sig improvement in perception of 
body image (p=0.01) 
Patikas et 
al. (2006) 
RCT  n=39, 6–16 years 
(mean 10.1 
years), 
GMFCS not 
specified 
1) presurgery and pretraining 2) 1-yr postsurgery 
3) f/up, 8 weeks’ strength training, 1–3x/week, 
physio & parent, hospital, training programme: 2 
sets of 5 reps 7 exercises-hip, knee and ankle 
extensor and flexors 
1) 3DGA 
2) GMFM 
3) EEI 
4) MAS 
1) no sig difference between group in 
spatiotemporal, kinematics & kinetics 
2) Sig improved dimension D 1yr 
postsurgery in exs group only 
(p<0.05), no sig difference between 
group 
3) Sig improved in EEI 1yr postsurgery 
in exs group only (P<0.05), no sig 
difference between group 
4) No sig change 
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Study 
(Author 
and Year) 
Design Participants (n, 
age, GMFCS) 
Programme details (Time and number of 
measurements, programme duration, 
frequency of the exercise, supervision, 
venue, training programme and exercises, 
other details) 
Outcome measures used Result for each outcome measure 
Taylor et al. 
(2013) 
RCT 
Single-
blind 
n=48, 14–22 
years (18.2), 
GMFCS 
(II=29,III=19) 
1) Before 2) After 3) 24w f/up, 12 weeks’ 
strength training, 2x/week, physio, community 
gym, training programme: 3 sets of 10–12 reps, 
exs based on instrumented gait analysis and 
targeted muscles contributing to walking 
difficulties, Control group: continued usual 
physiotherapy and usual recreation activity 
1) 6MWT 
2) GMFM D & E 
3) GPS 
4) FMS 
5) FAQ 
6) Isometric strength (handheld 
dynamometer) 
1) No sig change  
2) No sig change 
3) No sig change 
4) Sig change at 12w between groups 
(p<0.05) 
5) Sig change at 12w between groups 
(p<0.05) 
6) Sig change at 12w between groups 
(p<0.05)  
Bania et al. 
(2016) 
As above As above As above 1) Objective measurement of 
Physical activity (ActivPALTM) 
1) No significant change 
McNee et 
al. (2009) 
Pre-post 
test 
n= 13, 6–16 years 
(10.11), 
GMFCS 
(I=6,II=5,III=2)  
1) Before 2) 5w 3) After 4) 12w f/up, 10 weeks’ 
strength training, 4x/week, physio, home & 
tertiary centre, training programme: 3/4 sets of 
6–12 reps isotonic PF using TheraBand or body 
weight or back pack depending on individual 
strength, exercise logbook to record the training 
 
1) Passive range of motion 
2) Muscle volume (3D tracking 
system) 
3) TUG 
4) FMS 
5) FAQ 
6) number of heel raises 
1) No sig change 
2) Sig improvement at weeks 5, 10 
and f/up 
3) No sig change 
4) No sig change 
5) No sig change 
6) Sig improvement at weeks 5, 10 
and f/up 
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Study 
(Author 
and Year) 
Design Participants (n, 
age, GMFCS) 
Programme details (Time and number of 
measurements, programme duration, 
frequency of the exercise, supervision, 
venue, training programme and exercises, 
other details) 
Outcome measures used Result for each outcome measure 
Eek et al. 
(2008) 
Pre-post 
test 
n=16, 9–15 years 
(9.4),GMFCS 
(I=10,II=6) 
1) Before 2) After 8-week strength training, 
3x/week, physio & parent, physio department & 
home, training programme: strengthening of hip 
ext/flex/abd/add, knee ext/flex, ankle DF/PF  
 
1) Isometric strength 
(dynamometer) 
2) GMFM D&E 
3) 3DGA 
4) ROM 
5) MAS 
1) Sig increase in targeted muscle 
group strength (hip ext, hip add, hip 
abd, PF) p<0.05 
2) Sig change p<0.05  
3) Sig change in cadence p<0.05 
4) Sig change in ROM of knee ext 
p<0.05 
5) No sig change 
Chen et al. 
(2012) 
RCT n=28, 6–12 years 
(8.7), GMFCS 
(I=22, II n=6) 
1) Before 2) After 12 weeks’ virtual cycling 
training, 3x/week, research assistant, home-
based, training programme: 20-minute cycling 
using stationary cycle-progressive increase 
resistance, Control group – continue usual 
physical activity 
1) Bruininks-Oseretsky Test of 
Motor Proficiency 
2) Isokinetic Strength (isokinetic 
dynamometer) 
1) No sig change 
2) Sig change in Knee ext/flexor, 
p<0.05 
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Study 
(Author 
and Year) 
Design Participants (n, 
age, GMFCS) 
Programme details (Time and number of 
measurements, programme duration, 
frequency of the exercise, supervision, 
venue, training programme and exercises, 
other details) 
Outcome measures used Result for each outcome measure 
Scholtes et 
al. (2010) 
RCT 
Single-
blind 
n=49 
 
6 to 13 years 
(10.4 years) 
 
GMFCS (level I 
n=25, level II 
n=17, level III 
n=7) 
1) Before 2) During training 3) immediately after 
training 4) 6-week follow-up, 3x/week for 12 
weeks, research assistants, special schools, 
training programme: 5–10mins warm-up 
(stretching and aerobic), leg press, sit-to-stand, 
lateral step up, half knee-rise with weight, lateral 
step up with body weight, 5–10mins cool down 
(stretching), control group – continue 
physiotherapy programme 
1) Mobility as measured by 
GMFM 66, MobQues28, sit-to-
stand test and lateral step up 
test 
2) isometric strength (handheld 
dynamometer) 
3) spasticity 
1) No sig 
2) Significant improvement for knee 
extensor, hip adductor 
3) No sig 
Auld et al. 
(2014) 
Pre-post 
test 
n=10, 8–15 years 
(mean not 
specified), 
GMFCS (I=6, II=4) 
1) Before 2) After 8 weeks’ strength & balance 
training, 1x/week, physio, community gym, 
training programme: 2–3 sets of 10 reps, Upper 
limb and lower limb strength, core stability, 
balance training 
1) Isometric muscle strength 
(dynamometry), 2) Functional 
muscle strength (seated throw, 
distance jump, vertical jump, 
lateral step up) 
3) Balance 
1) Sig change in elbow flex, hip 
abductor, ankle dorsiflex, plantarflexor 
of the dominant side (p<0.05) 
2) Sig change in seated thrown 
distance jump 
3) Sig change in lateral reach, forward 
reach, lateral step 
Damiano et 
al. (1995) 
Pre-post 
test 
n=14, 6-14 years 
(9.1), GMFCS: not 
specified 
 
1) Before 2) 3w 3) 6w, 6 weeks’ strength 
training, 3x/week, not described, home-based, 
training programme: 4 sets of 5 reps, Isotonic 
open-chain concentric/eccentric knee extension-
4/5 reps, loads 65% of max 
1) isometric of knee extensor 
and flexor (handheld 
dynamometer) 
 
1) Significant increased quadriceps at 
30, 60, 90 degrees (p<0.001) 
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Study 
(Author 
and Year) 
Design Participants (n, 
age, GMFCS) 
Programme details (Time and number of 
measurements, programme duration, 
frequency of the exercise, supervision, 
venue, training programme and exercises, 
other details) 
Outcome measures used Result for each outcome measure 
Damiano et 
al. (1995) 
As above As above As above 1) 3DGA 1) No sig change 
Damiano et 
al. (1998) 
Pre-post 
test 
n=12, 6–12 years 
(8.8), 
GMFCS not 
specified 
1) Before 2) 6w 3) 18w f/up, 6 weeks’ strength 
training, 3x/week, physio & parent, home-based, 
3 sets of 8–10 reps, Isotonic open-chain 
exercise of lower limb 
1) Isometric strength of hip 
flex/ext, abd/add; knee ext/flex; 
ankle flex/ext 
2) GMFM 
3) 3DGA 
4) EEI 
1) Sig increased in target muscle 
(p<0.05) 
2) Sig improved Dimension E (p<0.05) 
3) Sig improvement in velocity, 
cadence and double support (p<0.05) 
4) No sig change 
Engsberg 
et al. 
(2006) 
RCT n=15 
6–13 years (9.5 
years); 
GMFCS not 
specified 
1) Before 2) After 12 weeks’ strength training, 
3x/week, physio, physio gym, training 
programme: 3 sets of 5 reps, Isokinetic exs, 
concentric and eccentric 3 sets/5 reps, Group 
1:DF, group 2:PF, group 3: DF&PF 
Control (group 4): continue daily activity 
1) Isokinetic strength ankle 
DF/PF(isokinetic machine) 
2) Spasticity ankle PF  
3) Passive ROM  
4) GMFM 
5) 3DGA 
6) PedsQoL 
1) Sig increase in trained eccentric 
muscle at 30, 90 degrees (p<0.05) 
2) Sig reduced spasticity in exs group 
p<0.05 
3) No sig change 
4) Sig increase for dimension E in exs 
group p<0.05  
5) Sig improvement in knee flexion 
minimum p<0.05 
6) Sig improvement in parent report, 
p<0.05 
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Study 
(Author 
and Year) 
Design Participants (n, 
age, GMFCS) 
Programme details (Time and number of 
measurements, programme duration, 
frequency of the exercise, supervision, 
venue, training programme and exercises, 
other details) 
Outcome measures used Result for each outcome measure 
Tweedy et 
al. (1997) 
Pre-post 
test 
 
n=12,10–18 years 
(13.8), GMFCS 
not specified 
1) Before 2) After 10 weeks’ strength training, 
3x/week, supervision, gymnasium, training 
programme: Isotonic closed and or open-chain 
concentric/eccentric hip and knee extensors-
weighted boots, weight machines, training diary 
1) Isometric quads strength at 
80-, 65-, 50-, 35-, 20-degree 
extension 
2) Isokinetic strength quads at 
60 degrees 
3) Flexibility-passive knee 
flex/ext, active knee ext 
4) Muscle tone of the knee-
isokinetic movement at 60, 40, 
20, 12 degrees 
1) Sig improvement in knee extension 
at 80, 65, 50 degrees; p<0.05 
2) Sig increase in peak torque knee 
extension; p<0.01 
3) Sig ROM knee flexion (p=0.005) 
4) Significant decrease right leg 
resistance to passive movement; 
p=0.046 
 
McBurney 
et al. 
(2003) 
 
Pre-post 
test 
n=11,8–17 years 
(12.9), GMFCS 
(I=2, II=2, III=7) 
1) After 6 weeks’ strength training, 3x/week 
physio & parent, home-based training 
programme: 3 sets of 8–10 reps, bilateral half 
squats, heel raises, and step-ups: Ankle 
plantarflexor, knee extension, hip extension 
1) In-depth interview on body 
function, activity, participation 
(ICF model) 
 
2) Improvement in perception of 
strength, flexibility, posture, walking 
and the ability to negotiate stairs, 
improvement in mobility, improvement 
in school, leisure and family events 
3DGA; three-dimensional gait analysis, abd; abduction,add; adduction, DF; dorsiflexion, EEI; energy expenditure index, exs; exercise, ext; extension, 
FAQ; Gillette Functional Assessment Questionnaire, flex; flexion, FMS; functional mobility scale, f/up; follow up, physio; physiotherapy, GMFCS; Gross 
Motor Functional Classification System, GMFM; Gross Motor Function Measure, dimension D; standing, dimension E; running,jumping, walking ICF; 
International Classification of Functioning, disability and health, MAS; Modified Ashworth Scale, max; maximum, mins; minutes, MobQues28; 28-item 
version mobility questionnaire for ambulant children with Cerebral Palsy,PedsQoL; Pediatric Quality of Life Inventory, PF; plantarfexion,RCT, 
randomised control trial,reps; repetition, RM; repetitive movement, ROM; range of motion, sig; significant, TUG; timed up and go test, w; week 
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Table 2.5 Studies of aerobic training in young people with cerebral palsy 
Study 
(Author 
and Year) 
Design Participants 
(n, age, 
GMFCS) 
Programme details (Time and number of 
measurements, programme duration, frequency 
of the exercise, supervision, venue, training 
programme and exercises, other details) 
Outcome measures 
used 
Result for each 
outcome measure 
Lunderberg 
et al. 
(1967) 
 
Pre-post 
test 
n=14,15–20 
years, 
GMFCS not 
specified 
1) Before 2) After 6 weeks’ community exercise, 
2x/week, physio, community gymnasium, training 
programme: Targeting large muscle group-Running, 
jumping, parallel bars 
1) VO2max (cycle 
ergometer-submaximal 
test), pulse rate and 
blood lactic acid 
1) Increase aerobic 
capacity  
(no statistical analysis 
was used) 
Berg 
(1970) 
Pre-post 
test 
n=22, 7–25 
years, 
GMFCS not 
specified 
1) Before 2) After 3) 3mo f/up, 1.5–6 months 
programme, 3x/week, physio, laboratory, training 
programme: Bicycle ergometer at varying intensity: 20 
mins 
 
1) muscle strength 
2) VO2max–bicycle 
ergometer 
 
1) Improvement in 
muscle strength 2) 
increase in maximal 
heart rate (no 
statistical analysis 
were used) 
Shinohara 
et al. 
(2002) 
 
 
Case 
series 
n=11,13.3–
15.8 years 
(mean not 
specified), 
GMFCS not 
specified 
1) Before 2) During 3) After 6–20-week programme, 
2x/week, not described, laboratory, training 
programme: cycle ergometer or arm cranking at the 
anaerobic threshold point for 20 mins 
 
1) Oxygen uptake (cycle 
ergometer), Interview of 
the children 
 
 
 
1) Sig improvement in 
oxygen uptake 
at the anaerobic 
threshold point 
increased significantly 
in the leg exercise 
group (p<0.05) 
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Study 
(Author 
and Year) 
Design Participants 
(n, age, 
GMFCS) 
Programme details (Time and number of 
measurements, programme duration, frequency 
of the exercise, supervision, venue, training 
programme and exercises, other details) 
Outcome measures 
used 
Result for each 
outcome measure 
Schlough 
et al. 
(2005) 
Case 
series 
n=3, 17–20 
years (mean 
18.3),GMFCS 
(I=1), III=2) 
 
1) Before 2) During 3) After 4) f/up, 10–21weeks 
exercise, 3x/week, not described, community 
gymnasium, training programme: Treadmill, elliptical, 
recumbent stepper 
1) Isometric strength of 
quadriceps, hamstrings, 
ankle plantarflexor, and 
dorsiflexor (handheld 
dynamometer) 
2) GMFM 
3) EEI 
4) self-perception profile 
(SPPCS) 
1) No sig change 
2) No sig change 
3) Mixed results 
4) No sig change 
EEI; energy expenditure index, f/up; follow up, GMFCS; Gross Motor Function Classification System, GMFM; Gross Motor Function 
Measure, mins; minutes, mo; months, Physio; physiotherapy, sig; significant, VO2max; maximal oxygen uptake 
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Table 2.6 Studies of strength and aerobic training in young people with Cerebral Palsy 
Study 
(Author 
and Year) 
Design Participants 
(n, age, 
GMFCS) 
Programme details (Time and 
number of measurement, 
programme duration, frequency of 
the exercise, supervision, venue, 
training programme and exercises, 
other details) 
Outcome measures used Result for each outcome 
measure 
Darrah et 
al. (1999) 
Pre-post 
test 
n=23, 11–20 
years (mean 
14.2), GMFCS 
not specified 
1) Before 3x 2) 10w 3) 20w f/up, 10-
week community programme, 
3x/week, physio student, community 
gym, training programme: aerobic 
exercise (progress from 10–13 min 
throughout the programme), 3 sets of 
12 reps for weight training circuit of 
upper and lower limb 
1) Isometric muscle strength 
(handheld dynamometer) 
2) EEI& submaximal heart rate (cycle 
ergometer) 
3) Flexibility (sit and reach test) 
4) Self-perception profile  
1) Sig improve post training 
and f/up p<0.01 
2) No sig change 
3) No sig change 
4) No sig change 
Unnithan et 
al. (2007) 
RCT  
 
n=13,14–18 
years (mean 
15.8), GMFCS 
II=4),III=9) 
1) Before 2) After,12w, 3x/week, 
physio, rehab centre, training 
programme: 5 sets of 10 reps 
strength training upper limbs, trunk, 
abs and lower limbs, aerobic interval 
training for 20–22mins (uphill walking 
reps), Both groups maintain the 
normal physio intervention 2x/week 
1) Submaximal heart rate (VO2max 
at 4 min max workload using arm 
cranking) 
2) Aerobic capacity (VO2max at 
plateau at the end of the test-
spirometry) 
3) GMFM 
1) Sig difference between 
group post training p<0.05 
2) Sig difference between 
group post training p<0.05 
3) Sig improve in exs group 
p<0.05 
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Study 
(Author 
and Year) 
Design Participants 
(n, age, 
GMFCS) 
Programme details (Time and 
number of measurement, 
programme duration, frequency of 
the exercise, supervision, venue, 
training programme and exercises, 
other details) 
Outcome measures used Result for each outcome 
measure 
Verschuren 
et al. 
(2007) 
RCT single-
blind 
n= 65, 7–18 
years (mean 
11.6),GMFCS 
(I=47,II=21) 
1) Before 2) 4 mo 3) 8 mo 4) 12 mo 
f/up, 8-month exercise training, 
physio, community gym, training 
programme: 25 to 30 mins functional 
aerobic, anaerobic and muscle-
strengthening exs, Control group-
maintain the normal rehabilitation 
care  
1) Aerobic capacity (10-m SRT) 
2) Anaerobic capacity (Muscle Power 
Sprint Test) 
3) Agility (10x5M Sprint Test) 
4) Muscle strength (30 sec reps max) 
5) Self-concept (SPPC) 
6) GMFM 
7) Participation (CAPE) 
8) Quality of life (TACQOL) 
1) Sig difference between 
group post training p<0.01 
2) Sig difference between 
group post training p=0.04 
3) Sig difference between 
group post training p<0.01 
4) Sig difference between 
group post training p<0.01 
5) Sig difference between 
group post training (athletic 
p=0.05) 
6)Sig difference between group 
post training dimension D 
p=0.03 
7)Sig different between group 
post training overall p=0.02 
8)Sig different between group 
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Study 
(Author 
and Year) 
Design Participants 
(n, age, 
GMFCS) 
Programme details (Time and 
number of measurement, 
programme duration, frequency of 
the exercise, supervision, venue, 
training programme and exercises, 
other details) 
Outcome measures used Result for each outcome 
measure 
post raining (basic motor 
function, cognitive p<0.05) 
Fowler et 
al. (2010) 
RCT single-
blind 
n=62, 7–18 
years (mean 
11.4), GMFCS 
(I=19,II=14),III
=29) 
1) Before 2) After 12-week exercise 
programme, physio, 3x/week, 
community-paediatric physio clinic 
training programme: Each session of 
60mins cycling inclusive of lower 
limbs strengthening and 
cardiorespiratory endurance, Control 
group- maintain normal physical 
activity 
1) 600-yard walk run test 
2) 30 secs walk test 
3) GMFM D&E 
4) Peak extensor and flexor isometric 
and isokinetic moments 
1) Sig improvement in exs 
group p=0.03 
2) No sig change 
3) No sig change 
4) Sig improvement in exs 
group knee extensor moment 
at 120ᵒ/s and knee flexor 
moment at 30ᵒ/s p<0.05 
Demuth et 
al. (2012) 
As above As above As above 1) PedsQoL& PODCI 1) Sig difference within group 
in emotional functioning 
(PedsQL) and treatment 
expectations (PODCI-parents) 
p<0.05 
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Study 
(Author 
and Year) 
Design Participants 
(n, age, 
GMFCS) 
Programme details (Time and 
number of measurement, 
programme duration, frequency of 
the exercise, supervision, venue, 
training programme and exercises, 
other details) 
Outcome measures used Result for each outcome 
measure 
Slaman et 
al. (2014) 
Multi-centre 
RCT 
n=57 
16 to 24 years 
(20 years) 
GMFCS (I=33, 
II=18, III=5, 
IV=1) 
1) Before 2) 14w 3) 26w 4) 1-yr f/up, 
6-months exercise programme, 
physio, fitness centre & home, 
training programme: 1) Weekly 
supervised centre and weekly home-
based fitness training (aerobic and 
strength) for 3 months 2) Counselling 
on daily physical activity for 6 
months, 30 mins duration per session 
3) Counselling on sports 
participation, 
Control group: continue regular 
physiotherapy treatment 
1) Cardiopulmonary fitness 
2) muscle strength 
3) body composition 
1) Sig improvement in VO2max 
on the anaerobic threshold 
after 3 months programme 2) 
No sig change 
3) Sig improvement at 12 
month follow-up in 
experimental group compared 
to control  
Slaman et 
al. (2014) 
As above As above As above 1) Fatigue 
2) Social participation 
3) Quality of life (SF36) 
4) GMFM 
1) Sig improvement post 
intervention p<0.05 
2) No sig change 
3) Sig improvement in (mental 
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Study 
(Author 
and Year) 
Design Participants 
(n, age, 
GMFCS) 
Programme details (Time and 
number of measurement, 
programme duration, frequency of 
the exercise, supervision, venue, 
training programme and exercises, 
other details) 
Outcome measures used Result for each outcome 
measure 
health) and family support 
(participation and involvement) 
post intervention and bodily 
pain, mental health) and family 
support (participation and 
involvement) at 1-yr f/up 
Slaman et 
al. (2015) 
As above As above As above 1) Objective measurement of 
movement behaviour (VitaMove 
system) 
2) PASIPD 
1) No sig change 
2) No sig change 
CAPE; Children Assessment of Participation and Enjoyment, EEI; energy expenditure index, exs; exercise, f/up; follow up, GMFCS; Gross Motor Function Classification 
System, GMFM; Gross Motor Function Measure, mins; minutes, mo; months, PASIPD, Self-reported physical activity (The Physical Activity Scale for Individuals with 
Physical Disabilities, PedsQoL; Pediatric Quality of Life inventory, PODCI; Pediatric Outcomes Data Collection Instrument, reps; repetition, sig; significant, SPPC; self-
perceived communication competence scale, TACQOL; TNO-AZL (Netherlands Organisation for Applied Scientific Research Academic Medical Centre) Children’s 
Quality of Life questionnaire, VO2max; maximum oxygen uptake, w; week, yr; year
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2.3.3 Gaps in the evidence and rationale for the studies included in this 
thesis 
There is a growing body of evidence with regards to exercise programmes for 
people with CP, and this has been discussed in relation to strength exercise, 
aerobic exercise and combined exercise programmes in section 2.3. The 
literature diverges in methodologies and results and this has been 
summarised and presented in Tables 2.4 to 2.6. The majority of the current 
evidence reveals that exercise programmes for people with CP have positive 
outcomes on one or more aspects of physical function. However, further 
investigations would add to our knowledge and should attempt to address 
some of the following gaps in the literature: 
 
 The majority of the studies (15 out of 25 studies) included children with 
CP (mean age < 16), with little attention paid to young people aged 
between 16 and 25 years. Future studies should thus include those 
who are just prior to entering and following transition to adult 
physiotherapy services. 
 A follow-up assessment following completion of the exercise 
programme is important for assessment of whether any benefits of the 
intervention have been sustained as well as to establish knowledge on 
participants’ physical activity or participation in exercise; therefore, this 
should be included in future studies. 
 Utilising valid and reliable outcome measures to assess the impact of 
an intervention on short- and long-term physical activity levels. 
 As a majority of the studies undertaken are small in size (only 7 out of 
25 studies with sample size n>30) and therefore often underpowered, 
larger, appropriately powered studies should be undertaken. 
 Implementing the exercise programme at a community leisure centre 
may allow increased participation and should be included in future 
work. 
 Only one study (McBurney et al. 2003) used in-depth interviews 
exploring the participants’ thoughts regarding the exercise 
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programme, which may provide fruitful feedback regarding the 
programme (i.e. why such a programme was/was not a success or 
sustainable); thus, qualitative methodologies should be included to 
establish this. 
 
2.3.4 Summary 
There is scope for continued clinically relevant research in exercise for young 
people with CP using high-quality study design, and this will contribute to the 
evidence for effective care and treatment options for those with CP. So far, 
however, there is limited evidence with regard to the effects of a pragmatic 
community exercise programme for young people with CP beyond the age of 
16 in the UK. The majority of the existing research studies paid more 
attention to children with CP who were below 16 years of age. Therefore, the 
intervention study (Study 3, Chapter 7) sought to address the gaps in the 
literature, that is, by conducting an exercise programme targeting individuals 
with CP between 16 and 25 years of age, a follow-up assessment following 
completion of the programme, using a large sample size and implementing 
the programme at a community leisure centre. 
 
The next section (2.4) will provide a literature background to the OMs used in 
the test-retest Study 2 (Chapter 5) and intervention Study 3 (Chapter 7). 
 
 
2.4 Outcome measures to be used in exercise intervention studies 
involving young people with cerebral palsy 
There are many OMs used in clinical and research settings when assessing 
people with CP as well as evaluating the effects of exercise intervention in 
this population. This section will explore the basic concept of the 
psychometric properties of OMs followed by the relevance of the OMs with 
regard to the International Classification and Functioning (ICF) (World Health 
Organization 2007). Then, the description, validity and reliability, feasibility 
and future work of the OMs chosen for this thesis will be discussed in detail. 
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2.4.1 Psychometric properties of outcome measures – A basic concept 
To objectively measure the impact of an exercise intervention, quantitative 
measurement is commonly used. There are a number of ways to achieve 
this; for example, performance-based tests, instrumental tools or self-
reported questionnaires (Patient Reported Outcome measures or PROMS). 
Apart from being valid, reliable and responsive to change, OMs must 
demonstrate their practicality (feasibility) when used in clinical or research 
settings where appropriate. The elements that contribute to the statistical 
adequacy of an instrument in terms of its reliability, validity, measurement 
error, responsiveness and internal consistency are known as its 
psychometric properties. Clinimetrics is a measurement of patients through 
clinical data involving scales, indexes and quantitative instruments (Gabel et 
al. 2012). 
 
2.4.1.1 Reliability 
According to Mokkink et al. (2013), reliability is the extent to which scores for 
patients who have not changed are the same across repeated 
measurements. Within the reliability domain there are several psychometric 
properties, which are: test-retest, inter-rater reliability, intra-rater reliability, 
measurement error and internal consistency. When the consistency of an OM 
is compared over time it is known as the test-retest reliability. Inter-rater 
reliability is established when comparing the outcome by different raters on 
the same occasion. Intra-rater reliability is assessed when comparing the 
results from the same rater on different occasions. Intraclass correlation 
(ICC) and weighted Cohen’s Kappa are the most common and appropriate 
statistical parameters used for continuous and ordinal scores, respectively, to 
assess ‘consistency’ when investigating the test-retest, inter-rater reliability 
and intra-rater reliability of a particular OM (Terwee et al. 2007). An ICC 
value >0.75 indicates good reliability, 0.50–0.75 indicates moderate test-
retest reliability and <0.50 represents poor test-retest reliability (Portney 
2000). According to Streiner and Norman (2008), Pearson correlation is not 
suitable for use as it measures the linear relationship and not systematic 
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differences. Measurement error, a measure of ‘agreement’, is the systematic 
and random error of a patient’s score that is not attributed to true changes in 
the construct to be measured (Mokkink et al. 2013). Examples of indices of 
measurement error are standard error of measurement (SEM) (Stratford 
1989), minimum detectable change (MDC) and limit of agreement (Bland and 
Altman 2007). Internal consistency is the degree of the interrelatedness 
among the items of an instrument, which is mostly relevant for 
questionnaires. Cronbach’s alpha is an adequate parameter to express 
internal consistency (Terwee et al. 2007). 
 
2.4.1.2 Validity  
Apart from reliability, another important psychometric property of an OM that 
should be established is its validity. Validity can be divided into content, 
construct and criterion (Mokkink et al. 2013). Content validity is relevant to 
questionnaires as it examines the extent to which the concepts of interest are 
comprehensively represented by the items in the questionnaire (Guyatt 
1993). There is no statistical parameter with which to measure content 
validity; however, according to Terwee et al. (2007), questionnaires should 
provide the measurement aim, target population, the concepts that are being 
measured and the item selection. In addition, the target population should 
have been involved during item selection, as well as either investigators or 
experts to establish content validity. The degree to which the scores of OMs 
are consistent with the hypotheses (for instance, with regard to internal 
relationships, relationships to scores of other instruments or the differences 
between relevant groups) is known as construct validity (Mokkink et al. 
2012). The Pearson correlation coefficient (r) is the parameter used to 
represent correlation. The strength of the correlation is regarded as small if r 
has a value in the range 0.1– 0.3, moderate if r falls within 0.3–0.5 and strong 
if r is within the range 0.5–1.0 (Portney and Watkins 2000). Criterion validity 
refers to the extent to which the scores on a particular instrument relate to a 
gold standard (Terwee et al. 2007). 
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2.4.1.3 Responsiveness 
Responsiveness is defined as the ability of an OM such as a questionnaire to 
detect clinically important changes over time, even if these changes are small 
(Guyatt et al. 1989). Terwee et al. (2003) suggested that responsiveness is a 
measure of longitudinal validity. Analogous to construct validity, longitudinal 
validity should be assessed by testing predefined hypotheses, e.g. about 
expected correlations between changes in measures, or expected 
differences in changes between ‘known’ groups (Terwee et al. 2003). This 
shows the ability of an OM to whether changes really taken place. 
Furthermore, the OM should be able to distinguish clinically important change 
from measurement error. There are various statistical approaches to 
calculating responsiveness (Crosby et al. 2003). According to Mokkink et al. 
(2013), the standardised response mean and effect size of the OM under 
investigation are inadequate to calculate responsiveness as they measure 
the effectiveness of the intervention rather than the quality of these 
measurement properties. Instead, these authors recommended analysing the 
correlation coefficients between the OM under investigation against another 
established OM (often the gold standard and ideally a patient-reported 
questionnaire) or by calculating the Receiver Operating Curve (ROC) to 
calculate the sensitivity or specificity of the OM in question. 
 
The parameter used to express responsiveness is the Minimum Clinically 
Important Difference (MCID). Any amount of change greater than the MCID 
threshold is considered to be clinically meaningful or important. The MCID is 
a concept that is more clinically oriented and is focused at the level of the 
individual patient. These concepts are important given that statistically 
significant change at the group level may not be clinically significant at the 
individual level, or vice versa. Further, average effects across a group may 
not be meaningful to interpret the degree of change in an individual patient 
(Schmitt and Di Fabio 2004, Guyatt et al. 2002). The anchor-based approach 
is the method recommended to quantify MCID (de vet et al. 2006). In the 
anchor-based approach, the magnitude of change in the OM under 
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investigation is compared with a more established OM or patient-perceived 
change in health status following the treatment. In the distribution-based 
approach, the variability of the OM itself is calculated, and this could be done 
by calculating the SEM or effect size of the score distribution (Jaeschke et al. 
1989). 
 
2.4.2 Outcome measure – linked with International Classification of 
Functioning 
The outcome measures (OMs) chosen in the current study can be 
categorised using the International Classification of Functioning (ICF) (World 
Health Organization 2007). The ICF is a model for describing health-related 
conditions and their impact on the individual. Moreover, it provides a 
universal framework for defining and classifying functioning and disability with 
its domains; body function and structures, activities and participation, as well 
as contextual factors (World Health Organization 2007). Comprehensive core 
sets of categories based on the ICF domains have been established for CP 
in patients aged 0 to 18 years. The ICF core sets for CP highlights the ‘what’ 
to measure and could be used to guide the clinician and researcher when 
assessing their CP client. The selection of the core set to be used will vary 
depending upon the intended purpose and setting. This means that the 
choices of OMs to be used can be variable when measuring the outcome in 
people with CP. It was also suggested that the selection of appropriate OMs 
depends on several factors, as follows: 1) the research questions, 2) the type 
of intervention, 3) the content and psychometric properties of the OMs, and 
4) the characteristics of the target population, for example, age (Schiariti et 
al. 2014). Hence, the current study has considered those factors when 
choosing the OMs to be used in the intervention study (Chapter 7). The OMs 
used in the exercise intervention study in relation to ICF are shown in Table 
2.7. The details of each OM inclusive of psychometric properties, rationale 
and content will be explained in the next section. 
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Table 2.7 Outcome measures used in this study 
ICF domains Code ICF category name Outcome measures used in 
this study 
Body functions b455 Exercise tolerance 
functions 
Shuttle Run test 
b710 Mobility of joint 
functions 
Photographic passive range of 
motion 
b730 Muscle power 
functions 
Isometric muscle strength 
b770 Gait pattern functions Three-Dimensional Gait Analysis 
Activity and 
participation 
d4 Mobility Gross Motor Function Measure 
Gillette Functional Assessment 
Questionnaire  
Canadian Occupational 
Performance Measure  
Objective Habitual Physical 
Activity (ActivPALtm) 
d450 Walking Timed Up Go test 
d9 Community, social 
and civic life 
Canadian Occupational 
Participation Measure 
Short Form 12 
Personal 
factors 
- - Rosenberg Self-Esteem Scale 
 
2.4.3 Outcome measures used in this study 
Previous studies have used many different OMs to measure the effects of an 
exercise programme, as shown in Table 2.8. These vary in terms of the 
construct measured, their psychometric properties and their feasibility of use 
in either clinical practice or a research setting. A discussion on the different 
OMs used in Study 3 (Chapter 7) and, where relevant, other similar OMs in 
past studies, will follow. The reader is also referred to section 2.3 and Tables 
2.4–2.6, where the previous exercise studies and the OMs used can also be 
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found. If studies evaluated the same outcome measure and were sufficiently 
homogenous (i.e. study population, design, measurement procedure, rating), 
their overall evidence was rated on the basis of the Cochrane Back Review 
Group Criteria as ‘strong’, ‘moderate’, ‘limited’, ‘conflicting’ or ‘unknown’ (van 
Tulder et al. 1976). The details of the Cochrane Back Review Group Criteria 
are as follows: 
a. strong – consistent findings in multiple studies of good methodological 
quality OR in one study of excellent methodological quality 
b. moderate – consistent findings in multiple studies of fair methodological 
quality OR in one study of good methodological quality 
c. limited – one study of fair methodological quality  
d. conflicting – conflicting findings 
e. unknown – only studies of poor methodologies. 
 
Table 2.8 List of outcome measures used in adolescents and young adults with 
cerebral palsy in previous exercise studies 
ICF 
domain  
Parameter/ 
Construct 
Outcome measures References of studies in which OM is 
used 
B
o
d
y
 f
u
n
c
ti
o
n
s
 
Aerobic capacity Oxygen uptake Lunderberg et al. (1967), Berg (1970), 
Shinohara et al. (2002), 
 10-m shuttle run test Verschuren et al. (2007) 
 VO2 max (maximum oxygen 
uptake) 
Unnithan et al. (2007), Slaman et al. 
(2014a) 
Anaerobic capacity Muscle power sprint test Verschuren et al. (2007) 
Muscle strength Dynamometry 
(manual or instrumented)  
MacPhail and Kramer (1995), Dodd et al. 
(2003), Eagleton et al. (2004), Taylor et al. 
(2013), Schlough et al. (2005), Darrah et 
al. (1995), Slaman et al. (2014a) 
Flexibility Sit and reach test Darrah et al. (1995) 
Range of motion Goniometer Healy (1958) 
Muscle tone Modified Ashworth Scale MacPhail and Kramer (1995), Patikas et al. 
(2006) 
Gait kinematics  Gait Profile Score Unger et al. (2006), Patikas et al. (2006) 
Taylor et al. (2013), 
A
c
ti
v
it
y
 a
n
d
 p
a
rt
ic
ip
a
ti
o
n
 
Gross motor function Gross Motor Function 
Measure 
MacPhail and Kramer (1995), Patikas et al. 
(2006), Taylor et al. (2013), Schlough et al. 
(2005), Unnithan et al. (2007), Verschuren 
et al. (2007), Slaman et al. (2014b) 
Cadence Visual observation Eagleton et al. (2004) 
Walking efficiency Energy expenditure index MacPhail and Kramer (1995), Eagleton et 
al. (2004), Schlough et al. (2005), Darrah 
et al. (1995), Patikas et al. (2006), 
Walking speed over 
short distance 
Self-selected walking speed Dodd et al. (2003) 
Walking speed in 
endurance test 
6-minute walk test Taylor et al. (2013) 
Functional capacity in 
Activities daily living 
Time stair test Dodd et al. (2003) 
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ICF 
domain  
Parameter/ 
Construct 
Outcome measures References of studies in which OM is 
used 
Functional mobility Functional Mobility Scale Taylor et al. (2013) 
 Functional Assessment 
Questionnaire 
Taylor et al. (2013) 
Physical activity and 
sedentary time 
Body-fixed accelerometer Slaman et al. (2015) 
Self-reported physical 
activity 
The physical activity Scale 
for Individuals with Physical 
Disabilities 
Slaman et al. (2015) 
Participation The CAPE Verschuren et al. (2007) 
 Life-H Slaman et al. (2014b) 
Quality of life TACQOL Verschuren et al. (2007) 
 PedsQOL Engsberg et al. (2006) 
 SF36 Slaman et al. (2014b) 
Fatigue Fatigue Subscale 
Fatigue Severity Scale 
Slaman et al. (2014b) 
P
e
rs
o
n
a
l 
fa
c
to
rs
 
Self-perception Self-perception 
Questionnaire 
Unger et al. (2006) 
 Self-perception profile Schlough et al. (2005), Darrah et al. 
(1995), Verschuren et al. (2007), Dodd et 
al. (2004) 
 Perception on body image, 
functional performance, 
social participation (semi-
structured interview) 
McBurney et al. (2003) 
CAPE; Children Assessment of Participation and Enjoyment, Life H; Assessment of life habits, 
PedsQoL; Pediatric Quality of life inventory, SF36; Short form 36, TACQOL;TNO-AZL (Netherlands 
Organisation for Applied Scientific Research Academic Medical Centre) Children’s Quality of Life 
questionnaire 
 
 
2.4.3.1 Isometric muscle strength 
Muscle weakness is common in CP (Malaiya et al. 2007, Lampe et al. 2006, 
Thompson et al. 2011). Decreased muscle strength in children with CP is 
often complicated by other factors such as spasticity (Ross and Engsberg 
2007a) and can lead to joint contractures that cause pain and fatigue (Vogtle 
et al 2013), limitations in walking (Desloovere et al. 2006, Ross and 
Engsberg 2007b) and reduced functional activity (Damiano and Abel 1998). 
 
Previous CP studies mostly used a handheld dynamometer to detect 
changes in muscle strength post exercise training (McPhail and Kramer 
1995, Dodd et al. 2003, Eagleton et al. 2004, Taylor et al. 2013, Schlough 
2005, Darrah et al. 1995). However, the measurements obtained when using 
a handheld dynamometer are dependent on the strength of the assessor. 
Alternatively, a fixed digital dynamometer allows the assessor to securely 
attach one end to a fixation point, thus removing the need for the assessor to 
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resist the muscle force. The fixed digital dynamometer has been used 
previously in children and adolescents with CP and has been found to be 
able to measure difference in muscle strength between ambulant CP children 
and their healthy peers (Thompson et al. 2011). An alternative method for 
measuring muscle strength lies in the use of sophisticated isokinetic testing 
equipment; however, this is expensive and is often not available in clinical 
and research settings (Berg‐Emons et al. 1996).  
 
Validity and reliability of handheld and fixed digital dynamometer  
The reliability of the handheld dynamometer for measuring isometric strength 
has been reported in a study of participants with brain injury (Riddle et al. 
1989). In particular, Riddle et al. (1989) reported good consistency, with an 
ICC of 0.9–0.96 (95% CI was not reported). It was also found to be reliable in 
healthy and CP children with ICCs of 0.84 (95% CI was not reported) (knee 
extensors) and 0.79 (hip extensor) (Seniorou et al. 2002). The test-retest 
reliability of the measurement of gluteus maximus strength using a fixed 
digital dynamometer was found to be good in a group of CP patients aged 6–
14 years with ICCs ranging from 0.75 to 0.83 (95% CI was not reported) (van 
der Linden et al. 2004). The correlation between a fixed handheld 
dynamometer and isokinetic dynamometer for isometric knee extensor 
strength was found to be strong (r=0.806, p<0.05) in a normal adult 
population (Kim et al. 2014). The study also found that the inter-rater and 
intra-rater reliabilities of the fixed handheld dynamometer were high, with 
ICCs ranging from 0.95 to 0.98 for knee extensor strength (Kim et al. 2014). 
 
Feasibility 
Standardised protocols are important when assessing the efficacy of 
treatment. Therefore, for Study 2 (Chapter 5) and Study 3 (Chapter 7), the 
protocol outlined by Thompson et al. (2011), the myometer (MIE Medical 
Research Ltd), was used. 
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Future work 
There is moderate evidence regarding the reliability of the fixed digital 
dynamometer in children with CP; however, this is not the case for 
adolescents. Therefore, isometric muscle testing using a fixed digital 
dynamometer was chosen for the test-retest reliability study (Study 2, 
Chapter 5) and the exercise intervention in Study 3 (Chapter 7), in order to 
address the gap in the present evidence. 
 
2.4.3.2 10m Shuttle Run Test (SRT) 
Aerobic capacity is defined as the ability to deliver oxygen to the muscles and 
to utilise it to produce energy during exercise (Armstrong and Welsman 
2007). High levels of aerobic capacity are shown to prevent health problems 
as a result of inactivity (Armstrong and Welsman 2007, Carnethon et al. 
2005), increase participation (Majnemer et al. 2008) and facilitate the 
completion of activities of daily living (Bjornson et al. 2008).   
 
Verschuren et al. (2007) used an adapted 10m shuttle walk/run test (10m 
SRT) to measure aerobic capacity in their study, including that of children 
and adolescents with CP. The usage of the 10m SRT is a more economical 
and practical method of assessing maximum aerobic capacity compared to 
the use of a treadmill in laboratory tests. 
 
The SRT was originally developed by Leger et al. (1988) to measure aerobic 
fitness in healthy adults. Verschuren et al. (2006) made some modifications 
to the SRT, specifically to measure aerobic fitness in children and 
adolescents with CP GMFCS levels I and II and, later, level III (Verschuren et 
al. 2011). This modification for CP requires participants to walk/run/jog 
between two markers that are 10m apart, compared to the original SRT in 
which the markers are 20m apart. The participants all walk/run/jog at the 
same time, using a pre-recorded bleep sound played from a standard audio 
compact disc (CD) player. The audio CD for those with GMFCS I and II is 
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different in terms of the starting speed; however, it has the same increment 
rate of 0.25km/hour approximately every minute. Participants with GMFCS 
level I start at 5km/hour while those with GMFCS level II begin at 2km/hour. 
Participants with GMFCS level III using the same audio CD as those with 
GMFCS II; however, these participants are required to walk/run/jog along the 
sides of a 7.5-metre square (thus requiring only a 90o rather than a 180o turn 
at each bleep) (Verschuren et al. 2011). At the end of each level, the 
participants are instructed to go a bit faster. The test ends if the participants 
are unable to keep going or fail to reach the next marker before the next 
bleep twice in a row. 
 
Validity and reliability 
The validity and reliability of the 10 m SRT in participants with CP aged 7–17 
GMFCS I and II have been reported by Verschuren et al. (2006). The authors 
reported that the test-retest reliability of peak heart rate derived from the 10m 
SRT was good, with ICCs of 0.97 and 0.94 (95% CI was not reported) for 
those with GMFCS I and II, respectively. The test-retest reliability in GMFCS 
III was also found to be good, with an ICC of 0.98. In terms of validity, peak 
oxygen uptake (VO2max) obtained from the 10m SRT and from a graded 
treadmill showed a strong correlation (r=0.96, p<0.01) for children with both 
GMFCS I and II (Verschuren et al. 2006). 
 
Feasibility 
The 10m SRT is a practical and preferable method to the measure estimation 
of maximal oxygen uptake using a treadmill (Verschuren et al. 2006). It 
requires space for a greater than 10m run/walkway and also for the 
participants to make a turn for the next walk or run. The only other equipment 
required are a CD and CD player (Verschuren et al. 2006) and two or four 
markers (i.e. cones) to mark the distances for GMFCS I/II or GMFCS III, 
respectively.  
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Further work 
There is limited evidence regarding the reliability of the 10m SRT in young 
people aged >16 years with CP as so far only one reliability study has been 
reported in children with CP aged 7–17. Thus, the test-retest reliability of the 
10m SRT was assessed as part of Study 2 (Chapter 5) and the exercise 
intervention in Study 3 (Chapter 7).  
 
2.4.3.3 Timed Up and Go Test 
The Timed Up and Go test (TUG) was originally designed to measure 
functional mobility in the elderly population (Podsiadlo and Richardson 1991). 
The TUG is a very simple and easy test that requires participants to stand up 
from a chair and walk at a normal pace around a cone that is placed 3 metres 
from the chair, prior to returning and sitting back on the same chair. The time 
taken to complete the test is recorded using a standardised digital timer. 
 
Validity and reliability 
Williams et al. (2005) found good consistency of the TUG, with an ICC of 
0.99 (95% CI 0.91–0.99), in a study of 33 participants with CP aged 3 to 19 
years. The study also found moderate negative correlation between TUG and 
GMFM (rho=-0.524, p=0.012). In addition, they found that TUG scores 
differed between young people with CP classified at GMFCS I, II and III. 
Similarly, Dhote Sanjivani (2012) reported a good ICC (0.99) (95% CI was 
not reported) in test-retest reliability in a study of children with CP aged 4–12 
years. 
 
Feasibility 
A very easy, simple and quick test to measure functional mobility with 
minimal equipment and space is needed. Equipment required: a chair with 
arm support, timer and cone (to mark the 3-metre distance). 
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Further work 
There is moderate evidence as to the psychometric properties of TUG in 
populations with CP; hence, further work on the reliability and validity of the 
TUG across the age range in CP is required. To confirm the results of 
previous work on the reliability of the TUG in adolescents with CP, the TUG 
was included in Study 2 (Chapter 5). The TUG is also utilised in the exercise 
intervention in Study 3 (Chapter 7). 
 
2.4.3.4 Three-Dimensional Gait Analysis 
Gait is the pattern movement of the limbs in humans during locomotion. Gait 
analysis provides a useful understanding of basic walking ability and 
abnormalities in pathological gait. There are various methods of gait analysis, 
comprising visual observation, video recording and computerised 3DGA 
(Levine et al. 2012). Visual gait analysis has several disadvantages as there 
is no permanent record; it thus depends on the skills of the observer and is 
subjective, which sometimes gives rise to bias if the observer is non-blind to 
the patient’s history. However, it should be acknowledged that visual gait 
analysis is beneficial in a clinical setting as there is no additional cost, space 
or time involved. Video-based observation allows the clinician to record the 
patient’s walking and thus overcome the issue of the lack of a permanent 
record and the difficulty of observing high-speed events. Several OMs can be 
used to score video-based observation, including the Edinburgh Visual Gait 
Score, Physician Rating Scale and Visual Gait Assessment Score, and 
produce outcomes in the coronal and sagittal planes during the swing and 
stance phase. In order to understand more complex gait pathologies or gain 
insight into the underlying mechanisms of abnormal patterns, a more 
complete motion analysis that measures kinematics and kinetics can be 
useful, and this can be achieved through the use of the 3DGA. The 3DGA 
method provides temporal-spatial parameters such as cadence, step length 
and walking velocity, in addition to kinematic (i.e. joint angles) and kinetic 
parameters (i.e. joint forces and moments) in all three planes of movement. 
Possibly the most common 3DGA system is Vicon (Oxford Metrics, Oxford, 
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United Kingdom). Other motion analysis systems that have been used in 
other CP studies are OrthoTrak (MotionAnalysis Corporation, Santa Rosa, 
CA, USA) and Optotrak (Northern Digital, Waterloo, Canada) (Mackey et al. 
2005, Grunt et al. 2010). For the current study, the Vicon 3DGA system was 
used, as the laboratory at Queen Margaret University is equipped with this 
system. 
 
Validity and reliability 
The reliability of spatial-temporal gait parameters and joint kinematics derived 
from 3DGA has been explored in many studies involving participants with CP 
(Mackey 2005, Redekop 2008, Klejman 2010, Steinwender 2000). Redekop 
et al. (2008) investigated test-retest reliability and reported good ICCs of 
between 0.76 and 0.84 (95% CI 0.57–0.95) for spatial-temporal gait 
parameters in children with CP with GMFCS I and a mean age of 8 years, 
one month. The test-retest results in a study of participants with CP aged 5 to 
16 showed ICCs for joint kinematics in the sagittal plane to be between 0.93 
and 0.99 (95% CI was not reported) (Mackey et al. 2005). A study of 17 
young people with CP aged 4 to 14 revealed that the intra-rater reliability of 
sagittal kinematics ranged between moderate and good (ICCs 0.58–0.99) 
(95% CI was not reported) and inter-rater reliability was between poor and 
good (ICCs 0.48–0.99; 95% CI was not reported) (Grunt et al. 2011). The 
means and standard deviations of coefficient of variation percentage for the 
cadence, stride length within days, were reported to be 3.9 (2.8)%, 6.6 
(4.6)% and 5.0 (3.4)% respectively in a study of 20 children with spastic 
diplegic between the ages of 7 and 15 years (Steinwender et al. 2000). A full 
appraisal of the psychometric properties of the 3DGA used in young people 
with CP are discussed in Study 1 (Chapter 4). 
 
Feasibility 
Measurement of joint kinematics, joint kinetics and spatial-temporal 
parameters using 3DGA systems produces quantitative data on gait patterns 
which other walking tests such as visual and video-based observations 
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cannot produce. However, the set-up (marker placement especially) is time-
consuming and training/familiarisation with the equipment is needed. Since 
QMU has a Vicon motion-analysis system, 3DGA was used for gait analysis 
in Study 3 (Chapter 7). 
 
Future work 
Clearly, the literature showed that there is strong evidence regarding the 
reliability of 3DGA. To further strengthen the current evidence, joint 
kinematics, as derived from 3DGA, will be included in Study 3 (Chapter 5). 
 
2.4.3.5 Gross Motor Function Measure 66 
Dimensions D and E in the GMFM represent areas that many young people 
with CP who are able to walk have difficulty with (Damiano et al. 1995). 
Unsurprisingly, most of the previous exercise intervention studies chose 
these dimensions when assessing their participants’ gross motor function 
(MacPhail and Kramer 1995, Patikas et al. 2006, Taylor et al. 2013, Schlough 
2005, Unnithan et al. 2007, Verschuren et al. 2007). Well-established 
protocols for administering the GMFM, as well as training material on how to 
score the measure, can be found in the user’s manual (Russell et al. 2002). 
Scores are presented as percentages. Separate scores can be calculated for 
each of the five dimensions as well as for the total scores (Russell et al. 
2002). Although the GMFM has been validated for use with patients with CP 
aged 4–18 years, it has also been used in an exercise study of CP with 
participants aged 25–47 (Andersson et al. 2003).  
 
The GMFM has been widely used in CP exercise intervention studies 
(MacPhail and Kramer 1995, Patikas et al. 2006, Taylor et al. 2013, Schlough 
2005, Unnithan et al. 2007, Verschuren et al. 2007). It is used to measure the 
change in gross motor function in children with CP (Russell et al. 2002). 
GMFM has five dimensions, as follows: (A) lying and rolling, (B) sitting, (C) 
crawling & kneeling, (D) standing, and (E) walking, running and jumping. 
Items are scored using a four-point Likert scale (0, could not initiate task; 1, 
64 
  
initiated task (<10% of task); 2, partially completed task (10 to <100%); 3, 
completed task). GMFM 66 is the most recent version and comprises 66 
items and is only suitable for use with children with CP (Russell et al. 2002). 
The original version, known as the GMFM 88, contains 88 items and has 
been validated for children with CP and Down’s syndrome (Russell et al. 
2009). It can also be used in children with osteogenesis imperfecta and acute 
lymphatic leukaemia (Russell et al. 2009). The differences between the 
GMFM 66 and 88 were described in a study of a group of children with CP 
who underwent a selective dorsal rhizotomy operation (Josenby et al. 2009). 
This study revealed that the total scores for the GMFM 88 indicated large 
changes in motor function sooner after the surgery in comparison with the 
GMFM 66 scores in children with GMFCS levels I–III and IV–V (Josenby et 
al. 2009).  
 
Validity and reliability 
The GMFM has been shown to be valid, reliable and responsive through a 
number of studies looking at motor status in CP, and to be able to quantify 
changes over time or as a result of intervention (Vos-Vromans et al. 2005, 
Russell et al. 2010, Nordmark et al. 2000, Oeffinger 2008). Bjornson et al. 
(2000), in a study of 21 participants with CP aged 4 to 18 years, reported that 
the ICC of the test-retest was good (0.99) (95% CI was not reported) for 
dimensions D and E. In a different study, the inter-rater reliability (ICC) was 
also found to be 0.99 (good) (95% CI 0.99) and the correlation between 
GMFM and video-based evaluation was strong (r=0.82, p<0.05) (Russell et 
al. 2012). Moderate correlation (r=0.42 and 0.43, p<0.05) between GMFM 
dimensions D and E and global rating scale for parents was reported in 
children with CP greater than 4 years of age. In addition, the effect size was 
moderate (0.47 and 0.67) in dimensions D and E respectively (Vos-Vromans 
et al. 2005).  
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Feasibility 
The GMFM 66 is very easy to administer, although it can be time-consuming. 
It can take approximately 45 to 60 minutes for someone familiar with the 
measure to complete, depending on the skill of the assessor, the ability level 
of the participant and the participant’s level of cooperation and 
understanding. The GMFM user manual provides very clear instructions on 
how to use it. As our participants were ambulant CP patients, we tested them 
only for dimensions D (standing) and E (walking, running and jumping) 
(Appendix 1). 
 
Future work 
The previous literature has shown there is strong evidence of the GMFM’s 
reliability; however, only one study included adolescents, with the majority of 
the studies focusing on children. Therefore, we included the GMFM 66 when 
measuring the outcome of exercise intervention in Study 3 (Chapter 7) to add 
to the currently available knowledge.  
 
2.4.3.6 Objective habitual Physical Activity  
Activity monitors are recommended since they provide more objective 
information about participants’ habitual daily physical activity. Participants 
can wear an activity monitor during their activities of daily living. Clanchy et 
al. (2011), in their review of objective measures for physical activity in 
adolescents with CP, reported HR flex, StepWatch, accelerometers and 
pedometers as the most commonly used devices among this population. 
Another activity monitor used in this population is the ActivPALTM (PAL 
Technologies Ltd, Glasgow, Scotland) (Grant et al. 2006). It is a single-unit 
monitor based on a uni-axial accelerometer. It records episodes of walking, 
standing and sitting/lying, thereby allowing the measurement of both activity 
and inactivity. In addition, the monitor records step count, instantaneous 
cadence and sit-to-stand transitions. 
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Validity and reliability 
A study in Scotland showed that ActivPALTM demonstrated excellent ability to 
distinguish between the sitting/lying and upright postures in a CP population 
(Tang et al. 2013). The Scottish study involved 15 ambulant children and 
adolescents with CP by comparing the ActivPALTM with video analysis. The 
results showed that the agreement was (mean±SD) between 97.4 ± 2.7% 
and 103.8 ± 10.1% (Tang et al. 2013). McAloon et al. (2014) compared the 
time spent standing and walking, number of steps taken and the number of 
transitions derived from the ActivPALTM with observations from video 
analysis. They found a high agreement between the two methods; the 
absolute difference between the two methods for walking time was 2.2s and 
for step counts was 3.2 steps in participants with CP hemiplegia aged 
between 4 and 18 years. ActivPALTM was also found to be valid in other 
populations, including healthy adults (Godfrey and Lyons 2007, Godfrey et al. 
2007, Ryan et al. 2006, Lyden et al. 2012, Hart et al. 2011, Harrington et al. 
2011) and other patient groups (Clarke-Moloney et al. 2007, Dahele et al. 
2007, Egerton and Brauer 2009). 
 
Feasibility 
Users of ActivPALTM require it to be attached to the front of the mid-thigh. 
The activity monitor is small in size (35 mm x 53 mm x 7 mm) and light in 
weight (20 mg). It is capable of recording time spent sitting/lying, standing 
and walking for a maximum of 10 days. 
 
Future work 
The previous literature shows there is limited evidence on the reliability of 
ActivPALTM in the CP population. Hence, ActivPALTM was included for the 
test-retest in Study 2 (Chapter 5) and the exercise intervention in Study 3 
(Chapter 7). 
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2.4.3.7 Gillette Functional Assessment Questionnaire (FAQ) 
Considering the importance of information obtained from participants and 
self-evaluation in terms of functional mobility after an exercise programme, 
the FAQ was used. The FAQ is a self-reported questionnaire with a ten-level 
classification of walking and 22 functional mobility activities on a five-level 
Likert-type difficulty scale (Appendix 2). 
 
Validity and reliability 
The inter-rater and intra-rater reliabilities of FAQ were found to be excellent 
in a CP study with good ICC (0.94, 95% CI 0.89–0.97) (Gunel et al. 2010). 
The correlation between FAQ and GMFCS was reported to be strong 
(r=0.82, p<0.01) (Gunel et al. 2010) and it was strong for the Functional 
Measure for Children (WeeFim) (r=0.64, p<0.01) (Novacheck et al. 2000). 
 
Feasibility 
The FAQ is a very simple questionnaire that includes questions on mobility 
level (one item to be selected from 10 items) and higher-level mobility skills 
that require participants to select things (it can be more than one) that they 
are able to do from a set of 15 skills (Appendix 2).  
 
Future work 
Although FAQ is widely used in the CP population, the reliability of FAQ 
among adolescents and young adults with CP is limited. Therefore, a test-
retest reliability study of FAQ was undertaken to further strengthen the 
previous findings. As such, FAQ will be included in Study 2 (Chapter 5) and 
Study 3 (Chapter 7). 
 
2.4.3.8 Canadian Occupational Participation Measure (COPM) 
The COPM is a client-centred OM (Dedding et al. 2004) as it requires 
participants to identify and prioritise problems that they encounter within their 
daily living activities and then rate their ‘performance’ and ‘satisfaction’ with 
regard to those identified activities. It is a 10-point scale with a ‘performance’ 
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rating that ranges from ‘not able to do it at all’ to ‘able to do it extremely well’ 
and a ‘satisfaction’ rating from ‘not satisfied at all’ to ‘extremely satisfied’ 
(Appendix 3). 
 
Validity and reliability 
The test-retest reliability of COPM has been found to be strong in two 
different studies looking at chronic obstructive pulmonary disease (r=0.76, 
p<0.01) and stroke patients (r=0.89, p<0.01) (Sewell and Singh 2001, Cup et 
al. 2003). The sensitivity of COPM was reported to be medium, with effect 
sizes of 0.78 and 0.69 for performance and satisfaction, respectively, in a 
group of 41 children with spastic hemiplegic CP three months post the 
occupational therapy intervention programme (Cusick et al. 2006). 
 
Feasibility 
It is easy to administer and provide flexible, consistent, individualised 
measures that accommodate the diverse aims of participants and exercise 
intervention. It may be time-consuming, especially for a first-time 
administrator (usually for the reassessment); however, over time it will 
become quicker as the participants become familiar with it. 
 
Future work 
Clearly, the reliability and validity of COPM in the CP population are unknown 
and limited, respectively. More high-quality psychometric properties are 
needed and, therefore, the COPM was included in the exercise intervention 
in Study 3 (Chapter 7) to fill in this gap in the knowledge. 
 
2.4.3.9 Short Form 12 version 2 (SF-12 v2) 
SF-12 v2 was used to assess the quality of life and health status of the 
participants in this study. This 12-item survey is a shortened version of the 
SF-36 (Ware et al. 1996). SF-12 v2 is a measure of general health status and 
measures eight domains of functioning and well-being: physical functioning, 
role limitations due to physical problems, bodily pain, general health 
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perceptions, energy and vitality, social functioning, role limitations due to 
emotional problems, and mental health (Ware et al. 1996). The physical and 
mental component scores (PCS and MCS) can be derived from the SF-12. 
The SF-36 has been used in previous studies that have included adults with 
CP (Jahnsen et al. 2004b, Opheim et al. 2009). 
 
Validity and reliability 
Cheak-Zamora et al. (2009) conducted a reliability and validity study of the 
SF-12 in the general population. The internal consistency of SF-12 was high 
(Cronbach’s alpha 0.80) and the test-retest reliability for the PCS was also 
high (ICC=0.78) and moderate for the MCS (ICC=0.60) (95% CI was not 
reported). The correlation between the EuroQoL-5 dimension and PCS was 
strong (r=0.56, p<0.01) and moderate (r=0.38, p<0.01) with MCS (Cheak-
Zamora et al. 2009). The SF-12 has been used in different CP studies for 
participants with ages ranging from 18 to 72 years (Jahnsen et al. 2004b, 
Vogtle et al. 2014, Schwartz et al. 1999). 
 
Feasibility 
It is very easy to administer with only 12 questions and requires minimal time 
for the participants to fill in the questionnaire (Appendix 4). 
 
Future work 
Although it has been implemented in many studies, the reliability of the SF-12 
is unknown in CP populations. Therefore, the test-retest reliability of the SF-
12 in young people with CP will be explored; hence, it was included in Study 
2 (Chapter 5) and Study 3 (Chapter 7). 
 
2.4.3.10 Rosenberg Self-Esteem Scale (RSES) 
According to the ICF, all the domains in this model have dynamic 
interactions, including personal factors and those that can influence the 
disability and health of a person (World Health Organization 2008). Personal 
factors can relate to age, gender, self-esteem and coping style. Self-esteem 
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is defined as how one feels about oneself (Mayberry 1990). It is believed to 
be associated with effective functioning (Gurney 1988) and personal 
satisfaction (Coopersmith 1967), and understanding this aspect is crucial in 
planning and exploring the effectiveness of interventions for people with CP. 
Exercise has been reported to improve self-esteem and self-confidence in 
both non-disabled children and adolescents (Ekeland et al. 2005) and young 
people with CP (Unnithan et al. 2006). The RSES is a scale developed to 
measure self-esteem and was originally tested on 5,024 high school students 
from 10 different schools in the US (Crandal 1973, Rosenberg 1965).  
 
Validity and reliability 
The internal consistency (Cronbach’s alpha) of the RSES was reported to be 
0.84 in a study of 50 children aged 9 to 18 years with CP (Manuel et al. 
2003). The RSES has also been found to be valid among adolescents and 
young adults within the healthy population (Scheier et al. 1994). An RCT 
conducted with a group of elderly participants (mean age of 69.6) showed 
that the RSES of the intervention group improved following a 16-week group 
exercise programme (Sung 2009). 
 
Feasibility 
The RSES is a simple questionnaire comprising 10 questions asking about 
general feelings and scored on a four-point Likert scale containing ‘strongly 
agree’, ‘agree’, ‘disagree’ and ‘strongly disagree’ (Appendix 5).  
 
Future work 
There is unknown evidence regarding the reliability of the RSES in young 
people with CP. To establish this, RSES was included in the test-retest in 
Study 2 (Chapter 5) and the exercise intervention in Study 3 (Chapter 7).  
 
2.4.4 Summary  
By reflecting on the OMs used in previous exercise studies, it is clear that 
there are many OMs available for use in assessing the effectiveness of 
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exercise programmes in young people with CP. As such, they provide 
information that can be used to guide clinicians regarding the outcome of 
rehabilitation programmes, including in the prescription of exercise for their 
patients. 
 
For the purposes of Study 3 (Chapter 7), outcomes were chosen which would 
gather data on the ‘body structures and function’, ‘activity’, ‘participation’ and 
‘contextual factors’ of the participants in accordance with the ICF model. OMs 
that had been evaluated for at least some of their psychometric properties 
were chosen to capture the wide range of areas that the proposed 
intervention sought to address. 
 
Several systematic reviews of the psychometric properties of tools that 
measure different aspects of function in populations with CP have been 
published; for example, balance (Saether et al. 2013), quality of life (Carlon 
et al. 2010) and daily living activity (James et al. 2013). However, up to now 
there has been no systematic review conducted to look into the psychometric 
properties of OMs that assess gait quality and walking performance in young 
people with CP. Such a review would provide both the clinician and 
researcher with essential information regarding the reliability, validity and 
responsiveness of the measures used for gait quality and walking 
performance in young people with CP, and this would perhaps assist them in 
their choice of appropriate OMs to evaluate the management of their patients 
or the efficacy of an exercise intervention in research studies. Therefore, a 
systematic review of the psychometric properties of the measures used for 
gait and walking performance in young people with CP was undertaken for 
Study 1 (Chapter 4). 
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CHAPTER 3 GENERAL METHODOLOGY 
3.1 Introduction 
This chapter contains information regarding the methods and outcome 
measures used in Study 2 (test-retest reliability study, Chapter 5) and Study 
3 (intervention study, Chapter 7). The protocols for both studies are 
described in their respective chapters (5 and 7). The psychometric properties 
of the main outcome measures have been discussed in the background 
chapter (Chapter 2), section 2.4.  
 
3.2 Anthropometric measures 
The anthropometric data measured includes body height (to the nearest 
centimetre) and body mass (to the nearest gram). Height was measured 
using a SECA height scale with the participant standing barefoot in the 
anatomical position against a wall. Body mass was measured using SECA 
scales with the participant barefoot in minimal clothing. Both of these 
measures were recorded for Studies 2 and 3. For Study 3, knee width (mm), 
ankle width (mm), leg length (mm) and tibial torsion (degrees) were also 
measured (Table 3.1). All of the above anthropometric measures were 
required for inputting into the Vicon Plug-In-Gait model. Regarding Study 2, 
no 3D motion analysis was performed; only body height and body mass were 
recorded for this study. Table 3.1 shows the details on how to measure knee, 
ankle width and tibial torsion. 
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Table 3.1 Details on the measurement of knee width, malleolar width, leg length and 
tibial torsion 
 
Knee width 
 
Measured between the medial and lateral epicondyles using  
large sliding callipers and applying gentle pressure. 
Malleolar 
width 
Measured between the medial and lateral malleoli using large sliding 
callipers and applying gentle pressure. 
Leg length When full knee extension is possible: Position the patient supine on 
the plinth with the pelvis as straight as possible. The trunk should be 
straight, head midline, arms by sides. The patient should not lift the 
head during measuring. Measured from the ASIS (press the end of 
the tape up against the underside of the ASIS) to the distal end of the 
medial malleolus.  
When significant knee deformity exists: Measured from ASIS to 
medial malleolus but via the medial condyle. Apply this method to 
both sides. 
Tibial 
Torsion 
(transmalle
olar axis) 
Footprint method (Hazlewood et al. 2007): 
 P
lace the foot on a sheet of lined paper, with the knee axis 
parallel with the lines. The thigh should line up with long axis 
of the paper, with the tibial tubercle pointing forward. When the 
knee is flexed and extended, the foot should stay aligned with 
the long axis of the paper. 
 D
raw round the foot 
 w
ith a set square; mark a point vertically below the middle of 
each malleolus. 
 R
emove the paper and draw a line through the two points 
marking the malleoli–ankle axis.  
 M
easure the angle between the ankle axis and any of the lines 
on the sheet of paper; this is the angle of the transmalleolar 
axis. 
 E
xternal rotation of the foot (most common) is entered as a 
negative value in Vicon. 
ASIS; anterior superior iliac spine 
 
3.3 10m Shuttle run test (Studies 2 and 3) 
Aerobic fitness was assessed using an adapted 10m shuttle run/walk test 
(10m SRT) as described by Verschuren et al. (2006). During the SRT 
participants walked/jogged/ran between two cones. They were instructed to 
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have arrived at the end of a ‘shuttle’ by the time the audio CD gave a bleep. 
For each level the time between the bleeps was reduced and the participants 
therefore had to increase their speed accordingly. If the participants were 
having trouble understanding the concept or adjusting their speed, the 
researcher ran the shuttles with them until they were comfortable with the 
concept. The 10m SRT was continued until the participants were unable to 
keep up with the pace of the bleeps, i.e. they failed to reach the cone before 
the next bleep. The participants were given the opportunity to ‘catch up’ on 
the next bleep if they failed to reach the end of one shuttle in time for the 
bleep. However, the test was ended if two consecutive shuttles were missed. 
The version of the 10m SRT used depended on the GMFCS level of the 
participant. Those classified at GMFCS levels I and II walked/ran between 
two markers set 10 metres apart; however, there was a different audio CD for 
the audio signals (‘bleeps’) for GMFCS levels I and II. The participants with 
GMFCS levels I and II started at speeds of 5km/hour and 2km/hour, 
respectively, with an increase of 0.25 km/h approximately every minute. 
Participants with GMFCS III used the same audio signals as those at 
GMFCS II; however, they walked/ran along the sides of a 7.5m square (thus 
requiring only a 90-degree turn and not a 180-degree turn at each bleep). 
 
3.4 Strength test (Studies 2 and 3) 
Isometric muscle strength (Nm) in a gravity-neutral position of the hip 
extensors, knee extensors and hip abductors was measured using a 
myometer (MIE ltd, Leeds, UK), according to Thompson et al. (2011). The 
test positions for each muscle group are described in Table 3.2. One padded 
strap was placed around the participant’s limb while the other strap was 
attached to a bar fixed to a wall (hip extensors, hip abductors) or plinth (knee 
extensors).  
 
Three trials were carried out for each muscle group and the participants were 
given a 30-second rest between trials. The highest of the three trials was 
selected for analysis. The force values were multiplied by the lever arm to 
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derive moments and these were normalised by dividing by body mass. The 
lever arm was the distance from the estimated joint centre of rotation to the 
point of application of the force (i.e. placement of the strap), measured with a 
tape measure to the nearest mm (Table 3.2). The muscle groups were 
evaluated bilaterally. 
 
Table 3.2 Details for isometric muscle testing 
Muscle group Position Stabilisation Resistance 
Lever arm 
distance 
from force to 
Hip extensors  Supine – Hip at 90° 
knee at 90° with lower 
leg supported, low 
bench under lower leg 
(or held if this was not 
possible) 
 
 
Hip belt – 
attached at an 
angle so it pulls 
downward and  
inferiorly 
Distal femur, 
proximal to 
femoral 
condyles 
Greater 
Trochanter 
Hip abductors Supine – Knee propped 
up on blanket to allow 
comfortable flexion of 
hip and knee and to 
raise limb slightly 
Hip belt Distal femur, 
proximal to 
femoral 
condyles 
Greater 
Trochanter 
Knee 
extensors 
Seated knee at 90° on 
chair with backrest 
(back of chair is pushed 
up against the plinth so 
that it is stable) 
Non-tested foot 
on floor 
Distal Shank  Lateral knee 
joint line 
 Direction of resistance from the myometer 
 Direction of resistance from the hip belt for stabilisation  
 
 
3.5 Three-dimensional gait analysis (Study 3) 
Three-dimensional gait analysis (3DGA) with an eight-camera Vicon Nexus 
System (100Hz) (Oxford, UK) was used to record lower limb and pelvis 
kinematics. Participants had 14mm diameter passive reflective spherical 
markers placed on their lower limbs and pelvis in line with the Vicon Plug-In-
Gait manual, which is based on the Helen Hayes marker system (Kadaba et 
al. 1990). A static trial was conducted using a Knee Alignment Device (KAD) 
to make a direct measure of the knee flexion extension axis. The KADs were 
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then removed and standard 14mm reflective markers were attached over the 
lateral epicondyle of each femur. Walking was assessed barefoot but with the 
participants’ usual walking aids. The participants were asked to walk a 
distance of about six metres across the laboratory while the Vicon motion 
analysis system was recording. Between three and six gait cycles were 
recorded for each assessment. Prior to each gait analysis session, calibration 
of the VICON Workstation software was conducted, which involved two 
stages – static calibration and dynamic calibration. The calibration carried out 
strictly followed the manufacturer (VICON software) manual.    
 
3.5.1 Data processing 
The data were processed to enable further interpretation and analysis. The 
VICON Plug-In-Gait was used to derive joint kinematics and kinetics data. 
For the purpose of the current study (Study 3), only kinematics data were 
reported. Prior to processing the data, the anthropometric data of the 
participant (i.e. height (cm), body mass (kg), knee width (mm), ankle width 
(mm), leg length (mm) and tibial torsion (degrees)) were entered into the 
software. To process the data, one static (standing) trial and the appropriate 
walking trials were prepared for processing first. This involved several steps, 
the first of which was identifying the markers, which was conducted manually 
for the static trial. Once the static trial had been labelled, modelling for the 
static data was carried out by running a static gait model. Then, a single 
walking trial was labelled followed by detecting the gait events for one 
complete gait manually. This was then followed by running a dynamic gait 
model. The steps were repeated for each of the walking trials.    
 
The processed data were then ready to be reported using the Polygon 
authoring tool. A report was created in the workstation under the respective 
session, which redirected the user to the Polygon authoring tool. The 
processed trials were then imported into the report and attached to the 
respective walks. The report includes graphical representation of the 
kinematics and kinetics of the data captured. The data were then exported to 
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Excel files and saved in their respective folders. The Excel files include 
numerical data for the temporal and spatial parameters, kinematics and 
kinetics for the movement recorded.  
 
3.5.2 Gait Profile Score 
The Gait Profile Score (GPS) is an index of overall gait pathology derived 
from specific gait parameters (can be taken over several kinematic variables 
along the entire gait cycle) and was calculated using the root-mean-square 
difference between a participant with CP data and the mean reference value 
of a healthy control in degrees (Baker 2009). GPS has previously been used 
to investigate improvements in gait quality as a result of single-event multi-
level surgery in children with CP (Rutz et al. 2013) as well as to quantify 
change in gait quality following progressive resistance training in young 
people with CP (Taylor et al. 2013). A customised script was written and run 
in Matlab (Mathworks, Natick, MA) to determine the GPS from the Excel files 
derived from the Polygon authoring tool. The variables used to calculate the 
GPS were pelvic tilt, pelvic obliquity, pelvic rotation, hip flexion/extension, hip 
abduction/adduction, knee flexion/extension, ankle dorsiflexion/plantarflexion 
and foot progression angle in the transverse plane. 
 
3.6 Gross Motor Function Measure 66 (Study 3) 
Gross Motor Function Measure (GMFM-66) dimensions D and E were used 
to assess gross motor function. The test consists of 66 items that have been 
grouped into five different dimensions of gross motor function: dimension (A) 
lying and rolling; (B) sitting; (C) crawling and kneeling; (D) standing; and (E) 
walking, running and jumping. For this thesis (Study 3), only dimensions D 
and E were used to assess participants with CP. Each item is scored on a 
four-point scale, as follows: 0 = does not initiate; 1 = initiates; 2 = partially 
completes; and 3 = completes. For more detail on the scoring instructions for 
each of the items used, the reader is referred to Appendix 1. The overall 
score was derived from each category (dimensions D & E) for a participant 
and was divided by the total possible points to produce a category 
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percentage score. These percentages were averaged for both dimensions to 
yield an overall score. The overall score for the GMFM 66 was calculated 
using the Gross Motor Ability Estimator version 1 computer program.  
 
3.7 Timed Up and Go test (Study 3) 
The Timed Up and Go (TUG) test requires participants to stand from their 
sitting position on a standard chair with armrests (chair height 45 cm, as 
measured from the top of the seat to the floor), then walk 3m to a cone, turn 
around and sit down on the chair again. The time taken for this activity (from 
getting up from the chair, walking to sitting down again) was measured using 
a standardised timer (Digital stop-clock TM-20A) (Williams et al. 2005). The 
participants were instructed to walk at their normal walking pace and were 
permitted to use their normal walking aids. The participants conducted the 
test with their shoes on. Three trials were performed, with the average of the 
three trials used for analysis. 
 
3.8 Objective habitual physical activity (Studies 2 and 3) 
The objective habitual physical activity level was assessed using the 
ActivPALTM activity monitor (Grant et al. 2006) (PAL technologies Glasgow, 
UK). This activity monitor recorder is small in size (35 mm x 53 mm x 7 mm) 
and records the number of steps, sit-to-stand and stand-to-sit transitions and 
the time spent either walking, standing or sitting/lying over a 10-day period. 
This unobtrusive activity monitor is the size of a credit card and is attached to 
the front of the thigh using special double-sided adhesive pads 
(PalstickiesTM). The participants were asked to wear the monitor for 7 days 
but were allowed to remove it at night (sleep time) and when showering or 
swimming. In addition, the participants were asked to record the days and 
duration that the monitor was worn. The ActivPALTM data were transferred 
and processed using software (ActivPALTM version 6.4.1 PAL technologies 
Glasgow, UK), which classified the data into sitting (hours/day), standing 
(hours/day), stepping (hours/day), step counts (steps/day) and sit-to-stand 
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transitions (numbers/day). For analysis, the data were also saved as Excel 
files. 
3.9 Short Form 12 version 2 (Study 2 and 3) 
To measure the quality of life, the Short Form 12 (SF-12) version 2 was used 
which consists of 12 questions (Ware et al. 1996) (Appendix 4). An algorithm 
provided by the distributor was used to calculate the physical and mental 
component of the SF-12 scores. Healthy participants were required to 
complete the questionnaire during sessions 1 and 2.  
 
3.10 Rosenberg Self-Esteem Scale (Studies 2 and 3) 
The RSES is a questionnaire consisting of 10 statements with which 
participants can either strongly disagree, disagree, agree or strongly agree 
(Rosenberg 1965) (Appendix 5). The total score is derived from an algorithm, 
generating a score of between 0 and 30, with a higher value indicating higher 
self-esteem.  
 
3.11 Canadian Occupational Performance Measure (Study 3) 
The COPM was administered through a short interview with the participants 
to get them to identify those activities of daily living that they need to do, want 
to do or are expected to do (Law et al. 1998) (Appendix 3). At their first 
assessment, the participants were then asked to rate the importance of these 
activities and select the 5 most important. For the 5 most important 
measures, the participants were then asked to rate their level of performance 
and satisfaction on a 10-point scale. Performance was rated from 1: ‘not able 
to do it at all’ to 10: ‘able to do it extremely well’, and satisfaction was rated 
from 1: ‘not satisfied at all’ to 10: ‘extremely satisfied’. At the next 
assessments, the participants were reminded of the activities they had 
selected in the initial assessment, as well as their respective scores, and 
were asked to rate their performance and satisfaction on those activities 
again and also to rate their performance and satisfaction on those activities 
again. The participants were provided with their baseline score to provide 
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them with a reference for scoring the current score. Thus, if they felt they had 
improved, they could give a higher score, and vice versa. In pilot studies it 
was noticed that some people found it difficult to provide a performance 
score, hence the reason for providing them with their baseline score. 
 
3.12 Gillette Functional Assessment Questionnaire (FAQ) (Study 
3) 
The FAQ is a self-reported questionnaire with a ten-level classification of 
walking and 22 functional mobility activities on a five-level Likert-type 
difficulty scale (Novacheck et al. 2000) (Appendix 2). The FAQ was designed 
for use in individuals with all levels of walking ability, and it focuses on what 
an individual can do independently with the use of assistive devices or 
orthoses, as needed to maximise function. The FAQ’s 22 functional mobility 
activities were designed to provide further differentiation of higher ambulatory 
levels. 
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CHAPTER 4 PSYCHOMETRIC PROPERTIES OF 
MEASURES OF GAIT QUALITY AND WALKING 
PERFORMANCE IN YOUNG PEOPLE WITH 
CEREBRAL PALSY: A SYSTEMATIC REVIEW 
 
4.1 Introduction 
The content of this chapter has been submitted for publication in Gait & 
Posture. 
 
The transition from child to adult services is a challenging time for young 
people with CP because of their distinctive health, vocational and social 
needs and the inter-agency cooperation that this transition requires (Bakheit 
et al. 2009, National Institute for Health and Care Excellence 2016). A 
reduction in health services, such as physiotherapy, at this time point is 
reported in a range of countries worldwide (Wright et al. 2016, Binks et al. 
2007). This is especially problematic as the research indicates that as young 
people with CP reach adulthood, they often experience decreased muscle 
strength accompanied by increased pain and joint deformity (Hilberink et al. 
2007). Additionally, for many young adults with CP, walking ability often 
deteriorates (Bottos et al. 2001, Andersson and Mattsson 2001). 
Unsurprisingly, there is a growing interest in the identification of interventions 
that specifically address the gait deterioration seen among this age group 
(Shortland 2009). Crucial for this research, and indeed for any research into 
the efficacy of interventions, is the use of reliable, valid and responsive 
outcome measures, to meaningfully evaluate the success of interventions 
such as exercise programmes (Gabel et al. 2012). Psychometric properties 
have been defined as the elements that contribute to the statistical adequacy 
of a measurement instrument in terms of reliability, validity, measurement 
error and internal consistency (Gabel et al. 2002). Critically evaluating the 
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psychometric properties of available OMs can provide essential knowledge 
and evidence for clinicians and researchers, thereby allowing for the 
selection of the most appropriate OM(s) for a specific clinical or research 
question.  
 
Three different research groups reviewed the measurement properties of 
measures of gait function and performance in neuro-paediatrics. The first 
review focused on the reliability and responsiveness of outcomes of gait 
function such as the Functional Mobility Score (FMS) and Gross Motor 
Function Measure (GMFM) (Ammann-Reiffer et al. 2014). Interestingly, in 
this review, little consideration was given to outcomes of gait quality (e.g. gait 
kinematics). Furthermore, these authors only reported on the measurement 
reliability and responsiveness, with no explicit consideration given to the 
validity of the OMs. The second review by Rathinam et al. (2014) critically 
appraised the reliability and validity of measures of gait quality but only those 
derived from observational gait assessment (OGA) tools used in paediatrics. 
Furthermore, the methodological quality of the outcome measures was not 
assessed using a standardised checklist such as the COnsensus-based 
Standards for the selection of health status Measurement INstruments 
(COSMIN) checklist (Terwee et al. 2012). As a result, it was not possible to 
assess the relative strength of the evidence provided to support their 
recommendations. A recent review appraised the OMs of walking ability in 
CP using the COSMIN checklist; however, this review focused only on OMs 
that were simple and quick to perform (Himuro et al. 2016). 
 
The COSMIN checklist, which is recommended for use in systematic reviews 
of measurement properties (Terwee et al. 2012), has been used previously to 
explore the psychometric properties of gait function (Ammann-Reiffer et al. 
2014) and other OMs such as balance, aerobic capacity and habitual 
physical activity in children with CP (Saether et al. 2013, Balemans et al. 
2013, Mitchell et al. 2013). Considering the increasing number of studies 
reporting the results of gait analysis, ranging from visual observation scores 
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to computerised three-dimensional gait analysis (3DGA), a review of the 
psychometric properties of the outcomes of both gait quality (i.e. gait 
characteristics) and gait performance using a standardised quality checklist 
appears to be warranted. Therefore, the aim of this study was to evaluate the 
methodological quality and the strength of the evidence of studies that 
reported an evaluation of the psychometric properties of OMs of gait quality 
and walking performance in young people with CP. In doing so, the current 
study has restricted the review to include only those studies wherein the 
majority of the participants were of an age at which gait is likely to have 
matured and additionally included participants at such an age as when 
transition to adult services often takes places or is initiated. 
 
4.2 Methods 
4.2.1 Search strategies 
The MEDLINE, CINAHL, PubMed and Scopus databases were searched 
using the main search categories of ‘cerebral palsy’, ‘gait’, ‘outcome 
measure’ and ‘measurement properties’ up to 14th January 2016. For the 
PubMed database, the same search strategy was applied but with a 
published additional sensitive search and exclusion filter for measurement 
properties (Terwee et al. 2009). Details pertaining to the search strategies 
employed are provided in Appendix 6. Finally, the reference lists of all the 
primary identified studies were manually searched and examined for studies 
that met the inclusion criteria. 
4.2.2 Inclusion and exclusion criteria 
The aim of this review was to explore and summarise the evidence presented 
in studies reporting the measurement properties of OMs for gait and walking 
performance in adolescents and young adults with CP just prior to and after 
transition to adult services. The current study therefore selected and 
implemented our inclusion criteria regarding age as follows: studies that 1) 
included one or more participants aged 16 years or over, as this is the age 
when transition from paediatric to adult services begins (Wright et al. 2016), 
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and 2) included participants with a mean age of ≥10 years, as this is the age 
at which gait has been shown to have matured (Berger et al. 1987). This 
review focused on five psychometric properties, namely reliability (test-retest 
reliability, inter-rater reliability and intra-rater reliability), measurement error, 
construct validity, criterion validity and responsiveness. The full list of study 
inclusion and exclusion criteria is shown in Table 4.1. 
 
Table 4.1 Inclusion and exclusion criteria of the systematic review 
Inclusion criteria 
 Study population: children, adolescents & young adults with CP with at least 
one participant aged 16 years, mean age of participants in the study ≥10 
years. 
 Studies reporting on psychometric properties (reliability, validity and 
responsiveness) of OMs of gait or walking performance. 
 The article should have been published in English.  
 Full-text, original article. 
Exclusion criteria 
 Abstracts, dissertation, conference proceedings, editorials, opinion pieces, 
review papers, letters, single case studies, short communications, technical 
notes. 
 Studies that validate translated versions of the OMs. 
 Primary aim of study is not to assess psychometric properties (e.g. 
intervention studies reporting on the practicality of the OMs).  
 Correlation between measures are investigated but the object of the study is 
not validation. 
 Studies that investigate the internal consistency of an OM. 
CP: cerebral palsy; OM: outcome measure 
 
4.2.3 Study selection process 
After removing duplicates, two reviewers (AZ and MvdL) independently 
screened the titles and abstracts of the studies generated by the literature 
search based on the above-stated inclusion and exclusion criteria. In case of 
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disagreement or uncertainty, the full paper was reviewed. A third reviewer 
(KJ or TM) was available in the event that no consensus could be reached. 
4.2.4 Quality assessment process 
Full articles that met the inclusion criteria were independently rated by two 
reviewers (AZ as main and MvdL or KJ) using the COSMIN checklist. In the 
case of disagreement, there was a discussion to reach consensus. Each 
study was rated to determine (i) the overall methodological quality of the 
studies investigating specific psychometric properties, and (ii) the quality of 
the psychometric properties. 
 
4.2.5 Evaluation of overall methodological quality scores 
To determine the methodological quality of the studies, the COSMIN 
checklist was used (Terwee et al. 2012). The COSMIN checklist consists of 
nine boxes (internal consistency, reliability, measurement error, content 
validity, structural validity, construct validity, cross-structural validity, criterion 
validity and responsiveness), each comprising 5–18 items, for checking the 
methodological standards of the paper in terms of its design and statistical 
approach. Each item was scored on a four-point rating scale (‘poor’, ‘fair’, 
‘good’ or ‘excellent’). The overall methodological quality score was based on 
the lowest rating of any items ticked in any box (Appendix 7).  
 
The original COSMIN criteria, which were developed to assess the 
psychometric properties of self-reported questionnaires, and studies with a 
sample size of less than 30 were given a methodological rating of ‘poor’. It 
was anticipated that studies on the psychometric properties of gait quality 
and performance measures would often have less than 30 participants, and 
the application of the original criteria would exclude studies with otherwise 
good or excellent methodological quality. Consequently, in this review, the 
current study did not use the sample size item for the rating of any of the 
psychometric properties. Instead, sample size was accounted for at the best-
evidence synthesis stage. This approach, which was first described by 
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Dobson et al. (2012) and was agreed by the COSMIN developers, was 
subsequently adopted in several other COSMIN reviews of outcomes used in 
the CP population (Ammann-Reiffer et al. 2014, Saether et al. 2013).    
 
As the definitions and terminology of certain psychometric properties adopted 
by COSMIN may not always be the same as those used by the authors of the 
articles reviewed, the current study applied the COSMIN taxonomy as 
opposed to the terms used in the articles. As recommended by COSMIN, 
small modifications can be made to each scoring system to suit the purpose 
of the review or the characteristics of the outcome measures (Mokkink et al. 
2010). The current study therefore developed ‘rules’ within the COSMIN 
rating to minimise the differences between reviewers in terms of their 
interpretations of the checklist items. The items relating to ‘missing items’ 
were not scored if the outcome measure was not a questionnaire or a test 
battery, as we regarded ‘items’ as questions in a questionnaire or parts of a 
test battery. With respect to the ‘time interval appropriate’ item, this was 
regarded as a time interval of two weeks or less to assess the test-retest 
reliability, as appropriate. For questionnaires, the minimum time interval for 
no recall was regarded as one week. Finally, in those studies assessing the 
validity of the observational gait analysis, 3DGA was accepted as the gold 
standard. 
 
4.2.6 Evaluation of the quality of the psychometric properties 
The quality of the psychometric properties, i.e. the strength of the evidence of 
the studies included in the review, was assessed using the quality criteria 
developed by Terwee et al. (2007), which have subsequently been revised by 
the author (Terwee 2012), as shown in Table 4.2. These guidelines were 
developed to score the quality of the studies in terms of their design, 
methods and outcome on the development and evaluation of the particular 
instruments. All of the OMs were rated as either ‘positive’ (+), ‘indeterminate’ 
(?) or ‘negative’ (-), depending on the results of the studies.  
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Of note, some of the OMs – for example the Edinburgh Visual Gait Score 
(EVGS) – may be given two ratings (i.e. ‘positive’ and ‘negative’). This is 
because these OMs have more than one component for which the strength of 
the evidence can be rated; for example, ‘knee angle at initial contact’ and ‘hip 
angle in stance’. If both a ‘negative’ and ‘positive’ rating are given for the 
different components, the evidence derived from these OMs will be rated as 
‘conflicting’ in the synthesis of best evidence, as described in the next 
section. 
 
Table 4.2 Quality measurements for psychometric properties (Terwee 2012 & Terwee et al. 2007) 
Property Rating Quality criteria 
Construct validity + At least 75% of the results are in accordance with 
these hypotheses 
 ? No correlations with instrument(s) measuring related 
construct(s) AND no differences between relevant 
group reported 
 - Criteria for ‘+’ not met 
Criterion validity + Convincing argument that gold standard is ‘gold’ 
AND correlation with gold standard ≥0.70 
 ? Not all information for ‘+’ reported 
 - Criteria for ‘+’ not met 
Measurement error + SDC or LoA < MIC 
 ? MIC not defined 
 - Criteria for ‘+’ not met 
Reliability + ICC or weighted Kappa ≥0.70 
 ? Doubtful design or method  
 - ICC or weighted kappa <0.70, despite adequate 
design and method 
Responsiveness + At least 75% of the results are in accordance with the 
hypotheses 
 ? No correlations with changes in instrument(s) 
measuring related construct(s) AND no differences 
between changes in relevant groups reported 
 - Criteria for ‘+’ not met  
+ positive, ? Indeterminate, - negative 
SDC: smallest detectable change, LoA: limit of agreement, MIC: minimal important change, 
ICC: interclass correlation coefficient 
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4.2.7 Synthesis of best evidence 
A synthesis of best evidence for every psychometric property for each OM 
was constructed using the combined results of the methodological quality 
from the COSMIN checklist and the quality scores according to the adapted 
quality criteria (Terwee et al. 2007). The scores for these syntheses were 
adapted from the Cochrane Collaboration Back Review (van Tulder et al. 
2003) and were also used in previous systematic reviews (Saether et al. 
2013, Ammann-Reiffer et al. 2014). A general score was given to each OM 
and was either (i) strong – consistent findings in multiple studies of good 
methodological quality OR in one study of excellent quality; (ii) moderate – 
consistent findings in multiple studies of fair methodological quality OR in one 
study of good methodological quality; (iii) limited – one study of fair 
methodological quality; (iv) conflicting – conflicting findings; or (v) unknown – 
only studies of poor methodological quality or indeterminate evidence. 
 
To account for the sample size, the following adapted ratings of the level of 
evidence were used: ‘strong’ when the total sample size of the combined 
studies was ≥100, ‘moderate’ for a total sample size between 50 and 99, 
‘limited’ for a total sample size between 25 and 49 and ‘unknown’ when the 
sample size was fewer than 25 (Dobson et al. 2012). 
 
4.3 Results 
4.3.1 Descriptive 
The search strategy resulted in the identification of 3318 articles. Figure 4.1 
shows the selection process used for the articles included in this review. 
Initial screenings based on the title resulted in the exclusion of 3089 articles. 
A further 45 and 69 articles were omitted based on the reviews of abstracts 
and full text, respectively. A final number of 20 articles reporting on 14 OMs 
were included for review via the COSMIN checklist, quality rating and 
synthesis of best evidence. The 14 OMs included in this review are shown in 
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Table 4.3. In agreement with the inclusion criteria, some studies were 
excluded from the present review because the study population did not fit the 
inclusion criteria or because the OMs of gait quality and walking performance 
were not the primary constructs of the outcome measure. In these instances, 
they were part of a wider assessment of physical and motor function, such as 
the Functional Independence Measure (WeeFim) and GMFM. 
 
The average age in the studies included for this review ranged from 10.3 to 
14.97 years. In terms of sample size, only 5 out of the 20 studies included 
less than 30 participants. Reliability was assessed 17 times (inter-rater 
reliability n=10, intra-rater reliability n=2 and test-retest reliability n=4) and 
measurement error once. For eleven OMs the validity was assessed 16 times 
(construct n=13 and criterion n=3). Responsiveness was assessed only four 
times in four different OMs. 
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Figure 4.1 Flow chart of the selection process of articles included in the review 
 
Articles identified through database 
search, i.e. Medline, Cinahl, EBSCOhost, 
PubMed and Scopus, n=3318 
Articles excluded, n=45 
Articles excluded, n=3089 
Articles excluded, n= 69 
Primary aim of study is not to assess 
psychometric properties, n=40  
Studies that investigate the internal 
consistency of an OM, n=3 
Correlation between measures 
are investigated but object of 
study is not validation, n=26 
 
Final number of articles included in 
the systematic review, n=20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of 20 included articles 
for methodological and quality 
assessment 
Articles included based on screening 
primary references, n=5 
Articles screened based on title, 
n=3223 
Articles screened based on abstract, 
n=134 
Full-text articles assessed for 
eligibility, n=89 
Articles after duplicates removed, n=3223 
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Table 4.3 Characteristics of the studies and ratings of methodological quality and quality of evidence of the included studies 
Outcome 
measure 
Study Diagnoses, n, age (y) COSMIN 
measurement 
property 
Results Rating 
Methodological 
quality 
(modified) 
Quality of evidenceb 
Visual Gait 
Assessment Scale 
(VGAS) 
Dickens 2006 
 
CP,31,5–17 (mean 
10.6) 
 
Intra-rater reliability Kappa Observer 1: -0.04–0.76, 
95% CI (-0.43–1.00) 
Kappa Observer 2: (0.07–0.84), 
95% CI (-0.32–1.00) 
Good + knee peak extension in TS,IFC, foot 
contact in stance, timing of heel rise, knee 
flex in sw,foot in stance) 
-hip in TS &swing, kneeflex in sw),IFC  
  Inter-rater reliability Kappa Session 1: (0.44–0.79), 95% 
CI (0.17–0.96)  
Kappa Session 2: (0.05–0.75), 95% 
CI (0.05–1.00) 
Good + foot contact in stance, initial foot contact 
- both observer hip in TS, MS, knee in TS 
& swing, timing heel rise, knee peak 
extension 
  Criterion validity 
 
 
Kappa VGAS & 3DGA: min KF -
0.11 (95% CI -0.38–0.16) - max KE 
0.51 (95% CI 0.26–0.76) 
Excellent 
 
 
- 
 
 
Visual gait score 
(VGS) 
Kawamura et 
al. 2012 
CP,50,>8 (mean 13.7) 
 
Inter-rater reliability Kappa Lt HA at LR 0.25 - Rt IFC 
0.88 (95% CI was not reported) 
Fair + ankle DF in IC 
- HE in TS,KF in IC, KE in TSt, KF in Sw, 
pelvic obliquity, Had in LR, pelvic rotation, 
hip rotation in MSt, foot progression at Mst 
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Outcome 
measure 
Study Diagnoses, n, age (y) COSMIN 
measurement 
property 
Results Rating 
Methodological 
quality 
(modified) 
Quality of evidenceb 
  Criterion validity VGS & 3DGA Kappa 
IFC 0.01 – KF at IC 0.65) 95% CI 
was not reported) 
Good - 
Edinburgh Visual 
Gait Score 
Viehweger 
2010 
CP,10,9–16 (mean 
12.6) 
 
Intra-rater reliability  ICC: -0.34 to 0.99 (95% CI was not 
reported) 
Good + for total score (OS,OS+GLM,NS, 
resident OS, PT+GLM), for trunc (resident 
OS), PT+GLM, for hip (OS+GLM, 
PT+GLM), for knee (all observer except 
P+GLM, PT), for foot (all observer except 
PT) 
- for total (P+GLM,PT), for trunc (all 
observer except resident OS+GLM), for 
pelvis (all observers), hip(all observers 
except OS+GLM, PT+GLM),knee (P+GLM, 
PT), foot (PT) 
  Inter-rater reliability % agreement 
Max KE 21.4% - Foot rotation & 
max lateral trunk shift in stance 
Good ? 
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Outcome 
measure 
Study Diagnoses, n, age (y) COSMIN 
measurement 
property 
Results Rating 
Methodological 
quality 
(modified) 
Quality of evidenceb 
67.9 
Gupta 2012 CP,50,6–19 (mean 
11.44) 
Responsiveness MCID After 6mo 10.62, 12mo 14.98 
Effect size After 6mo 1.19, 12mo 
1.22 
Poor ? 
Physician rating 
scale 
Wright 1999 CP,25,6–18 (mean 
11.2) 
 
Test-retest reliability Within session ICC: 0.65-0.93 (95% 
was not reported) 
Between session ICC: 0.45 0.94 
(95% was not reported) 
Good + for (step length, foot angle, velocity) 
- for (step width) 
  Inter-rater reliability ICC: 0.84-0.99 (95% CI was not 
reported) 
Good + 
Timed up & down 
stairs (TUDS) 
Chrysagis et al. 
2014 
CP, 35,12–18 (mean 
14.97) 
Inter-rater reliability ICC: >0.90 (95% CI was not 
reported) 
Fair + 
  Construct validity TUDS & GMFM88 r= -0.5, p<0.01 Fair + 
Timed Up Go Test 
(TUG) 
Chrysagis et al. 
2014 
CP, 35, 12–18 (mean 
14.97) 
Inter-rater reliability ICC: >0.90 (95% CI was not 
reported) 
Fair + 
  Construct validity TUG & GMFM88 r= -0.6, p<0.01 Fair + 
Hassani et al. CP,168, 8–18 (mean Construct validity ANOVA: Fair + 
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Outcome 
measure 
Study Diagnoses, n, age (y) COSMIN 
measurement 
property 
Results Rating 
Methodological 
quality 
(modified) 
Quality of evidenceb 
2014 12.9) GMFCS I<III, GMFCS II<IIII, p<0.01 
  Responsiveness Mean change GMFCS I,II,III non -
surgical /surgical: 0.4s,0.2s,-0.1s/–
0.1s,0.6s,3.0s 
Poor ? 
1 minute walk test 
(1MWT) 
McDowell 2009 CP,34, 4–16 (mean 
11.3) 
 
 
Construct validity 
 
1MWT (distance) & GMFM88 
scores r2=0.84, p<0.001 
1MWT (distance) & GMFM66 
scores r2=0.80, p<0.001 
Fair + 
Kerr et al. 2007 CP,46, 5–17 (mean 
11.68) 
Construct validity 1MWT (distance) & 02 cost 
r=0.69p<0.001 
Good 
 
+ 
 
Chrysagis et al. 
2014 
CP, 35, 12–18 (mean 
14.97) 
Inter-rater reliability ICC: >0.90 (95% CI was not 
reported) 
Fair + 
   Construct validity 1MWT & GMFM88 r=0.8, p<0.01 Fair + 
Hassani et al. 
2014  
CP,168, 8–18 (mean 
12.9) 
Construct validity ANOVA: 
GMFCS I>II, GMFCS I>III, GMFCS 
Fair + 
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Outcome 
measure 
Study Diagnoses, n, age (y) COSMIN 
measurement 
property 
Results Rating 
Methodological 
quality 
(modified) 
Quality of evidenceb 
II>III, p<0.01 
  Responsiveness Mean change GMFCS I,II,III non-
surgical/surgical: 
1.1,4.4,4.3/10.7.5.6.-4.9 
Poor ? 
Functional Mobility 
Scale (FMS) 
Harvey et al. 
2007 
CP,118,2–18 (mean 
10.3) 
Inter-rater reliability Kappa; agreement: 5m 0.87, 96%, 
50m 0.92, 98%,500m 0.86, 96% 
Good + 
Harvey et al. 
2010a 
CP,66,6–16 (mean 
10.0)) 
Responsiveness OR(CI) 3mo, 6mo,24mo 
5m: 0.13(0.07–0.24), 0.36(0.23–
0.58), 2.08(1.33–3.24) 
50m: 0.09(0.04–0.17), 0.32(0.19–
6.55), 2.16(1.37–3.41) 
500m: 0.24(0.14–0.43), 0.50(0.32–
0.8), 2.23(1.44–3.45) 
Fair ? 
Graham et al. 
2004 
CP,18,8–17 (mean 
12.8) 
Construct validity FMS & observation 
Weighted kappa: 5m=0.71, 
50m=0.76, 500m=0.74 
Good +  
Chrysagis et al. CP, 310,4–18 (mean Inter-rater reliability ICC: 5m 0.95, 50 m 0.94, 500 m Good + 
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Outcome 
measure 
Study Diagnoses, n, age (y) COSMIN 
measurement 
property 
Results Rating 
Methodological 
quality 
(modified) 
Quality of evidenceb 
2014 11.0) 0.95 (95% CI was not reported) 
10 metre Fast 
Walk test 
Chrysagis et al. 
2014  
CP, 35, 12–18 (mean 
14.97) 
Inter-rater reliability ICC: >0.90 (95% CI was not 
reported) 
Fair + 
  Construct validity 10MWT & GMFM88 r= 0.6, p<0.01 Fair + 
6 minute walk test 
(6MWT) 
Nsenga 
Leunkeu et al. 
2012 
CP,41,11–16 (mean 
13.6) 
Test-retest reliability  ICC (single session, 30mins 
interval) 0.93–0.98 (95% CI was not 
reported) 
Fair + 
  Measurement error LOA: -44m and 42m Fair ? 
Bagley 2007 CP,12,10–16 (mean 
14.2) 
 
Test-retest reliability ICC (one week) 0.8 (95% CI was 
not reported) 
Good + 
  Construct validity 6MWT(distance) & VO2peak r=0.625, 
p<0.05 
Fair + 
Gillette functional 
Assessment 
Questionnaire 
 (FAQ) 
Mackey 2005 CP, 758,4–18 (mean 
11.0) 
Construct validity GMFCS I & II – GMFM66 AUC 
90.3%, sensitivity 86.6%, specificity 
82.8%, p<0.001 
GMFCS II & III GMFM66-E AUC 
Fair + 
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Outcome 
measure 
Study Diagnoses, n, age (y) COSMIN 
measurement 
property 
Results Rating 
Methodological 
quality 
(modified) 
Quality of evidenceb 
94%, sensitivity 93.3%, specificity 
82.2%, p<0.001 
3D gait –
kinematics, 
temporal spatial 
Massaad 2014 CP,10,5–16 (mean 
12.0) 
Test-retest reliability Within session (r) 
Sagittal: tr tilt 0.82 – ankle DF 0.98 
Frontal: pelv obliquity 0.88 – tr 
obliquity 0.91, p<0.001 
Transverse: tr rotation 0.81 – foot 
rotation 0.91, p<0.01 
Between session 
Sagittal: pelvic tilt 0.93 – KF/KE 
0.99 
Frontal: foot progression 0.81 – HA, 
HAb 0.95, p<0.01 
Transverse: Kn rotation 0.82 – foot 
rotation 0.92, p<0.01 
Good + 
GDI Molloy 2010 CP,134, 5–20 (mean 
10.5) 
Construct validity GDI & GMFCS r= -0.44, p<0.01 Poor + 
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Outcome 
measure 
Study Diagnoses, n, age (y) COSMIN 
measurement 
property 
Results Rating 
Methodological 
quality 
(modified) 
Quality of evidenceb 
Baker 2009 CP & 
healthy,150(CP),4–17 
(mean 10.8) 
Construct validity GDI & GMFM66 r=0.70, p<0.001 
GDI & GMFM88 r= 0.67, p<0.001 
Fair + 
GPS Massaad 2014 CP, Orthopaedic& 
neurology condition, 
271 (CP), <18 (mean 
12.0) 
Criterion validity GPS & GDI r=0.995, p<0.001 Good + 
 Baker et al. 
2009  
CP, Orthopedic & 
neurology condition, 
271 (CP), <18 (mean 
12.0) 
Criterion validity GPS & GDI r=0.995, p<0.001 Good + 
GMFCS-Gross motor function classification score, SEM-standard measurement error, LOA-limit of agreement, OR-odds ratio, AUC-area under the curve,CI-confidence 
interval, SD-standard deviation, MDC-minimal detectable change, MCID-minimal clinically importance difference, m-metres, mo-months, s-seconds, ICC-interclass 
correlation coefficient, CV-coefficient of variance, r-Pearson correlation, pelv-pelvic, tr-trunk, KF-knee flexion, KE-knee extension, DF-dorsiflexion, MS-midstance, MSw-
Mid swing, TS-terminal swing, IFC-initial foot contact, KF-knee flexion, KE-knee extension, HA-hip adductor, HAb-Hip abduction, HF-hip flexion, HE-hip extension, IR, 
internal rotation, LR-loading response, Rt-right, Lt-left, pelv-pelvic, tr-trunk, Max-maximum, Kn-knee, GVS- gait variables score, GPS- gait profile scores, GDI- gait 
deviation index, OS-orthopedic surgeon, GLM-gait lab member, NS-neurosurgeon, PT-physiotherapist, P-physiatrist, bTerwee et al. 2007
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4.3.2 Overall methodological quality scores 
The methodological quality of all the studies included in this review was rated 
using the modified COSMIN checklist, and the results are shown in Table 
4.3. The methodological quality of the studies assessing the psychometric 
properties of the OMs was rated as ‘excellent’ (once), ‘good’ (14 times), ‘fair’ 
(18 times) and ‘poor’ (four times). The most common reason for a ‘poor’ 
rating was inappropriate statistical analysis used in the studies.  
 
4.3.3 The quality criteria of the psychometric properties (Strength of 
evidence) 
In terms of quality criteria, the majority of the psychometric properties of the 
OMs in this review were rated as ‘positive’ (24 times), with the remainder 
being rated as ‘indeterminate’ (six times), ‘negative’ (twice) and 
‘positive/negative’ (five times). The inter-rater, intra-rater and test-retest 
reliability of OMs such as Visual Gait Assessment Scale (VGAS), Visual Gait 
Score (VGS), EVGS and Physician Rating Scale (PRS) were rated both 
‘positive/negative’, as these OMs included the rating of different gait events 
(e.g. initial contact, heel strike, etc.) or gait characteristics (i.e. peak knee 
flexion in swing). For example, the intra-rater and inter-rater reliability of 
VGAS, VGS, EVGS and PRS all received a ‘positive’ rating for type of initial 
foot contact. In contrast, the inter-rater reliability of VGAS and VGS to 
determine hip position in terminal stance and knee flexion in swing was 
scored as ‘negative’ (Dickens 2006, Kawamura et al. 2007).  
 
4.3.4 Synthesis of best evidence 
The overall levels of evidence, synthesising methodological quality and the 
strength of the evidence for each of the OMs, are presented in Table 4.4. 
Only the scores on the FMS were found to have ‘strong’ levels of evidence 
regarding inter-rater reliability. ‘Moderate’ levels of evidence were found for 
criterion validity of the Gait Profile Score (GPS). The majority of the OMs 
have limited positive evidence for one or more psychometric properties, i.e. 
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Timed up and down stairs (TUDS) (inter-rater reliability, construct validity), 
TUG (inter-rater reliability, construct validity), 1MWT (inter-rater reliability, 
construct validity), 10m FWT (inter-rater reliability, construct validity), 6MWT 
(test-retest reliability), FAQ (construct validity) and GDI (construct validity). 
The evidence for the reliability of VGAS, VGS and PRS was found to be 
‘conflicting’. The evidence for the responsiveness of all four of the OMs for 
which this was investigated was rated as ‘unknown’.  
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Table 4.4 Synthesis of quality rating for each outcome measure 
Domain 
 Reliability     Validity    
OMs Test-
retest 
Intra-rater Inter-rater Measurement error  Construct Criterion  Responsiveness 
VGAS  +/- +/-    -   
VGS   +/-    -   
EVGS   ? ?      ? 
PRS +/-  +/-       
TUDS    +   +    
TUG    +   +   ? 
1MWT   +   +   ? 
FMS   +++   ?   ? 
10m FWT   +   +    
6MWT +   ?  ?    
FAQ      +    
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Domain 
 Reliability     Validity    
OMs Test-
retest 
Intra-rater Inter-rater Measurement error  Construct Criterion  Responsiveness 
3DGA ?         
GDI      +    
GPS        ++   
+++ or ---strong: consistent findings in multiple studies of good methodological quality OR in one study of excellent quality 
++ or – moderate: consistent findings in multiple studies of fair methodological quality OR in one study of good methodological quality 
+ or – limited: one study of fair methodological quality  
+/- conflicting: conflicting findings 
? unknown evidence: only studies of poor methodological quality and/or indeterminate rating for measurement property 
VGAS-visual gait assessment scale, VGS-visual gait score, EVGS-Edinburgh Visual Gait Score, PRS-Physician Rating Scale, TUDS-Timed up and 
down stairs, TUG-Timed up and go test, 1MWT-one minute walk test, FMS-functional mobility scale, 6MWT-six-minute walk test, FAQ-Gillette functional 
assessment questionnaire, 3DGA-three-dimensional gait analysis, GDI- gait deviation index, GPS-gait profile score  
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4.4 Discussion 
This is the first systematic review of studies evaluating the psychometric 
properties of both gait quality and walking performance OMs in young people 
with CP using standardised checklists to assess both methodological quality 
and strength of evidence.  
 
The current study identified 14 OMs, the psychometric properties of which 
were studied, that were used to assess gait quality and walking performance, 
with a CP population which included at least one person aged 16 or over and 
with an average age of 10 years and over. Of these 14 OMs, none had a 
strong level of evidence for all of the psychometric properties considered in 
this review. Only one measure (FMS) was found to have a strong level of 
evidence regarding reliability. The reason for this may be attributed to the 
relatively simple rating system used in the FMS. Our finding of strong 
evidence in the reliability of FMS was in agreement with Ammann-Reiffer et 
al. (2014), who used the same methodology in their synthesis of the level of 
evidence. While there was strong evidence as to the reliability of FMS, the 
evidence for the construct validity and responsiveness of FMS was rated 
‘unknown’ in this review. The level of evidence with regard to the reliability of 
6MWT and TUG was rated as ‘limited’ in the current review, while in contrast, 
Ammann-Reiffer et al. (2014) reported a moderate level of evidence of 
reliability for both measures. The discrepancy between the results is likely 
due to the different number of studies included for review, since Ammann-
Reiffer et al. (2014) included all studies with participants between 1 and 18 
years old. 
 
Although the current review showed limited evidence for the reliability and 
none for the responsiveness of the 6MWT and TUG, these OMs have been 
used in the CP population to assess the effect of exercise interventions 
(Taylor et al. 2012, McNee et al. 2009). The likely reason for this use is that 
both OMs are very simple, practical and easy to perform. However, both TUG 
and 6MWT provide information only on gait performance and not gait quality 
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such as gait kinematics. The latter information is obtained via both 
instrumented and observational gait analysis and is also of interest when 
monitoring potential gait deterioration in early adulthood (Shortland 2009).  
 
A previous review of five OGA measures suggested EVGS as being the best 
currently available OGA with which to assess gait pattern in children with CP 
(Rathinam et al. 2014). Interestingly, this recommendation did not seem to be 
based on methodological ratings of reliability and validity, as EVGS did not 
obtain higher scores compared to other OGAs in that review. In addition, the 
rating appraisal used in this previous review focused primarily on 
methodological qualities with no explicit rating for the strength of evidence, as 
in the guidelines proposed by Terwee et al. (2007) which were applied in the 
current review. Comparison with our results is therefore difficult.  
 
The majority of the visual observation scores received ‘conflicting’ evidence 
for their reliability because the ratings for several components of the score 
were reliable while others were not. The limited positive evidence for the 
reliability of gait kinematics was reduced to ‘unknown’ because of the small 
sample size of the only study (Mackey 2005) in our review which reported on 
this psychometric property. The evidence for the construct validity of the GDI 
was ‘limited’ because of the ‘fair’ and ‘poor’ methodologies of the two studies 
which reported on this outcome measure (Massaad 2014, Molloy 2010). 
 
The methodological quality of the majority of the psychometric property 
studies in this review was rated as follows: ‘excellent’ (once), ‘good’ (14 
times), with approximately one-third rated as ‘fair’ (18 times) or ‘poor’ (four 
times). The majority of the studies displayed similar methodological 
shortcomings. For reliability studies, the common reason for not being rated 
‘excellent’ was that the model of the ICC was not reported.  
 
One study (Harvey et al. 2010b) that employed ordinal scoring did not report 
the weighted kappa coefficient, thus reducing its rating to ‘good’. In terms of 
105 
  
studies assessing construct and criterion validity, no hypotheses were 
formulated in the majority of the studies (Chrysagis et al. 2014, Hassani et al. 
2014, Bagley 2007, Molloy 2010) and this resulted in a ‘fair’ rating.  
 
Responsiveness was reported only for the FMS, EVGS, TUG and 1MWT in 
three separate studies (Gupta 2012, Hassani et al. 2014, Harvey et al. 2007). 
However, for all of these OMs the evidence-level rating for responsiveness 
was classed as ‘unknown’. The reason for this lack of evidence was due to 
the ‘poor’ rating of the methodological quality for EVGS (Bagley 2007), TUG 
and 1MWT (Hassani et al. 2014) and the ‘indeterminate’ rating for FMS in 
terms of quality criteria (Gupta 2012). 
 
This review also highlights the limited number of studies that included 
participants aged 16 and above and where the majority were of an age at 
which gait had matured (Berger et al. 1987). Applying our inclusion criteria 
regarding age resulted in the omission of 30 studies, thereby leaving only 14 
studies available for this review. The majority of the studies omitted included 
much younger participants. This may be expected as CP is often considered 
as a childhood disease and the majority of interventions, such as multi-level 
surgery and botulinum toxin injections, take place in childhood. 
 
Young people affected by CP aged 16 years and older are often not included 
in intervention and psychometric studies. This is problematic as this is the 
age group at which both the transition from paediatric to adult health services 
is initiated or occurs (Wright et al. 2016, Binks et al. 2007) and gait function 
often starts to deteriorate (Bottos et al. 2001, Andersson and Mattsson 2001). 
Future studies should therefore evaluate interventions addressing the gait 
deterioration that often occurs during adolescence or early adulthood while 
others should assess the psychometric properties of the OMs commonly 
used with this age group.  
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Although we did not score the sample size items in the COSMIN checklist, 
we did account for sample size in our synthesis of best evidence after 
combining the sample sizes of studies with a similar methodology, as carried 
out in previous reviews (Ammann-Reiffer et al. 2014, Dobson et al. 2012), in 
agreement with the COSMIN developers. Even after adding the sample sizes 
of those studies with the same methodology, the psychometric properties of 
the OMs did not reach an adequate level of evidence due to the small sample 
size of the individual studies. Future research on the psychometric properties 
of the measurements to be used in populations of young people with CP 
should consider adopting multi-centre research designs that could overcome 
this issue of sample size.  
 
This review has a few other limitations. Firstly, the current study did not 
include composite OMs that have walking performance as part of the 
assessment, such as the GMFM and WeeFim, because these OMs have 
been included in other reviews on activity limitation and functional motor 
abilities in children with CP (Harvey et al. 2008, Debuse and Brace 2011, 
Ketelaar et al. 1998). Another limitation of this review is the language 
restriction, since we opted to include only English-language articles.  
 
Additionally, while the current study acknowledges the importance of the 
clinical utility of any OMs, this review focused only on the psychometric 
properties of the OMs of gait quality and walking performance. 3DGA is likely 
to be impractical in most clinical settings due to the increased time, cost and 
space requirements associated with this type of assessment. In comparison, 
the FMS is a very simple questionnaire used to describe functional mobility 
and could potentially be routinely implemented in clinical practice to assess 
walking performance in young people at their transition from paediatric to 
adult services.  
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4.5  Conclusions 
This systematic review reported the psychometric properties of OMs 
assessing gait quality and walking performance in young people with CP. 
Only the reliability of FMS was found to have a ‘strong’ level of evidence, with 
the majority of the outcome measures having a conflicting or limited level of 
evidence. No evidence was found for responsiveness for any OMs in this 
review. This result is of concern as any ability to assess changes in gait 
quality and/or walking performance in patients following an (exercise) 
intervention requires OMs that are responsive to change. Future research is 
suggested to provide more studies with a high-quality design to assess the 
responsiveness of OMs of gait quality and walking performance in young 
people with CP, especially of those who are just coming up to and following 
transition to adult physiotherapy services. 
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CHAPTER 5 RELIABILITY OF PHYSICAL FUNCTION, 
HABITUAL PHYSICAL ACTIVITY, QUALITY OF LIFE 
AND SELF-ESTEEM OUTCOME MEASURES IN 
YOUNG PEOPLE WITH CEREBRAL PALSY AND AGE-
MATCHED CONTROLS 
5.1 Introduction 
Assessing physical function, habitual physical activity, quality of life and self-
esteem using valid and reliable outcome measures (OMs) is important to 
evaluate the effects of treatment/interventions for individuals with CP. One 
essential psychometric property of an OM is reliability, which refers to the 
reproducibility of measurements (Portney and Watkins 2000) or, more 
specifically, the extent to which scores for patients who have not changed are 
the same across repeated measurement (Mokkink et al. 2012). 
 
An OM’s reliability is assessed by administering a test to a group of people, 
in the same way, on two or more different occasions, hours, days or weeks 
apart (Portney 2000, Mokkink et al. 2012). Test-retest reliability assures 
clinicians and researchers that the OM yields the same result, in a stable 
patient or participant, each time it is used.  
 
According to Nelson et al. (1979), two assumptions need to be considered in 
test-retest reliability assessment. Firstly, the true score does not change 
between administrations. Secondly, the time period between administrations 
is sufficiently adequate to prevent learning, carry-over effects or recall 
(Nelson et al. 1979). An understanding of the stability or variability in the 
outcome being measured, and the characteristics of the participants involved 
in the reliability study, should guide the time interval between administrations 
(Vaz et al. 2013). 
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The reliability of physical function OMs such as the Timed up and Go test 
(TUG), 10m Shuttle Run Test (SRT) and isometric muscle strength (ISM), 
habitual physical activity (activity monitor), quality of life measured using 
Short Form 12 version 2 (SF-12) and the RSES has been reported previously 
and is discussed in Chapter 2 (Section 2.4). However, there is a lack of 
evidence concerning the reliability, in particular the test-retest reliability, of 
these OMs in young people with CP, especially in those just before and after 
the transition to adult physiotherapy services, i.e. those aged 16 and over. 
 
5.2 Study aims 
 To establish the test-retest reliability of physical function OMs (TUG, 
SRT, ISM), habitual physical activity (activity monitor), quality of life 
(SF-12) and self-esteem (RSES) in young people with CP.  
 
 To establish the test-retest reliability of physical function OMs (TUG, 
SRT, ISM), habitual physical activity (activity monitor), quality of life 
(SF-12) and self-esteem (RSES) in age-matched healthy controls.  
 
5.3 Methods 
5.3.1 Participants 
For the CP group, the participants were identified from the patient database 
of the Anderson Gait Analysis Laboratory, SMART centre, Astley Ainslie, 
Edinburgh. The inclusion criteria for the CP group were (a) individuals with 
CP between 16 and 25 years of age, (2) able to ambulate 100 metres with or 
without aids. Participants or the carer (on behalf of the participant) were 
asked to fill in the questionnaires (SF-12 and RSES) before the baseline 
assessment took place. Patients were excluded from the study if they had 
any of the following: (a) insufficient cognitive ability to give informed consent, 
understand and provide answers to the questions in the questionnaire 
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booklet, (b) medical contraindications to participate in exercise testing 
(American College of Sports Medicine 1991), or (c) orthopaedic surgery or 
Botox injection in the last 6 months. Participants with CP for the current 
reliability study comprised a subset of participants (those assigned to the 
control group) of the RCT (into the effects of a community exercise 
programme) (Study 3, Chapter 7). 
 
For the age-matched healthy controls, a convenient sample of 18 participants 
was recruited from Queen Margaret University (QMU) through online 
advertisement in the QMU moderator and through the local managers of 
rugby clubs near Musselburgh and Edinburgh, with ages ranging between 16 
and 25 years. The justification for assessing the test-retest in healthy controls 
was twofold: firstly, to be able to compare the test-retest reliability between 
the two populations, thus providing more insight into the consistency and 
measurement error of these OMs. Secondly, the test-retest reliability 
assessments of the healthy controls allowed for more practice with the OMs 
prior to conducting the assessments with the primary population, i.e. young 
people with CP. 
 
Participants were excluded if they had any neuromuscular, musculoskeletal 
or cardiopulmonary disease which would affect their physical function. This 
study was approved by the QMU Research Ethics Board and National Health 
Services (NHS) research ethics committee (see Appendix 8). 
 
5.3.2 Study protocol 
All study assessments took place in the Motion analysis Lab at Queen 
Margaret University (QMU), Edinburgh except for those for the 10m SRT, 
which took place at the sports hall of the QMU sport centre. Participants gave 
their informed consent prior to participating (Appendix 9) in the baseline 
measurement (T0). After informed consent was given by the participants, the 
assessment started with the TUG and ended with the 10m SRT (Figure 5.1). 
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Basic demographic data for the age, date of birth, date and time of 
assessment, with the GMFCS level also recorded for the CP group, was 
recorded using a standardised data collection sheet (Appendix 10). After 
completion of the assessments, the activity monitor (ActivPALTM) and 
adhesives to attach the activity monitor to the leg (PalstickiesTM) were given 
to the participants in addition to verbal and written instructions regarding 
usage of the activity monitor usage (Appendix 11). Stamped addressed 
envelopes were provided to the participants for returning the ActivPALTM after 
seven days, where appropriate (i.e. only for those participants who were non-
QMU based). Otherwise, the participants were instructed to drop off the 
ActivPALTM at the QMU school office. Session 2 (T1) was planned for 
approximately 6 weeks after T0, whereby all of the OMs were repeated, and 
this was a period during which no changes in the measures of physical 
function, habitual physical activity, quality of life and self-esteem were 
expected. The order of the measurements was exactly the same for both 
sessions.  
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Figure 5.1 Flow chart during the baseline assessment (T0) and session 2 (T1) for both CP group and healthy 
controls 
5.3.3 Outcome measures 
Three tests (TUG, isometric strength tests, 10m SRT) and two questionnaires 
(SF-12 v2, RSES) were administered twice, with approximately 6 weeks 
between the assessments. In addition, the participants were required to wear 
the activity monitor (ActivPALTM) for seven days. For more details on the 
outcome measures, readers are referred to the general methodological 
chapter (Chapter 3). 
Baseline 
assessment (T0) 
Informed consent provided 
Timed Up and Go test 
Isometric Strength tests (hip extensors and 
abductors) 
Filled in questionnaires (SF-12 and 
RSES) 
Isometric Strength tests (knee extensors) 
10m Shuttle Run Test 
Activity monitor given to participants to wear 
for seven days 
Session 2 (T1) All the assessments were repeated and activity monitors were 
given for participants to wear for seven days 
 
Approximately 6 weeks after T0 
 
Took place at the motion gait 
lab QMU 
Took place at the sports hall 
QMU 
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5.3.4 Statistical analysis 
Statistical analysis was performed using Statistical Package for Social 
Science (SPSS) version 21. Reliability (consistency) was assessed using the 
ICC, including 95% confidence intervals (CIs). The ICC model (2,1) was used 
to generalise the reliability of the data beyond the confines of the current 
study. Furthermore, the ICC model (2,1) used in the current study takes 
account of variance between the test-retest scores and was applicable 
because each participant was measured on each occasion (Portney 2000). 
ICC values >0.75 indicate good reliability, 0.50 to 0.75 indicates moderate 
test-retest reliability and <0.50 represents poor test-retest reliability (Portney 
2000). 
 
In addition, standard error of measurement (SEM) and minimal detectable 
change (MDC) were calculated to quantify the measurement error in the units 
of measurement used in this study. The SEM determines how much a score 
varies with repeated measures, taking into account the within-patient 
variability of the score (Harvill 1991, Weir 2005). Derived from the SEM is the 
MDC, which is considered to be the minimal amount of change that is not 
likely to be due to chance variation in the measurement. The MDC thus 
provides information on the minimal difference needed to consider the 
change as being a ‘true’ change. The SEM was calculated as SD x √1-
ICC(2,1), where SD is the standard deviation of the grand mean (mean of 
session 1 and session 2) from all participants (Flansbjer et al. 2005). The 
MDC was calculated at a 95% confidence level as SEM x 1.96 x √2. The 
MDC is presented both in the unit of measurement and as a percentage of 
the grand mean (MDC%). MDC% was calculated by dividing the MDC by the 
average of the measurement (both sessions) and multiplying by 100. 
The participants’ habitual physical activity data derived from the ActivPALTM, 
were included for analysis if at least four full days (24 hours each) of data 
were available. The data were visually inspected and from this it was 
subjectively judged whether the ActivPALTM was worn or not. 
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5.4 Results 
5.4.1 The test-retest reliability of the physical function outcome 
measures (TUG, SRT, ISM), habitual physical activity (activity monitor), 
quality of life (SF-12) and self-esteem (RSES) in young people with CP 
The overall mean age for the CP participants for this reliability study was 
20.28 (3.43) years. Test-retest reliability data were available for eight CP 
participants (n=5 females) with GMFCS I–III (Table 5.1). From Table 5.1, the 
participants with GMFCS level I have the highest mean body mass, at 90 kg, 
in comparison with the participants with GMFCS levels II and III, who have a 
mean body mass of 55.0 kg and 49.5 kg, respectively. The two participants 
with CP classified as GMFCS level I had the highest mean body mass index 
(BMI=26.4kg/m2) compared to the participants with CP classified as levels II 
and III.  
 
Table 5.1 Characteristics of participants with cerebral palsy (n=8) 
 Overall GMFCS I n=2 GMFCS II n=3 GMFCS n=3 
Gender 
(female:male) 
5:3 0:2 3:0 2:1 
Mean Age (SD) 
(yrs) 
20.28(3.43) 18.67(1.2) 22.37(4.30) 19.8(3.63) 
Mean body mass 
(SD) (kg) 
64.8(21.5) 85.0(11.3) 55.0(15.7) 49.5(4.1) 
Mean height 
(SD) (m) 
1.61(14.2) 1.79(1.9) 1.50(5.3) 1.53(7.1) 
BMI (kg/m2) 23.3(4.0) 26.4(4.3) 23.7(5.0) 21.0(2.1) 
SD; standard deviation, yrs; years, kg; kilogrammes, m; metres, BMI; body mass index 
GMFCS; Gross Motor Function Classification System 
 
Nine participants were tested at T0. One participant in GMFCS I did not 
return (contact lost) for T1; this participant was not considered in the 
analysis. With regards to the habitual physical activity measured by the 
activity monitor (ActivPALTM), only six participants had their data for both 
baseline and session 2. Two of the participants’ physical activity data were 
missing due to the failure of their activity monitors to record their activity. 
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The raw data (mean and standard deviations) for the OMs used in this study 
are shown in Table 5.2. The reliability (ICC values) results based on the raw 
data (Table 5.2) are presented in Table 5.3. Good reliability based on the 
criteria suggested by Portney (2000) were observed for TUG (ICC=0.95) 
(95% CI 0.77–0.99), 10m SRT (0.92) (95% CI 0.44–0.97), hip extensor 
strength, habitual physical activity for sitting/lying, standing, stepping (0.76–
0.86) (95% CI 0.02–0.98) with the exception of the sit-to-stand transitions 
derived from the activity monitor (ActivPALTM) (ICC=0.75) (95% CI -0.03–
0.96) which indicated moderate reliability. For the other OMs, i.e. hip 
abductor and knee extensor strength, and PCS (derived from the SF-12), the 
reliability was moderate, with ICCs ranging from 0.54 to 0.74 (95% CI -0.28–
0.96). Only MCS and RSES were found to have poor reliability, with ICCs of 
0.45 (95% CI -0.45–0.90) and 0.13 (95% CI -0.69–0.81), respectively (Table 
5.3).  
 
Agreement as indicated by SEM for the TUG and 10m SRT were 2.48 secs 
and 1.3 (shuttles) respectively. For ISM, the smallest SEM was found for hip 
abductor strength at 0.16Nm/kg, with the highest found for knee extensor, at 
0.27Nm/kg. The SEM for the step counts was 962 steps/day (where the 
mean score was 8695 steps/day). From the SEM, MDC95 was derived, which 
is considered to be the minimal amount of change that is not likely (95% 
certainty) to be due to chance variation in the measurement. The MDC thus 
provides information on the minimal difference needed to consider the 
change as being a ‘true’ change. Values for the MDC95 in the units of 
measurement and MDC95% (dimensionless) are given in Table 5.2. The 
highest MDC95% found in the current study was for knee extensor strength, 
with 80.58%, and the lowest was RSES, with only 8.46% (Table 5.2).  
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Table 5.2 Mean (SD) of the outcome measures for healthy controls and participants with CP at 
baseline (T0) and second assessment (T1) 
  Healthy Cerebral Palsy 
TUG (seconds) T0 6.7(0.9) 18.6(12.6) 
T1 6.6(0.8) 15.8(9.9) 
10m SRT (shuttles) T0 15.0(4.0) 8.6(4.0) 
T1 15.0(4.0) 9.0(3.0) 
HE (Nm/kg) T0 2.06(0.88) 1.32(0.55) 
T1 2.16(0.76) 1.52(0.70) 
HA (Nm/kg) T0 1.05(0.24) 0.57(0.31) 
T1 0.97(0.26) 0.58(0.29) 
KE (Nm/kg) T0 1.43(0.37) 0.85(0.36) 
T1 1.36(0.23) 1.02(0.51) 
Sitting/lying* 
(hours/day) 
T0 19.0(1.6) 21.6(1.4) 
T1 18.8(1.6) 21.0(1.6) 
Standing 
(hours/day)* 
T0 3.3(1.2) 1.8(1.0) 
T1 3.7(0.9) 2.1(1.2) 
Stepping 
(hours/day)* 
T0 1.6(0.5) 0.7(0.4) 
T1 1.8(0.7) 0.8(0.4) 
Step counts* 
(steps/day) 
T0 8236(2635) 2967(2391) 
T1 9874(4136) 2967(2391) 
Sit to stand* 
(number/day) 
T0 45(10 33(10) 
T1 45(10) 34(10) 
PCS T0 56.6(3.5) 42.4(8.0) 
T1 55.7(3.7) 40.1(10.3) 
MCS T0 45.5(7.8) 49.7(10.7) 
T1 50.1(6.8) 55.7(7.6) 
RSES T0 23(4.0) 23(4.0) 
T1 23(5.0) 26(1.0) 
TUG, Timed up and go test; 10m SRT, 10m Shuttle run test; HE, hip extensor strength; HA, 
Hip abductor strength; KE, knee extensor strength; PCS, physical component score (SF-12); 
MCS, mental component score (SF-12); RSES, Rosenberg Self-Esteem Scale 
*data for four days 
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Table 5.3 Test-retest reliability indices of consistency (ICC2,1) and agreement (SEM and MDC) 
 Healthy controls  CP 
 ICC 95%CI SEM MDC95 MDC%  ICC 95%CI SEM MDC95 MDC% 
TUG (s) 0.80 0.48–0.93 0.38 1.06 15.93  0.95 0.77–0.99 2.48 6.88 37.03 
10m SRT 
(shuttles) 
0.92 0.77–0.97 1.13 3.13 21.21  0.86 0.44–0.97 1.30 3.62 42.51 
Hip extension 
(Nm/kg) 
0.36 -0.19–
0.74 
0.62 1.73 80.81  0.89 0.56–0.98 0.22 0.60 45.87 
Hip abduction 
(Nm/kg) 
0.57 0.08–0.84 0.16 0.45 44.58  0.65 -0.28–0.92 0.16 0.44 76.69 
Knee 
extension 
(Nm/kg) 
0.16 -0.39–
0.62 
0.28 0.78 56.42  0.58 -0.14–0.90 0.27 0.74 80.58 
 
Sitting/lying 
(hours/day)* 
0.50 -0.11–
0.84 
1.10 3.06 16.18  0.80 0.15–0.97 0.65 1.80 8.46 
Standing 
(hours/day)* 
0.38 -0.25–
0.78 
0.83 2.29 68.59  0.76 0.02–0.96 0.54 1.49 77.05 
Stepping 
(hours/day)* 
0.39 -0.24–
0.79 
0.50 1.37 81.18  0.86 0.3–0.98 0.15 0.42 56.61 
Step counts 
(steps/day)* 
0.24 -0.39–
0.72 
3037 8418 92.96  0.81 0.14–0.97 962 2667 75.79 
Sit to stand 
(numbers/day)* 
0.46 -0.16–
0.82 
6.69 18.54 43.09  0.75 -0.03–0.96 4.89 13.56 40.32 
PCSµ 0.53 0.03–0.82 2.43 6.73 11.98  0.74 -0.03–0.96 4.76 13.21 32.77 
MCSµ 0.57 0.08–0.84 4.98 13.80 28.89  0.45 -0.45–0.90 8.03 22.26 41.26 
RSES 0.96 0.88–0.99 0.91 2.52 11.01  0.13 -0.69–0.81 2.73 7.56 30.69 
ICC, Intraclass Correlation Coefficient; CI, Confidence Interval; SEM, Standard Error Measurement; MDC, Minimal Detectable Change; TUG, Timed Up 
and Go test; 10m SRT, 10-metre shuttle run test; GMFM, Gross Motor Function Measure; GPS, Gait Profile Score; COPM, Canadian Occupational 
Performance Measure; FAQ, Gillette Functional Assessment Questionnaire; PCS, Physical Component Score; MCS, Mental Component Score; RSES, 
Rosenberg Self-Esteem Scale, *derived from activity monitor known as ActivPALTMfor four days, µ derived from Short Form 12 version 2 (SF-12)
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5.4.2 The test-retest reliability of physical function OMs (TUG, SRT, 
ISM), habitual physical activity (activity monitor), quality of life (SF-12) 
and self-esteem (RSES) in age-matched healthy controls 
Eighteen (11 female) participants were recruited for the healthy control 
group; age was 20.5±4.0 years. Eighteen participants were assessed at T0. 
Four participants failed to return for T1 due to clinical placement (n=2) and 
school examination (n=2). Of the 14 participants who came for both sessions, 
three sets of ActivPALTM data were missing at session 2 (T1) due to a failure 
of the activity monitor (ActivPALTM) to capture the activity (n=2) and the 
participant being unable to wear it due to an examination commitment (n=1). 
Hence, test-retest reliability data were only available for 14 participants, with 
the exception of data for habitual physical activity, for which 11 sets of 
participant data were analysed. The demographic data of the healthy 
participants is shown in Table 5.4.  
 
Table 5.4 Demographic data of age-matched healthy controls (n=14) 
 Overall Male n=7  Female n=11 
Mean age (years) 20.5(4.0) 17.4(1.17) 24.3(0.44) 
Mean body mass 
(kg) 
68.10(14.6) 76.20(18.0) 63.40(10.99) 
Mean height (m) 1.71(8.5) 1.76(6.2) 1.59(7.8) 
Kg; kilogrammes, m; metres 
  
With regard to the healthy control group, based on the ICC values, good 
reliability was shown for TUG, 10m SRT and RSES, with ICCs of 0.79, 0.92 
and 0.96, respectively (Table 5.3). Moderate reliability was found for 
sedentary behaviour and SF-12 (both PCS and MCS). Poor reliability with an 
ICC <0.50 was found for all isometric strength tests, standing, stepping, step 
counts and sit-to-stand transitions. The SEM value for the TUG was 0.38 
secs (where the mean value was 6.64 secs) and for the 10m SRT it was 1.13 
(shuttles). The highest MDC% found in the current study was 94% for step 
count; in contrast, the lowest MDC% was 11.01% for RSES.  
119 
  
5.5 Discussion 
The focus of this study was to investigate the test-retest reliability of the OMs 
for physical function (TUG, ISM, 10m SRT), habitual physical activity, quality 
of life and self-esteem in young people with CP and age-matched healthy 
controls. The values for reliability and measurement error were all derived 
using a test-retest study design with an interval period of approximately 6 
weeks between tests. This is the first study to determine reliability indices for 
the physical function, quality of life and self-esteem OMs in young people 
with CP and age-matched healthy controls aged between 16 and 25 years.  
Because of the small sample sizes of the groups, difference between the 
average body mass cannot always be avoided. The CP subgroups were very 
small, with only two males with a higher body mass in the GMFCS level I 
group compared to the three females with GMFCS level III. The large 
differences between the values for average body mass imply that the group 
characteristics differed between the groups, which could have confounded 
the outcomes of the subgroup analysis. 
  
Overall, the ICC values suggest the majority of the PA OMs were more 
consistent in the CP groups than for the healthy controls. The reason for this 
finding may be due to the fact that healthy controls have the option of being 
more physically active, but they can also undertake less physical activity and 
be more sedentary if they so wish. Many people with CP may not have such 
a range of physical activity/behaviour as compared to that seen in their 
healthy peers. 
  
Both healthy controls and the CP group showed good test-retest reliability for 
the TUG test, with ICCs of 0.8 (95% CI 0.48–0.93) and 0.95 (95% CI 0.77–
0.99), respectively. Our reliability results confirmed the previous results 
reported for this OM in the CP population (test-retest reliability) with a one-
week interval: Dhote et al. (2012) reported an ICC of 0.99 (95% CI was not 
reported), Williams et al. (2005) reported an ICC of 0.98 (95% CI 0.91–0.99) 
and Gan et al. (2008) reported an ICC of 0.99 (0.98–0.99). 
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The MDC value for the TUG test was calculated to be 6.88 secs for the 
participants with CP in this study. This value is slightly lower than those 
recorded in a recent study by (Carey et al. 2016) in children with CP. They 
reported an MDC95 value of 8.74s in children aged 3–10 years with CP with 
GMFCS I–III. A study of older children with Acquired Brain Injury (mean age 
of 11 years, 11 months) classified as GMFCS I–II revealed considerably 
lower MDC95 (1.2 secs), and this may be due to the shorter intervals of 
between 24 and 36 hours (Baque et al. 2016) in comparison to those in the 
current study.  
 
The reliability for the 10m SRT tested in the CP group was also good in the 
current study, with an ICC of 0.86 (95% CI 0.44–0.97), which is consistent 
with that found in previous work by Verschuren et al. (2006), who reported 
ICCs of 0.97 and 0.94 (95% CI was not reported) for GMFCS I and II, 
respectively, and an ICC of 0.98 (95% CI 0.93–0.99) for GMFCS III 
(Verschuren et al. 2011). The current study acknowledges that, ideally, the 
reliability of the 10m SRT should be analysed according to GMFCS level as 
the 10m SRT includes different starting points (speeds) depending on the 
GMFCS level, i.e. GMFCS I starts at 5km/h, and GMFCS II starts at 2.5km/h. 
However, due to the restriction imposed by small sample size in the current 
study, this was not possible. Future studies with a higher number of 
participants allowing for investigation of the reliability of the 10m SRT for 
different GMFCS levels are therefore warranted. 
 
The MDC value for the 10m SRT was calculated as 3.6 shuttles, and 
therefore a difference of at least 4 levels is required to be sure that the 
difference in the fitness level in a participant with CP is beyond measurement 
error. To our knowledge, this is the first study to explore the measurement 
error of the 10m SRT in young people with CP. Thus, this study provides 
further evidence on the reliability (consistency) of the 10m SRT. 
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The current study found good to moderate reliability in the CP group, with 
ICCs of 0.89 (95% CI 0.56–0.98) for hip extensor, 0.65 for hip abductor (95% 
CI -0.28–0.92) and 0.58 (95% CI -0.14–0.90) for knee extensor. The results 
of good reliability for the hip extensor in the current study were consistent 
with those found in previous work by Seniorou (2002), who reported an ICC 
of 0.79 (95% CI not reported) for hip extensor strength. However, contrary to 
the current study, they also reported good reliability for hip abductors and 
knee extensors, with ICCs of 0.79 and 0.84, respectively. Seniorou (2002) 
included the participants’ age, ranging from 5 to 6 years, with a one-week 
interval using handheld myometry. The differences in the ICCs between this 
study and the previous study could be due to a longer time interval in our 
study, differences in measurement technique and the range of strength 
values.  
 
The MDCs for isometric strength of hip extensor, hip abductor and knee 
extensor in the current study ranged from 0.77 to 0.44 Nm/kg. The MDC of 
lower limb strength in the CP population has been reported in previous 
studies; however, comparison with the current study is difficult as the 
previous studies reported non-normalised torque values (Verschuren et al. 
2008b) and one study reported N/kg (Willemse et al. 2013). However, the 
MDC% ranging from 50% to 84% is comparable with the study by 
Verschuren et al. (2008) with a similar population (participants with CP, mean 
age of 11.1 years, GMFCS I–II) with MDC% calculated as 72%–77%.  
 
The reliability of the habitual physical activity captured by the same activity 
monitor (i.e. ActivPALTM) was found to be good in CP. Our ICC finding of 
0.81 (95% CI 0.14–0.97) for step counts was in agreement with a study by 
Bania (2014) of participants with CP and a mean age of 18.6 years with 
GMFCS II–III. However, our ICCs were higher for sedentary behaviour (0.80, 
95% CI 0.15–0.97) and standing (0.76, 95% CI 0.02–0.96) than those 
reported in the previous study (Bania 2014), with moderate ICCs of 0.66 
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(95% CI -0.81–0.19) for sedentary behaviour and 0.60 (95% CI -0.21–0.95) 
for standing. 
 
A change in the number of hours per day of at least 2.14 (MDC) on the time 
spent sitting or lying, as measured by the ActivPALTM, would be required in 
order to see a real difference in the sedentary behaviour of the CP 
participants in the present study. This value is similar to that observed in a 
repeatability study with a similar population conducted by Bania (2014). In 
that study, the MDC was calculated to be 2.55 hours/day (grand mean 
20.27±1.58, ICC 0.66, SEM 0.92). In terms of stepping, the current study 
revealed a somewhat higher MDC (3049 steps/day) in comparison with that 
in Bania (2014), who reported MDC as 2624 steps/day (grand mean 
4383.5±26262 steps/day, ICC 0.87, SEM 946.82 steps/day). In contrast, we 
found a slightly lower MDC for the time spent standing (MDC 1.68 hours/day 
in our sample compared to Bania’s study, which established an MDC value of 
2.2 hours/day (grand mean 2.77 hours/day, ICC 0.60, SEM 0.79 hours/day)). 
 
The test-retest reliability for PCS was good (ICC 0.74, 95% CI -0.03–0.96), 
whereas it was poor for MCS (ICC 0.45, 95% CI -0.45–0.90). Although test-
retest reliability has been demonstrated for PCS and MCS in older 
populations (Ware et al. 1996), the current study is the first to demonstrate 
test-retest reliability for the SF-12 among young people with CP. The ICC of 
PCS in the CP group of the present study is consistent with studies among 
patients with stroke (Bohannon et al. 2004) and rheumatoid arthritis (Hurst et 
al. 1998). Bohannon (2004) reported an ICC of 0.80 (95% CI was not 
reported) for PCS in a study of 31 stroke survivors with a mean age of 66.5 
years and a mean interval time of 16.2 days. Another study involving 233 
participants with rheumatoid arthritis aged between 21 and 87 years reported 
ICCs of 0.75 (95% CI 0.64–0.87) and 0.71 (95% CI 0.60–0.83) for PCS and 
MCS, respectively, with an interval of over 3 months (Hurst et al. 1998). 
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For the PCS and MCS, the MDCs were calculated to be 12.56 and 18.58, 
respectively, and therefore a difference of 13, 19 or more points, respectively, 
would be required to see a real difference in the quality of life of a participant 
with CP. The MDCs calculated in the previous study by Hurst (1998) were 
13.44 (PCS) and 18.36 (MCS) in the rheumatoid arthritis population, which 
are similar to those found in the current study. 
 
The current study reported poor reliability (ICC 0.11, 95% CI -0.69–0.81) of 
RSES in the group of participants with CP. With an MDC value of 6.29 for the 
RSES, this means that a difference of at least 7 points is required to detect a 
real change in the self-esteem score of young people with CP. So far, no 
studies have presented the MDC value of RSES in the CP population. As this 
is the first measurement of error values presented for RSES in young people 
with CP, it will perhaps provide reference values for future studies, although 
the current study does have the limitation of a low sample size. 
 
5.6 Limitations 
The healthy controls were recruited from a convenience sample and 
therefore may not be representative of the general population, although they 
were representative of young people (adolescents/young adults) attending 
high school and university in Musselburgh. The main limitation of the study 
with regards to the participants with CP and controls was the low number of 
participants, which resulted in a ‘poor’ rating for methodological quality in the 
original COSMIN rating (Mokkink et al. 2011). With regard to the original 
COSMIN rating, a sample size >100 rates as excellent, 50–99 as good, 30–
49 as fair and <30 as poor. These ratings by COSMIN, however, were initially 
developed for questionnaires and therefore the sample size requirement 
using these guidelines may be questionable for different types of OMs. 
Further, neuropaediatric field studies are often limited by small sample size 
(Ammann-Reiffer et al. 2014, Saether et al. 2013), However, the large 
number of participants (>100) required to achieve a COSMIN rating of 
excellent might be achievable if the potential participants were identified from 
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multiple rehabilitation centres/clinics across the region. In terms of habitual 
physical activity data, only data for four of the participants were available for 
analysis, and therefore the results need to be treated with caution. Another 
possible limitation is that in the current study, the parents were permitted to 
complete the questionnaires (SF-12 and RSES) on behalf of the participant 
(if needed), and this may have affected the QoL and self-esteem scores. 
With regard to COPM, the participants were not blind to their previous 
scores; as such, bias or overestimated improvement may have occurred. 
 
5.7 Conclusion 
The TUG, 10m SRT, isometric hip extensor strength and habitual physical 
activity (sedentary behaviour, standing, stepping, step counts, sit to stand) 
derived from the activity monitor (ActivPALTM) were found to have good 
reliability in young people with CP. In the current study, we found that only 
TUG, 10m SRT and RSES were shown to have good test-retest reliability in 
healthy controls. The MDC values reported in this study may be of use to 
clinicians in helping to interpret any change in their results as being either a 
real change or due to measurement error in young people with CP with 
regard to their physical function and habitual physical activity derived from 
activity monitor (ActivPALTM) measures. The same does not apply, however, 
for QoL and self-esteem, as more studies are needed to investigate these 
two measures.  
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CHAPTER 6 PHYSICAL FUNCTION, HABITUAL 
PHYSICAL ACTIVITY, QUALITY OF LIFE AND SELF-
ESTEEM IN YOUNG PEOPLE WITH CEREBRAL 
PALSY AND AGE-MATCHED CONTROLS: A COHORT 
STUDY 
6.1 Introduction 
It is well established that children with CP have decreased muscle strength 
(Brown et al. 1991, Elder et al. 2003, Engsberg et al. 2000), show decreased 
physical activity levels (Bjornson et al. 2007, Pirpiris and Graham 2004, Van 
den Berg-Emons et al. 1995) and report a lower quality of life (Bjornson et al. 
2008) compared to typically developing children. The majority of the studies 
above included children aged below 16 years; however, little is known 
regarding physical function, habitual physical activity, quality of life (QoL) and 
self-esteem in young people with CP just before and after the transition to 
adult health services (16–25 years of age) in comparison with their age-
matched peers.  
 
6.2 Study aims 
 To compare the physical function, habitual physical activity, QoL and 
self-esteem between young people with CP (16–25 years of age) and 
age-matched healthy controls. 
 
6.3 Methods 
For the CP group, the participants were identified from the patient’s database 
of the Anderson Gait Analysis Laboratory, SMART centre, Astley Ainslie, 
Edinburgh. The inclusion criteria for the CP group were (a) individuals with 
CP between 16 and 25 years of age, (b) able to ambulate 100 metres with or 
without aids. The participant or carer (on behalf of the participant) were 
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asked to fill in the questionnaires (SF-12 and RSES) before the baseline 
assessment took place. Patients were excluded from the study if they had 
any of the following: (a) insufficient cognitive ability to give informed consent, 
understand and provide answers to the questions in the questionnaire 
booklet, (b) medical contraindications preventing them from participating in 
exercise testing (American College of Sports Medicine 1991), and (c) 
orthopaedic surgery or Botox injection in the last 6 months. The participants 
with CP for this cohort study comprised those in both the control and 
intervention groups of the RCT (into the effects of a community exercise 
programme) (Study 3, Chapter 7). 
 
For the age-matched healthy controls, a convenient sample of 18 participants 
was recruited from Queen Margaret University (QMU) through online 
advertisement in the QMU moderator and from among secondary school 
pupils through the manager of local rugby clubs near Musselburgh and 
Edinburgh, with ages ranging between 16 and 25 years. Participants were 
excluded if they had any neuromuscular, musculoskeletal or cardiopulmonary 
disease which could affect their physical function. This study was approved 
by the QMU Research Ethics Board and National Health Services (NHS) 
research ethics committee (see Appendix 8). 
The OMs used for this cohort study are physical function (TUG, 10m SRT, 
isometric strength test), habitual physical activity (ActivPALTM), quality of life 
(SF-12) and self-esteem (Rosenberg Self-Esteem Scale).  
 
6.3.1 Statistical analysis 
Statistical analysis was performed using Statistical Package for Social 
Science (SPSS) version 21. The data were retrieved from the baseline 
assessment dataset of 1) Study 3 for the CP group, and 2) Study 2 for the 
healthy controls. Due to the small sample size, comparisons of differences 
between groups were analysed using non-parametric tests. Firstly, the Mann-
Whitney test was performed to compare the mean differences for measures; 
TUG, 10m SRT, isometric muscle strength, habitual physical activity 
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(sitting/lying, standing, step counts, stepping, sit to stand), QoL and self-
esteem between the healthy and CP groups. The level of statistical 
significance was set at p<0.05. Secondly, to establish the mean differences 
of all the measures based on functional mobility, a Kruskal-Wallis test was 
performed. For this analysis, comparison of the three groups – (1) healthy 
group, (2) participants with CP rated level I on the GMFCS, and (3) 
participants with CP rated at levels II and III on the GMFCS – were 
performed. Participants with CP classified as GMFCS levels II and III were 
combined for the analysis between groups due to the small sample size of 
these groups. If significant differences were found between groups, a post-
hoc test (Mann-Whitney) was performed to determine individual group 
differences with a Bonferroni adjustment. This resulted in an alpha level of 
0.016. 
For the habitual physical activity data derived from the ActivPALTM, 
participants’ data were included for analysis if at least four full days (24 hours 
each) of data were available. The data were visually inspected and from this 
it was subjectively judged whether or not the ActivPALTM was to be worn. The 
data for time spent sitting/lying was reported over a 24-hour period and thus 
is inclusive of nocturnal sleeping time and non-wearing time. The current 
study also did not consider weekdays and weekend days when analysing the 
data. However, the majority of the participants wore the monitor for seven 
days, hence including both weekdays and weekend days. 
 
6.5 Results 
Seventeen participants with CP and 18 age-matched healthy controls were 
tested at baseline. One healthy participant’s activity monitor (ActivPALTM) 
failed to capture the physical activity data; therefore, only 17 sets of physical 
activity data were analysed for the healthy control group. The demographic 
data of the participants with CP and healthy controls are presented in Table 
6.1.  
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As expected, the healthy participants achieved scores indicating a higher 
level of physical function than the CP group (all GMFCS levels), with 
statistically significant differences between the two groups found for the TUG 
(p=<0.001), 10m SRT (p=0.01), hip extensor strength (p=0.03), hip abductor 
strength (p<0.001), knee extensor strength (p<0.001) and all habitual 
physical activity (time spent sitting/lying (p<0.001), time spent standing 
(p=0.001), time spent stepping (p<0.001), step count (p<0.001) and sit-to-
stand transitions (p=0.03)) (Table 6.2).  
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Table 6.1 Demographic data of participants with CP and age-matched healthy controls 
 Healthy controls n=18  Participants with CP  
   Overall n=17 GMFCS I n=6 GMFCS II/III n=11 
Gender 
(female:male) 
11:7  11:6 3:3 8:3 
Mean age (years) 22.73(3.6)  20.02(3.16) 19.02(2.26) 20.56(3.54) 
Mean weight (kg) 69.01(14.06)  60.97(20.1) 64.5(19.46) 59.05(21.11) 
Mean height (m) 1.71(8.3)  1.61(10.9) 1.68(9.9) 1.57(9.6) 
CP; cerebral palsy, kg; kilogrammes, m; metres, GMFCS; Gross Motor Function Classification Score
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When analysing the differences between the participants with CP classified 
as GMFCS level I and the healthy control group, scores indicating a 
statistically lower level of physical function in the CP GMFCS I group were 
found for TUG (p=0.01), 10m SRT (p=0.01), hip abductor strength (p=0.002) 
and knee extensor strength (p=0.005) (Table 6.2). Comparison among 
GMFCS levels showed the time required to complete the TUG significantly 
differed between GMFCS levels I and II/III (p=0.012). Time increased with 
increasing severity. In addition, hip extensor strength for the participants in 
the CP group with GMFCS level I was significantly higher than in the CP 
group with GMFCS levels II/III (p=0.015). No significant differences were 
found between GMFCS level I and levels II/III in other physical function 
measures, i.e. 10m SRT (p=0.25), hip abductor strength (p=0.13) and knee 
extensor strength (p=0.55), as well as habitual physical activity (time spent 
sitting/lying (p=0.07), time spent standing (p=0.48), time spent stepping 
(p=0.23), step counts (p=0.19) and sit-to-stand transitions (p=0.056).  
 
With regards to QoL, the PCS derived from the SF-12 was significantly lower 
in the CP group in comparison with healthy peers (p=0.043) (refer to Table 
6.2). The mean score of MCS in the CP group was lower than for the healthy 
controls (45.72 versus 48.44); however, this was not statistically significant 
(p=0.25) (Table 6.2). Investigation between GMFCS level I and levels II/III 
also showed a significant difference in PCS scores, showing that the 
participants with GMFCS levels II/III reported lower scores in the physical 
component of QoL compared to those with GMFCS level I (p=0.016). With 
regards to self-esteem, no significant difference was found between the CP 
and healthy control groups, neither was there any significant difference 
between the GMFCS levels.  
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Table 6.2 Physical function, habitual physical activity, quality of life and self-esteem in the group of young people with CP and age-matched healthy controls 
  Mean (SD) 
Outcome 
measures 
  Healthy controlsµ  CP group 
     CP overall n=17 GMFCS I n=6 GMFCS II/III n=11 
Physical 
function 
TUG (s)  6.62(0.85)  18.17(11.81)a 9.33(2.74)bc 22.99(12.13)d 
10m SRT 
(shuttles) 
 15.0(3)  9.0(5.0)a 8.0(6.0)bc 9.0(4.0) 
Isometric 
strength 
tests 
Hip extension (Nm/kg) 2.03(0.82)  1.17(0.49)a 1.60(0.34)c 0.98(0.42)d 
Hip abduction (Nm/kg) 1.22(0.44)  0.57(0.29)a 0.68(0.23)bc 0.50(0.31) 
Knee extension 
(Nm/kg) 
1.47(0.35)  0.84(0.30)a 0.92(0.32)bc 0.80(0.30) 
Physical 
activity 
Habitual 
physical 
activity 
Sitting/lying (hours/day) 18.88(1.39)  20.98(1.54)a 20.08(1.89)c 21.47(1.12) 
Standing (hours/day) 3.30(1.20)  1.97(0.82)a 2.24(0.75)c 1.82(0.86) 
Stepping (hours/day) 1.58(0.50)  0.72(0.40)a 0.91(0.46)bc 0.61(0.86) 
Step counts (steps/day) 8575(2763)  3421(2396)a 4628(2926)bc 2762(1886) 
Sit-to-stand transitions 42.94(9.94)  36.06(12.50)a 44.84(14.37)c 31.27(8.68) 
Quality of 
life 
SF-12 PCS (34.75–56.71) 56.14(3.54)  42.11(8.87)a 48.17(7.11)c       38.82(8.2)d 
MCS (15.37–62.39)          47.78(7.59)  45.72(13.57) 40.86(17.78) 48.38(10.71) 
Self-
esteem 
RSES (0-
30) 
 22.89(4.32)  19.76(6.69) 17.50(9.35) 21.00(4.80) 
µn=18 for all OMs in exception for physical activity n=17 
aHealthy versus CP (all GMFCS levels) p<0.05; bHealthy versus GMFCS level I p<0.016; cHealthy versus GMFCS levels II/III p<0.016; dGMFCS level I 
versus GMFCS levels II/III p<0.016 
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6.6 Discussion 
The aim of this study was to compare the physical function (TUG, ISM, 10m 
SRT), habitual physical activity, QoL and self-esteem in young people with CP 
and age-matched healthy controls. The present study shows that the physical 
function (TUG, 10m SRT, isometric muscle strength), habitual physical activity 
and the physical component of QoL between young people with CP and age-
matched healthy controls were significantly different. The TUG test results, hip 
extensor strength and PCS were also significantly different between the two 
groups with different GMFCS levels (I<II/III, p<0.05).  
 
As expected, the healthy participants showed faster TUG times in comparison 
with the participants with CP in this study. The CP group took an average of 
18.17 secs to complete the TUG test, which was nearly three times the average 
time taken by the healthy group (6.62 secs, p<0.05). Zaino (2004) also 
compared the TUG test between healthy controls and children with CP (mean 
age 10.9±0.7) classified as GMFCS I–III and reported similar findings. The 
average time taken for the healthy controls was 5.1 secs in the study by Zaino 
(2004), thus similar to the finding of the present study for the healthy controls. 
With regard to the CP group, Zaino (2004) reported averages of 6.1 secs and 
8.1 secs in participants with GMFCS I and II/III, respectively, and these values 
were lower than the present study, which recorded averages of 9.3 secs and 23 
secs for GMFCS level I and levels II/III, respectively. This dissimilarity could be 
due to the age group difference since Zaino (2004) focused on children, 
whereas the current study focuses on adolescents and young adults with CP. 
Evidence has shown than functional mobility decreases with age (Day et al. 
2005).  
 
The mean TUG score of 18.17 secs in the CP group was similar to that found in 
a previous study with a similar population (i.e. GMFCS I, II and III), mean age of 
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14.97±2.03 years with TUG scores of 18.34±9.66secs (Chrysagis et al. 2014). 
The results of the current study demonstrate the differences in TUG test 
performance between young people with CP classified as GMFCS levels I and 
II/III. Not surprisingly, the time to complete the test increased from GMFCS level 
I to level III. These findings are in agreement with previous research in which 
TUG scores increased between GMFCS levels I and III (Hassani et al. 2014).  
 
The healthy control group achieved a statistically significant higher number of 
shuttles in the 10m SRT compared to the number achieved by the CP group 
(p=0.001). The healthy controls reached an average of 15 shuttles in the 10m 
SRT. The CP group achieved averages of 8 and 9 shuttles for GMFCS I and 
II/III, respectively. The CP group with GMFCS level I and healthy controls 
started at 5km/h, while the CP group with GMFCS II/III started at 2.5 km/h. As 
such, comparison between the different GMFCS levels is difficult. The reference 
values (number of shuttles) in relation to height for the 10m SRT have been 
reported by Verschuren et al. (2010) based on their study of participants with CP 
ranging from 6 to 19 years of age (mean 12 years) with GMFCS I and II. In the 
current study, the average height of the participants with CP classified as 
GMFCS I was 179.5 cm, and the average number of shuttles was 8, which 
means that the participants’ achievements fell between the 25th and 50th centiles 
for their height (Verschuren et al. 2010). Regarding the participants with GMFCS 
II in the current study, the 10m SRT revealed their fitness level to be around the 
50th centile (i.e. average). The usage of this reference value is recommended to 
keep track of fitness levels in individuals with CP with GMFCS I and II.  
 
With regard to isometric muscle strength, in the current study, the CP group 
showed statistically significant lower values than the healthy controls, i.e. hip 
extensor (1.17 vs 2.3 Nm/kg), hip abductor (0.57 vs 1.22 Nm/kg) and knee 
extensor (0.84 vs 1.47 Nm/kg). Our findings of significant lower strength values 
in the CP group compared to healthy controls are in agreement with those 
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reported in previous studies (Damiano and Abel 1998, Thompson et al. 2011, 
Wiley and Damiano 1998). A previous study by Thompson et al. (2011) reported 
differences in strength between the CP group and healthy controls. In particular, 
the relative differences between the CP group and healthy controls in hip 
abduction and knee extension in the present study appear higher than those 
seen in Thompson et al. (2011). In the current study, we have relative 
differences for hip extension of 0.65Nm/kg and knee extension of 0.63Nm/kg. In 
comparison, Thompson et al. (2011) found differences of 0.44Nm/kg for hip 
extension and 0.32Nm/kg for knee extension. This is more likely due to the 
discrepancies in terms of GMFCS levels and age group between our study and 
Thompson et al. (2011). The hip abductor (0.57Nm/kg) and knee extensor 
(0.84Nm/kg) strength values of the CP group (all GMFCS levels) in the current 
study were consistent with those in previous CP studies (Thompson et al. 2011, 
Dallmeijer et al. 2011). Dallmeijer et al. (2011) included participants with a mean 
age of 18.9±2.0 years, classified as GMFCS II and III, and strength was 
measured using a handheld dynamometer. They reported the normalised torque 
for hip abductor as 0.59Nm/kg and knee extensor as 1.04Nm/kg. However, the 
hip extensor strength in our study (CP overall group) was higher (1.17 Nm/kg) 
than that in Dallmeijer et al.’s study, which reported 0.89Nm/kg. Thompson et al. 
(2011) also reported an almost similar torque to that found in the current study 
for hip abductor (0.61Nm/kg) but not for hip and knee extensor, whereby they 
reported higher torque (2.37Nm/kg and 1.50Nm/kg, respectively) than both the 
current study’s finding and that of Dallmeijer et al. (2011).   
 
Young people with CP have been reported to have lower levels of habitual 
physical activity compared to their healthy peers (Carlon et al. 2013). The 
current study reveals that the mean step count for the healthy group was 8574 
steps/day, which was more than double the step count of 3420 steps/day in 
participants with CP (p<0.05). The sedentary behaviour (sitting/lying) between 
the healthy control and CP groups was significantly different, with the CP groups 
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spending 2 hours more on sedentary behaviour (p<0.05). Our results are in 
agreement with those in the study by Stevens et al. (2010), who compared the 
physical activity measured by the step activity monitor (Orthocare SAMTM) in 
children with CP and typically developing (TD) children. They reported a 
significant difference in step counts (CP 3171 vs healthy 6812 steps/day, 
p<0.001) and time spent sitting/lying (CP 80.7% vs healthy 67.0%/day, p<0.001) 
in older children (14–18 years) in comparison with the TD group (Stevens et al. 
2010). In terms of the number of hours spent on sedentary activity in the CP 
group, our result of 21.3 hours/day is consistent with that from a previous study 
by Bania et al. (2016) (participants with CP; mean age 18.9 years; GMFCS II 
and III). In the Bania et al. (2016) study, physical activity was recorded using the 
same activity monitor as that used in the current study, revealing that the 
average time spent sitting/lying was 20.1 hours daily, which was two hours 
greater than that found in the current study. Sedentary time, however, is difficult 
to compare between studies and even within participants, since the current 
study includes non-wear time. 
 
The physical component summary (PCS) derived from the SF-12 v2 was 
significantly lower in the CP group compared to the healthy controls, (42.11 
versus 56.14, p=0.023). Using the Child Health Questionnaire Child Form 
(CHQCH) to measure quality of life, Bjornson et al. (2008) also reported that the 
physical function component in the CHQCH perceived by the youth with CP was 
significantly lower than for the healthy controls (p<0.01). In terms of the mental 
component summary (MCS), no significant difference was found between the 
healthy controls and CP groups in the current study (p=0.1). The average PCS 
(42.11) and MCS (45.72) of the CP group in the present study are comparable 
to those in a previous study by Saebu and Sørensen (2011), which investigated 
the factors associated with physical activity among young adults with physical 
disability between the ages of 18 and 30 years. In that study, they found the 
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physical and mental scores to be 40.9 and 40.2 respectively (Saebu and 
Sørensen2011).   
 
There was no significant difference between the healthy controls and CP groups 
with regard to their self-esteem scores as measured by RSES. Magill and 
Hurlbut 1986 examined the self-esteem of 22 adolescents with CP aged 
between 13 and 18 years and found no significant differences compared with 
healthy peers for overall self-esteem, as measured using the Tennessee Self-
Concept Scale (Fitts and Roid 1964). The CP group (overall) in the present 
study scored an average of 21. So far, only one study has published the results 
of self-esteem in young people with CP, and this was a study by Manuel et al. 
(2003) involving participants with CP, with a mean age of 13.0 (3.0) years. 
Thirty-seven per cent (n=7) of the participants with CP in the current study 
reported a low self-esteem (scores ≤18). Lower self-esteem in young people 
with CP was also reported by Manuel et al. (2003), who conducted a study with 
pre-adolescents and adolescents with CP aged from 9 to 18 years and found 
similar results, with 30% scoring below the cut-off point for low self-esteem. A 
study investigating self-esteem from adolescence to adulthood in a healthy 
population indicated that self-esteem increases as individuals move out of 
adolescence, as this group has a less dependent relationship with their parents, 
a greater reliance on their peer group and a greater emphasis on education and 
career development (Magill-Evans and Restall 1991). 
 
6.7 Limitations 
The healthy controls were recruited from a convenience sample and therefore 
may not be representative of the general population, although they may be 
representative of those at school or university. Due to the small sample size of 
participants with CP, the results of the current study should be treated with 
caution. The current study also did not consider weekdays and weekend days 
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separately when analysing the data. There is a possibility of differences in the 
participants’ levels of physical activity during weekdays in comparison to 
weekend days. 
6.8 Conclusions 
This study confirms that the young people with CP that were studied have lower 
physical function, habitual physical activity and physical component scores for 
quality of life than their age-matched peers. This study highlights important 
considerations with regard to future studies looking to recruit larger number of 
participants with CP, especially with regard to those before and after the 
transition to adult health care services. These results can thus serve as a 
benchmark for studies aiming to improve physical function, physical activity, QoL 
and self-esteem in young people with CP. 
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CHAPTER 7 EFFECTS OF AN 18-WEEK PRAGMATIC 
COMMUNITY EXERCISE PROGRAMME ON THE 
PHYSICAL FUNCTION, GAIT QUALITY, HABITUAL 
PHYSICAL ACTIVITY, QUALITY OF LIFE AND SELF-
ESTEEM OF YOUNG PEOPLE WITH CP: A SINGLE-
BLIND RANDOMISED CONTROLLED TRIAL (RCT) 
 
7.1 Introduction 
In Chapter 2, the evidence regarding the efficacy of exercise interventions for 
young people with CP was explored through a narrative review, and gaps were 
identified. In addition, Chapter 2 described potential outcome measures. Several 
potential outcome measures which may be used to assess the effects of an 
exercise programme were explored in terms of their reliability, validity and 
feasibility. This study aims to address some of the gaps in this evidence by 
evaluating the effects of an 18-week pragmatic community exercise programme 
on the physical function, gait quality, habitual physical activity, quality of life and 
self-esteem of young people with CP. The primary end point for this study was 
selected as 6 weeks as this interval has been suggested as the time over which 
the effects of an exercise programme on physical fitness occur (Taylor et al. 
2013). In addition, this primary end point will maximise the possible sample size 
for analysis as dropout is common in exercise studies. 
 
7.2 Research questions 
1) What are the effects of a 6-week pragmatic community exercise programme 
on the outcomes of physical function (Timed Up and Go Test, 10m Shuttle 
139 
  
Run Test, isometric muscle strength, Gross Motor Function Measure 66) and 
gait quality (Gait Profile Score) compared to a usual care control group? 
 
2) What are the effects of a 12-week pragmatic community exercise programme 
on the outcomes of objective habitual physical activity patterns, self-reported 
function (Canadian Occupational Performance Measure, Gillette Functional 
Assessment Questionnaire), quality of life and self-esteem compared to a 
usual care control group? 
 
3) How does exposure to a pragmatic community exercise programme affect 
the outcomes of physical function and gait quality at 6, 12 and 18 weeks 
compared to the outcomes at baseline? 
 
4) How does exposure to a pragmatic community exercise programme affect 
the outcomes of objective habitual physical activity patterns, self-reported 
function, quality of life and self-esteem at 12 weeks compared to the 
outcomes at baseline?  
 
5) What is the feasibility of an 18-week pragmatic community exercise 
programme in adolescents and young adults with CP? 
 
6) What is the perception of adolescents and young adults with CP with regard 
to an 18-week pragmatic community exercise programme? 
 
7.3 Null hypotheses 
H0 1 – Exposure to 6 weeks of a pragmatic community exercise programme will 
not elicit statistically significant differences in the outcomes of physical function 
and gait quality compared to a usual-care control group. 
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H02 – Exposure to 12 weeks of a pragmatic community exercise programme will 
not elicit statistically significant differences in the outcomes of objective habitual 
physical activity patterns, self-reported function, quality of life and self-esteem 
compared to a usual-care control group. 
 
H03 – Exposure to 18 weeks of a pragmatic community exercise programme will 
not elicit statistically significant differences in the outcomes of physical function 
and gait quality at 6, 12 and 18 weeks compared to the outcomes at baseline. 
  
H04 – Exposure to 12 weeks of a pragmatic community exercise programme will 
not elicit statistically significant differences in the outcomes of objective habitual 
physical activity patterns, self-reported function, quality of life and self-esteem at 
12 weeks compared to the outcome at baseline. 
 
7.4 Methodology 
7.4.1 Study design 
The initial aim was to undertake a single-blind randomised control trial (RCT) 
with each participant involved over a period of 18 weeks. The study compared 
two groups, one receiving the exercise (intervention) and one group acting as a 
control group, who continued with their usual care. The participants were 
randomised by minimisation using GMFCS level as a factor. Randomisation was 
performed by the students’ supervisor, who was not involved in the data 
collection. The researchers (CS & AZ) responsible for the data collection and 
analysis were blind to the group allocation. 
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7.4.2 Sample size calculation 
The sample size calculation was based on a reported effect size of d=1.17 for 
the GMFM 66 dimensions D & E in a study investigating the effects of sit-to 
stand resistance exercise for children with CP (Liao et al. 2007). To achieve 
80% power of detecting a difference with a significance level of 0.05, a sample 
size of 14 participants in each group was required. Taking into account 10% 
attrition, 36 participants (18 in each group) were needed for an appropriately 
powered RCT with one primary end point, which in this study was at 6 weeks. 
 
7.4.3 Participants 
Potentially eligible participants were identified from the patient database of the 
Anderson Gait Analysis Laboratory, SMART centre, Astley Ainslie Hospital, 
Edinburgh. The inclusion criteria were (a) individuals with CP between 16 and 
25 years of age, and (b) individuals able to ambulate 100 metres with or without 
aids. Patients were excluded from the study if they had any of the following: (a) 
insufficient cognitive ability to give informed consent, understand and provide 
answers to the questions in the questionnaire booklet, (b) medical 
contraindications to participating in exercise testing (American College of Sports 
Medicine 1980) and (c) orthopaedic surgery (last 12 months) or Botox injection 
in the last 6 months. All of the participants signed an informed consent form prior 
to taking part and the study was approved by the QMU Research Ethics Board 
and National Health Services (NHS) local research ethics committee (Appendix 
8). Management approval was provided by NHS Lothian Research and 
Development. 
 
7.4.4 Exercise programme: Exercise logbook, Frequency of Training and 
Supervision 
Each of the participants in the exercise group received an exercise logbook prior 
to the exercise programme. The exercise logbook was designed for easy 
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transport within the home and leisure centre. The exercise logbook included the 
structure of the exercise programme (Figure 7.1), information on aerobic and 
strength training, instructions on how to log the workouts, pictorial descriptions 
of the exercises, instructions on how to increase resistance and weekly exercise 
logs. Each participant in the exercise group was asked to log each exercise 
session by completing the relevant boxes in their logbook (Figure 7.1), and 
fitness instructors and a physiotherapist (when present) were asked to sign off 
each log. This allowed the researcher and physiotherapist to check the 
participants’ fidelity to the exercise programme. 
 
The participants in the exercise group undertook (supervised, when required, by 
a fitness instructor) circuit exercise training (a combination of aerobic and 
muscle strength exercises) at their local leisure centre or health club. On the first 
visit and then for between two and four further visits, a paediatric physiotherapist 
experienced in exercise referrals to leisure centres instructed both the 
participants and the fitness instructor on the content and execution of the 
exercises. This was done to ensure the exercises were at the appropriate level 
for the participants’ capability and fitness. The participants were subsequently 
prescribed to attend the local leisure centre to exercise three times per week for 
the first six weeks (1–6), (ii) twice per week for weeks 7–12 (with 
encouragement to complete a third unsupervised session each week, and finally 
(iii) to attempt to complete three exercise sessions each week for weeks 13–18. 
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Figure 7.1 Front page of the logbook and example of a written exercise log 
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7.4.5 Content of the exercise programme 
A schematic of the structure of the initial exercise programme is given in Figure 
7.2. The choice of the particular strength exercises (i.e. how the exercises were 
performed) was based on the recommendation of an experienced NHS 
paediatric physiotherapist, and the progression of the exercise (both strength 
and aerobic) was based on recommendations outlined in (ACSM’s exercise 
management for persons with Chronic Illnesses and disabilities 2003). Each visit 
to the leisure centre was broken into blocks of aerobic exercise interspersed 
with two blocks of different strength training exercises, which could be adapted 
to the ability of the participant (Table 7.1). At the start of the programme the 
participants were asked to do one set of 10 repetitions of lifting weights and this 
was done at the rate of 10 repetitions maximum (10RM) wherever possible. 
10RM is the maximum amount of weight that can be lifted 10 times while 
maintaining a good form (ACSM 2003). The 10RM was performed according to 
the guidelines outlined by the ACSM (2003). The participants were asked to 
carry out a warm-up and stretching of the lower limbs prior to starting the test. 
Then, the participants were asked to perform the exercise for five repetitions for 
familiarisation. After resting for 3 to 4 minutes, the test began with the lightest 
weight and the participants were asked to repeat this 10 times. Once they had 
finished, the participants were asked whether they were able to repeat the 
exercise more than 10 times, and if they could, additional weights were added. 
The procedure was repeated up to the maximum weight that the participants 
could lift 10 times. A resting time of between 3 and 4 minutes was compulsory 
between the tests (if weight was added). 
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Initial programme 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 7.2 Standard exercise programme structure 
 
For the aerobic blocks, the participants had the option of either a reclining or 
upright exercise bike, treadmill, Motomed (motorised exercise bike), cross 
trainer or rowing machine. The participants were asked to exercise at a 
perceived level of exertion of 13 (‘somewhat hard’) on the 6–20 Borg Scale 
(Borg 1970). 
5-min aerobic exercise & 
warm-up 
4 strength exercises 
4 strength exercises 
5-min aerobic exercise 
Stretch and cool down 
5-min aerobic exercise 
Progression: 
 
Every 2 
weeks, if 12 
reps can be 
comfortably 
achieved, 
increase 
resistance 
Progression 
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Table 7.1 Strength exercise descriptions 
Muscle group Exercise description Progression – as 
required by 2-week ‘self-
assessment’ 
Illustrations 
Plantarflexors Leg press machine, seat 
adjusted so legs are 
straight, press against 
machine with toes as if 
pressing a pedal 
Increase resistance on the 
machine by 2–5% 
(smallest increment) 
 
Start Position 
 
End position 
Alternative 1: Seated on 
floor, legs straight, holding 
TheraBand looped over 
foot, point toes against 
resistance. Each foot 
separately. 
Shorten/double 
TheraBand, or use one 
which provides greater 
resistance (should be 
working at about 10RM) 
 
Start position 
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Muscle group Exercise description Progression – as 
required by 2-week ‘self-
assessment’ 
Illustrations 
End position 
Alternative 2: heel raises, 
stabilise with hand(s) on 
wall. Each limb 
simultaneously or 
separately. 
On only one leg or while 
holding free weight, 
increase resistance by 2–
5% 
 
Start position End Position 
OR 
 
Start position   End Position 
Dorsiflexors Walk on heels n/a  
Alternative: seated on 
floor with legs straight, flex 
n/a  
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Muscle group Exercise description Progression – as 
required by 2-week ‘self-
assessment’ 
Illustrations 
toes towards knees 
Knee extensors Leg press machine Increase resistance by 2–
5% 
 
Start position 
 
End position 
Hip extensors Standing (adjustable 
pulley) machine with knee 
raises. 
Each limb separately 
Increase resistance by 2–
5% 
 
Start position 
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Muscle group Exercise description Progression – as 
required by 2-week ‘self-
assessment’ 
Illustrations 
 
End position 
Alternative: on hands and 
knees, tighten glutes, lift 
leg. Each limb separately. 
n/a 
 
Start position 
 
End position 
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Muscle group Exercise description Progression – as 
required by 2-week ‘self-
assessment’ 
Illustrations 
Hip abductors Standing (adjustable 
pulley machine) with ankle 
out to the side. 
Each limb separately. 
Increase resistance by 2–
5% 
 
Start position 
 
End position 
Side lying, leg raises with 
or without TheraBand for 
resistance. Each limb 
separately. 
Shorten/double 
TheraBand, or use one 
which provides greater 
resistance (should be 
working at about 10RM) 
 
Start position 
 
End position 
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Muscle group Exercise description Progression – as 
required by 2-week ‘self-
assessment’ 
Illustrations 
Alternative: sideways 
walking 
n/a  
Core Seated on ball, twist side 
to side, with or without 
weight in hands 
Add/increase weight by 2–
5% 
 
Start position     Twist right         Twist left 
Core+lower body Single leg standing, add 
dip if possible 
 
 
Start position            Add dips 
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Muscle group Exercise description Progression – as 
required by 2-week ‘self-
assessment’ 
Illustrations 
Core+lower body Squat, with or without free 
weights held at sides 
Add/increase weight by 2–
5% 
 
Start position End position      Variations 
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7.4.6 Progression within the exercise programme 
At week 5, an individual component of the programme was included. The 
physiotherapist identified individual weaknesses to work/focus on and selected 
four strength exercises for which participants should complete two sets instead 
of only one. The structure of the programme remained the same. The 
participants just completed a second set of 10 reps (or as close to 10 as 
possible) of the chosen exercises before moving on to the next exercise. 
 
Throughout the programme, every two weeks (including the first 4 weeks), the 
participants were asked to perform a ‘self-assessment’, which they also had the 
option of completing with the fitness instructor if they so wished. This 
assessment was used to determine whether or not to increase the resistance 
during an exercise. For each exercise the participants attempted to complete 12 
repetitions on their last (or only) set. If 12 repetitions could be achieved 
comfortably, the resistance for that exercise would be increased incrementally 
during the following training session. For the weight machines and exercise 
where free weights were used as resistance, this was done by increasing the 
weight by the smallest increment. In cases where the TheraBandTM provided 
resistance, the TheraBandTM was shortened or doubled, or a band with greater 
resistance was used. If increasing the weight was not possible, then the number 
of repetitions was increased in order to achieve exercise progression. 
 
Progression of the aerobic component was achieved by increasing either the 
duration or the level of resistance of the exercise bikes or the walking speed for 
the treadmill, so long as the perceived exertion remained at ‘somewhat hard’ 
(level 13). 
The participants were asked to record their exercise sessions in a logbook, with 
the fitness instructor or physiotherapist, if present, adding his or her signature. 
The participants in the control group continued with their normal routine but were 
offered the same exercise programme after completion of the trial. Justification 
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of the exercise programme using the FITT principles (Heyward 2010) is shown 
in Table 7.2. 
 
Table 7.2 Justification of the exercise programme using the FITT principles (Heyward 2010) 
FITT principle 
(Heyward 2010) 
 Exercise 
programme in 
the present 
study 
Justification 
Frequency  3x/week for 
Block 1, 
2x/week for 
Block 2 
For novice/beginner it is 
recommended to do exercise 2–
3x/week (ACSM 2003) 
Intensity  10 repetitions 
for strength 
training, Borg 
Scale of ‘13’ for 
aerobic training 
The intensity and progression of 
the exercise are based on the 
guidelines from ACSM (2003)  
Time Duration of the 
training in each 
session 
Approximately 
1 hour 
Recommended by ACSM (2003) 
 Duration of the 
exercise 
programme 
18 weeks  - to stimulate improvement in 
physical function, habitual physical 
activity, quality of life and self-
esteem 
- to promote exercise behaviour 
Type  Aerobic and 
strength 
training 
Recommended by experienced 
paediatric physiotherapist and as 
outlined by ACSM (2003) 
ACSM; American College of Sports Medicine 
7.4.7 Assessments 
Assessments at the QMU gait analysis laboratory took place at baseline before 
the exercise programme took place and at approximately 6, 12 and 18 weeks 
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during the programme for both groups. The six-week interval between 
assessments was considered an appropriate time during which intervention-
induced changes in strength may be detectable in young people with CP (Taylor 
et al. 2004). Travel expenses to and from QMU were reimbursed. A detailed 
assessment protocol is given below. 
 
Assessment Sessions 
Four assessments for each participant would take place at QMU over the 18-
week study. The following section describes the protocol for these sessions. The 
first section covers the preparation to go through before the participant arrived 
followed by the protocol followed during the actual data collection. Three 
questionnaires, namely the SF-12, RSES and FAQ, were mailed to the 
participants a few days before the assessment took place together with the 
appointment letter. In the appointment letter, the participants were instructed to 
fill in the questionnaires in advance and were asked to bring these with them on 
the day of assessment at QMU. 
 
Preparation 
The following section outlines what needed to be completed/checked prior to the 
arrival of the participant.  
Motion analysis system set-up 
 Create session and subject 
 Calibrate the system and save/record camera residuals 
 Reset and zero FP and ensure they are working properly 
 Required equipment: 
 Markers with tape 
 Extra tape 
 Wrap/tape/Velcro strap to hold wands on 
 Clean shorts 
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Strength set-up 
 Have straps and myometer prepared 
 Required equipment: 
 One padded thigh strap with buckle 
 Two padded shin straps 
 Karabiner attached to either end of the myometer (with straps) 
 Adjustable-length strap attached to fixed rail 
 Small stool/table 
Anthropomorphic measures 
Required equipment: 
 Measuring tape 
 Lined paper, protractor, ruler, square 
 Callipers 
GMFM 66 (Dimensions D & E) 
Ensure all required supplies are present: 
 Ball 
 Stick 
 Ruler 
 Low stool 
 High bench 
 Mat 
 Stopwatch 
Fitness testing 
 Space booked (QMU sports hall) 
 Floor marked with proper distance 
 CD player available 
157 
  
ActivPALTM 
 Charged and set to record 
 Adhesives (Palstickies) available to hand out to participants 
Data Collection 
The following section describes the protocol that was followed during the data 
collection session once the participant had arrived. 
Consent 
 Ensure informed consent is obtained prior to beginning any of the testing 
 Describe what will be asked of the participant and answer any questions 
he/she may have  
 Obtain informed consent on the appropriate consent form. 
Canadian Occupational Performance Measure (COPM) 
Short interview with the participants to get them to identify activities of daily 
living that they need to do, want to do or are expected to do. Get them thinking 
about a number of different activities with the help of the categories on the 
COPM. Get the participant to rate the importance of these activities and pick out 
the 5 most important.  
 
For the 5 most important measures, get the participant to rate their level of 
performance and satisfaction on a 10-point scale. Performance is rated from 1: 
‘not able to do it at all’ to 10: ‘able to do it extremely well’, and satisfaction is 
rated from 1: ‘not satisfied at all’ to 10: ‘extremely satisfied’.   
 
To calculate a score, take the average of the performance and satisfaction 
scores.  
Patient Information 
Basic participant information should be recorded, such as: 
 details of the use of any walking aids 
158 
  
 information on any surgery undergone 
 any other conditions the participant has 
 the gross motor function classification according to the guidelines for 12–18-
year-olds. 
Timed up and Go (TUG) 
Participant is seated in a chair with arms and a backrest. Place a mark on the 
floor 3 m away. Ask the participant to get up, walk to the line, cross it, turn 
around and return to a seated position in the chair. This should be performed at 
a comfortable pace. Time how long this takes from when the participant begins 
standing to when he/she is seated again. Repeat until 3 trials are recorded.  
Strength Testing 
Strength is measured using a handheld myometer, fixed to a solid support. It is 
measured in a gravity-neutral position for each muscle group. Three trials are 
completed for each muscle group and the participants are given a 30s rest 
between trials. The myometer is zeroed with no tension on the device. 
The muscle groups to be evaluated are (bilaterally): 
 Hip extensors 
 Hip abductors  
 Knee extensors  
Details for each muscle group: 
 
Muscle group Position Stabilisation Resistance 
Lever arm distance 
from force to 
Hip extensors  Supine – Hip at 
90°, knee at 90° 
with lower leg 
supported, low 
bench under 
lower leg (or held 
if this is not 
possible) 
Hip belt – 
attached at 
an angle so it 
pulls 
downward 
and inferiorly 
Distal femur, 
proximal to 
femoral 
condyles 
Greater Trochanter 
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Hip abductors Supine – Knee 
propped up on 
blanket to allow 
comfortable 
flexion of hip and 
knee and to raise 
limb slightly 
Hip belt Distal femur, 
proximal to 
femoral 
condyles 
Greater Trochanter 
Knee extensors Seated, knee at 
90° on chair with 
backrest (back of 
chair is pushed up 
against the plinth 
so that it is stable) 
Non-tested 
foot on floor 
Distal Shank  Lateral knee joint line 
 
 Direction of resistance from the myometer 
 Direction of resistance from the hip belt for stabilisation  
Anthropomorphic Measures 
These are basic body measures which are required for gait analysis. They 
include: 
 Height (mm) 
 Weight (Kg) 
 Knee width (mm) 
 Malleolar width (mm) 
 Leg length (mm) 
 Tibial Torsion (deg) 
Knee width 
Measured between the medial and lateral epicondyles using the large sliding 
callipers and applying gentle pressure. 
Malleolar width  
Measured between the medial and lateral malleoli using the large sliding 
callipers and applying gentle pressure. 
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Leg length 
When full knee extension is possible: Position the patient supine on the plinth 
with the pelvis as straight as possible. The trunk should be straight, head 
midline, arms by sides. The patient should not lift the head during measuring. 
Measure from the ASIS (press the end of the tape up against the underside of 
the ASIS) to the distal end of the medial malleolus.  
 
When significant knee deformity exists: Measure from ASIS to medial malleolus 
but via the medial condyle. Apply this method to both sides. 
 
Tibial Torsion (transmalleolar axis) 
Footprint method: 
 Place the foot on a sheet of lined paper, with the knee axis parallel to the 
lines. The thigh should line up with the long axis of the paper, with the 
tibial tubercle pointing forward. When the knee is flexed and extended, 
the foot should stay aligned with the long axis of the paper. 
 Draw round the foot 
 With a set square, mark a point vertically below the middle of each 
malleolus. 
 Remove the paper and draw a line through the two points marking the 
malleoli – the ankle axis.  
 Measure the angle between the ankle axis and any of the lines on the 
sheet of paper – this is the angle of the transmalleolar axis. 
 External rotation of the foot (most common) is entered as a negative 
value in Vicon. 
Marker Placement 
The marker placements are based on the Plug-in-Gait model for Vicon. For 
details refer to the document ‘Procedure for Marker Placement’ 
(markerplacement.doc), version 6, 07/03/2011. 
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Motion Capture 
Motion capture is performed using the plug-in-gait model in Vicon. A balance 
test will be performed in addition to level gait. Kinetic data will be recorded using 
the two AMTI force plates. A minimum of 5 trials for each side of kinematic data 
should be available for analysis as well as 3 trials of kinetic data.   
Static trial 
A static trial is recorded for a couple of seconds with the knee alignment devices 
(KADs) in place. Ensure that all markers are visible in the trial. Remove the 
KADs and replace with 1 marker on the lateral knee joint centre.  
Walking trial 
The participants will be asked to look straight ahead and walk at a comfortable 
pace across the lab. The starting position should be adjusted to allow the force 
plates to be struck properly. The kinetic data can only be analysed properly if 
one foot, and only one foot, lands completely on the force plate. The participants 
should not be made aware of the force plates since this could lead to targeting 
and altered gait patterns.  
Gross Motor Function Measure 
The Gross Motor Function Measure (GMFM) will be evaluated for dimensions D 
and E. The scoring used will be that used for the GMFM-66 (with only 37 of 66 
items tested), which involves using the Gross Motor Ability Estimator (GMAE) 
software. 
 
Scoring of the GMFM is detailed in the user’s manual (Russell D et al. 2002). 
Training on scoring of the measure should be completed using the training CD 
that accompanies the manual (Gross Motor Function Measure (GMFM) Self-
Instructional Training CD-ROM). 
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Shuttle Run Test 
The shuttle run test used will be dependent on the GMFCS of the participant. 
Those at GMFCS I and II will run between two marks that are 10 m apart; 
however, there is a different audio CD for the bleeps in each case. Those at 
GMFCS I begin at 5 km/h with an increase of 0.25 km/h approximately every 
minute. Those at GMFCS II begin at 2 km/hour with an increase of 0.25 km/h 
approximately every minute. 
The participants with a GMFCS III will use the same audio signals as those at 
GMFCS II; however, they will run along the sides of a 7.5-metre square (thus 
requiring only a 90° turn and not 180° turn at each bleep). 
 
During the shuttle run test the participants will walk/jog/run between marks on 
the floor. They should arrive at the end of a ‘shuttle’ by the time the audio CD 
gives a bleep. For each level the time between bleeps is reduced and the 
participants must increase their speed accordingly. If the participants are having 
trouble understanding the concept or adjusting their speed, the researchers 
should run the shuttles with them until they are comfortable with the concept. 
The shuttle run test should be continued until the participants are too tired to 
keep up with the pace of the beeps. The participants are given the opportunity to 
‘catch up’ on the next bleep if they fail to reach the end of one shuttle in time for 
the bleep. However, the test ends when two shuttles are missed in a row. 
ActivPALTM 
At the end of the assessment the participants should be provided with an 
ActivPALTM unit to wear for 7 days. Each participant should be told how to use 
the ActivPALTM and given written instructions on its use. They should also be 
provided with a padded envelope in which to return the unit after the 7 days are 
complete.  
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7.4.8 Outcome measures 
Physical function was measured with the TUG, 10m SRT and isometric muscle 
strength (hip extensors, hip abductors and knee extensor), GMFM 66 
dimensions D & E, COPM and FAQ. Gait quality was assessed by calculating 
the gait profile score (GPS) derived from the three-dimensional gait analysis 
(3DGA) gait kinematics. Seven healthy controls were recruited by CS (previous 
research assistant responsible for the pilot study of the CP exercise study). The 
mean age of the healthy controls was 23.6 years and the standard deviation was 
0.89. Objective habitual physical activity was measured using the activity 
monitor (ActivPALTM). To measure QoL, the Short Form 12 (SF-12) version 2 
was used. The RSES was administered to assess the participants’ self-esteem. 
The reader is referred to Chapter 3 (General Methodology) for further details 
relating to each outcome measure. 
 
In addition, at the end of the 18 weeks, the participants in the exercise group 
were asked to complete a questionnaire exploring their perception of several 
characteristics of the exercise programme (e.g. frequency of the exercise 
sessions, level of difficulty, variation, etc.), as well as information on their current 
exercise or physical activity routine (Appendix 12). 
7.4.9 Statistical analysis 
All analyses were performed using SPSS version 21 (SPSS Inc, Chicago, IL, 
USA). A significance level of p<0.05 was used for all tests. The following 
analyses were performed: 
a) to determine any differences between the exercise and control groups at 
baseline, Mann-Whitney and Fisher exact tests were used as appropriate. 
b) a repeated measure of the General Linear Model Analysis of Variance 
(ANOVA) was performed to detect a possible interaction effect between 
time and group, i.e. for research questions 1 and 2.   
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c) a non-parametric Friedman test was performed to investigate, in the 
intervention group alone, any within-group changes for the outcomes of 
physical function and gait quality at 6, 12 and 18 weeks, i.e. for research 
question 3.  
d) the Wilcoxon Signed-Rank test was performed to investigate the 
outcomes of objective habitual physical activity patterns, self-reported 
function (COPM, FAQ), QoL and self-esteem in the exercise group 
changes from baseline to 12 weeks (i.e. for research question 4). 
 
For the habitual physical activity data derived from the ActivPALTM, the 
participants’ data were only included for analysis if at least four full days (24 
hours each) of data were available. The data were visually inspected and from 
this it was subjectively judged whether the ActivPALTM was worn or not. 
 
When a significant effect over time was identified with analysis c, a post-hoc test 
(Wilcoxon Signed-Rank) was performed with a Bonferroni adjustment with the 
level of significance set as p<0.017 (comparisons of three situations: baseline–6 
weeks, baseline–12 weeks, baseline–18 weeks). 
 
Cohen’s d values were calculated to obtain the effect sizes of the exercise 
programme at each time point (6 weeks, 12, weeks, 18 weeks) in the 
experimental group (Cohen 1988) and interaction groups x time at week 6 for 
physical function and gait quality and at 12 weeks for self-reported function, 
habitual physical activity, QoL and self-esteem. Effect size (d) was regarded as 
‘small’ if d = 0.2–0.49, ‘moderate’ if d = 0.5–0.79, and ‘large’ if d > 0.8 and was 
calculated using the following formula (Cohen 1988): 
d = M1  - M2 
          SDpooled 
Where M1 and M2 are the means of intended outcome measure (i.e. TUG) for the 
experimental and control groups, respectively, and SDpooled is the pooled 
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standard deviation for the samples (intended outcome measure). SDpooled is 
calculated using this formula: 
 
SDpooled = SD12 + SD22 
                   2 
Where SD1 and SD2 represent the standard deviations for the experimental and 
control groups, respectively. 
7.5 RESULTS 
7.5.1 Participants 
Four hundred and thirty young people with CP aged 16 to 25 years old were 
sent information about the study and were invited to take part, which was carried 
out in two batches approximately 1.5 years apart (Figure 7.3). The duration of 
the participants’ recruitment for both batches was approximately 1.5 years. In 
total, 28 individuals returned the form expressing their interest in taking part. Of 
those 28, one was not suitable for inclusion as he was already following a gym-
based exercise programme, and eight changed their minds or did not attend for 
the initial assessment.  
 
Nineteen participants gave informed consent at their baseline assessment and 
were randomly allocated to either the exercise (experimental) or control group. 
At the week 6 assessment, one participant from the control group discontinued 
participation in the programme. After the 6-week assessment, one participant in 
the control group wished to join in the exercise programme. After week 12, two 
participants in the experimental group withdrew from the programme due to 
unrelated existing health problems (one participant due to high 
anxiety/depression and another participant due to chronic fatigue syndrome). 
Three participants in the control group subsequently enrolled in the exercise 
programme after the 12-week assessment, thus leaving two participants in the 
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control group for the period of weeks 12–18. At week 18, one participant in the 
control group did not attend the assessment. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Over the course of the study there were missing data for some outcome 
measures. If the assessor (CS or AZ) deemed it clinically unsafe to perform the 
outcome measure (e.g. hip extensor and abductor strength test aggravating 
Replied and expressed interest n= 
28 
Excluded n=9 (1x 
ineligible; 8x lost 
interest) 
 
Allocated to exercise group n=10 
 
 
Allocated to control group n=9 
 
Randomised (n=19) 
Enrolment 
Recruitment packs sent to eligible 
patients n= 430 
Assessed at 12 weeks n=7 
 
Assessed at 6 weeks n=9 
 
 
Assessed at 12weeks n=5 
 
 
Assessed at 6 weeks n=7 
 
 
Wish to start exercise 
programme n=1 
Lost interest n=1 
 
Assessed at 18 weeks n=7 
 
Assessed at 18weeks n=1 
 
Start exercise 
programme n=3 
Lost interest n=1 
Assessed at baseline n=8 
 
 
Assessed at baseline n=9 
 
 
Stopped 
because 
(unrelated) 
health 
issues n=2 
Lost interest 
n=1 Lost 
interest 
n=1 
Lost interest 
n=1 
 
Figure 7.3 Flow chart of participants through the 18-week study period 
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back pain), then the test was not completed and it was recorded as missing 
data. This occurred on two occasions with participant (P994) with GMFCS level 
I. One participant in the exercise group was unable to perform the 10m SRT and 
data for one participant, 3DGA, could not be recorded as his walking frame 
obscured and knocked off some of the reflective markers. One participant was 
not able to perform the 10m SRT. 
 
7.5.3 Descriptive results 
Table 7.3 provides the demographic data for each group – experimental and 
control – for which at least two assessments (i.e. baseline and 6 weeks) were 
available. The age, height, body mass, gender distribution and means of all 
outcome measures were similar in the two groups (Table 7.4) at baseline.  
 
Table 7.3 Demographics of the participants at baseline in Study 3 
 Experimental group Control group 
Number of participants 9 7 
Gender M:F 3:6 3:4 
Age (years) 20.0(3.0) 20.0(3.2) 
Body mass (kg) 61.3(22.8) 62.8(18.3) 
Height (m) 1.62(9.3) 1.61(13.3) 
GMFCS I:II:III 4:2:3 2:3:2 
Diagnosis Hemiplegia: 2 
Diplegia: 6 
Ataxia: 1  
Hemiplegia: 3 
Diplegia:3 
Tetraplegia:1 
Walking aids   
No walking aid 6 6 
Canes  1 - 
Walker 2 1 
M:males; F:females; kg: kilogrammes; cm:centimetres; GMFCS: Gross Motor Function 
Classification Score 
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Table 7.4 Comparison of baseline measures between groups 
 Experimental n=9 Control n=7 p-value* 
Gender (M:F) 3:6 3:4 0.55 
Age (years) 20.04(3.0) 19.97(3.2) 1.00 
TUG(s) 19.0(12.6) 18.5(12.7) 0.87 
10m SRT 8.7(6) 8.7(4) 0.86 
Hip extension (Nm/kg) 1.04(0.5) 1.32(0.6) 0.25 
Hip abduction (Nm/kg) 0.49(0.2) 0.57(0.3) 0.63 
Knee extension (Nm/kg) 0.85(0.3) 0.85(0.4) 0.87 
GMFM D & E  69.5(15.9) 70.0(13.4) 0.56 
GPS 15.66(5.7) 13.7(4.9) 0.56 
Sitting/lying (hour/day) 20.90(1.2) 21.49(1.4) 0.49 
Standing (hour/day) 2.09(0.7) 1.78(1.1) 0.49 
Steps/day 3587(3532) 3300(2038) 1.0 
Sit to stand (no/day) 39.75(17.9) 35.29(11.8) 0.91 
COPM (performance 0-10) 3.6(2.1) 3.9(1.2) 0.57 
FAQ (0-25) 15(7) 16(9) 0.67 
PCS (34.75-56.71) 42.72(10.1) 42.40(8.0) 0.87 
MCS (15.37-62.39) 41.76(15.6) 49.71(10.7) 0.22 
RSES 16.56(7.3) 23.0(3.7) 0.06 
*All tested with Mann-Whitney test except for gender for which the Fisher Exact was used 
TUG: Timed Up and Go test; s:seconds; 10m SRT:10-metre shuttle run test; Nm/kg: 
NewtonMetre/kilogramme; GMFM D & E: Gross Motor Function Measure Dimensions D &E; 
GPS: Gait Profile Score; COPM: Canadian Occupational Performance Measure; FAQ: Gillette 
Functional Assessment Questionnaire; PCS:Physical Component Score; MCS: Mental 
Component Score; RSES: Rosenberg Self-Esteem Scale 
 
7.5.2 Feasibility aspects of the study: adherence, adverse events, 
missing data and feedback regarding the exercise programme 
7.5.2.1 Adherence 
Exercise session attendance was recorded for the experimental group at week 6 
(Block 1), week 12 (Block 2) and week 18 (Block 3). Overall adherence in Block 
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1 was 86% (124 out of a possible 144 sessions). For Block 2, the adherence 
was 90.6% (87 out of the minimally prescribed number of 96 sessions) (Table 
7.5). Interestingly, only two participants (P15, P17) exercised thrice weekly in 
Block 2, and this dropped to once or twice a week in Block 3. There was no 
prescribed minimal exercise frequency for Block 3, but the participants exercised 
on average once per week (ranging from less than once a week to twice a 
week). 
  
Table 7.5 Number of exercise sessions as a proportion of the prescribed number of sessions for 
each block of six weeks 
 Block 1 Block 2 Block 3 Total 
 Week 1–6a Week 7–12b Week 13–18c  
P449 16 13 8 37 
P848 18 5 5 28 
P318 18 12 12 42 
P994 n/a n/a n/a n/a 
P236 18 6 2 26 
P11 10 0 0 10 
P12 11 15 12 38 
P15 18 18 8 44 
P17 15 18 11 44 
Total 124/144 (86%) 87/96 (90.6%) 58  
n/a – not available (participant did not return their exercise logbook) 
a three prescribed sessions per week with 18 possible sessions for the whole of Block 1 
b two prescribed sessions per week with 12 possible sessions for the whole of Block 2 
c self-directed/unsupervised exercise sessions 
144 sessions= 8 (participants) x 6 (weeks) x 3 (sessions/week) 
 
 
7.5.2.2 Adverse effects 
There were no serious adverse effects during the exercise programme apart 
from minor musculoskeletal aches and general fatigue claimed by one 
participant (P15 in one session). P236 commented in their logbook regarding 
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tiredness during nearly all of the sessions from week two onwards; however, 
P236 attended 100% of the sessions for the first block and for two weeks of the 
thrice-weekly sessions in the second block prior to withdrawing from the 
programme due to chronic fatigue syndrome. 
 
7.5.2.3 Feedback on the exercise programme 
All nine of the participants in the exercise group completed the feedback 
questionnaire (Table 7.6). All of the participants considered the length of the 
session (one hour) to be just right and would have liked to continue the 
programme. However, opinions on the content of the programme varied. Five of 
the participants found the programme to at times be too easy, while three found 
it too hard at times. Two did not like the fact there were no changes in the 
content of the programme and would have liked more variety to be introduced, 
but the others (n=7) liked the fact there were no substantial changes. 
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Table 7.6 Feedback on exercise programme questionnaire results 
 
Level of 
exercises 
Group or 
individual 
Length 
of 
session 
Variety of 
exercises 
Alterations 
to the 
programme 
Adverse 
effects 
Amount of 
supervision/ 
instruction 
Location of 
exercise 
Benefits 
noted 
Would you 
continue 
with the 
exercise 
programme? 
If, so which 
components? 
And 
where? 
Other 
physical 
activity? 
Start any 
new 
activities? 
Other 
comments? 
P
3
3
9
 
Usually 
but 
sometimes 
too easy 
Makes no 
difference 
Just 
right 
Good 
variety of 
exercises 
There were 
no 
alterations 
and I liked 
that 
At the start 
I had sore 
legs 
Just right, 
the 
instructors 
were very 
good 
Local leisure 
centre 
Transferring 
was easier 
Yes, but only 
for 1-2 
sessions a 
week 
Strength, 
aerobic 
I’d like to 
continue 
going to my 
local leisure 
centre 
Boccia No N/A 
P
8
4
8
 
Usually 
but 
sometimes 
too easy 
Alone Just 
right 
Not 
enough 
variety 
There were 
no 
alterations 
and I liked 
that 
No Not enough, 
instructors 
hardly in the 
gym 
Local leisure 
centre 
Results 
were 
positive as 
muscles 
become 
looser and 
range of 
motion 
better, also 
lost some 
weight 
Yes Strength, 
stretching 
I’d like to 
continue 
going to my 
local leisure 
centre 
Baseball, 
swimming 
no Exercises 
too 
repetitive, 
not enough 
variety 
P
4
4
9
 
Usually 
but 
sometimes 
too easy 
Group Just 
right 
Not 
enough 
variety 
There were 
no 
alterations 
and I liked 
that 
No Just right Local leisure 
centre 
Feel 
stronger 
and fitter 
Will change 
to a different 
programme 
Strength, 
aerobic 
I’d like to 
continue 
going to my 
local leisure 
centre 
Horse 
riding, 
swimming 
No I did not find 
it varied 
enough and 
I would like 
the 
progamme 
to change 
every 4 
weeks 
P
2
3
6
 
Usually 
but 
sometimes 
too difficult 
Group Just 
right 
Good 
variety of 
exercises 
I liked how 
the 
sessions 
were altered 
as I got 
more used 
to the 
exercises 
Felt dizzy 
and tired 
after gym, 
it was 
bearable 
but as we 
went on it 
got worse 
Just right, 
Gill was a 
great support 
Local leisure 
centre, 
Meadowbank 
not a good 
venue 
Feel 
weaker but 
felt that is 
Post Viral 
Fatigue 
Syndrome 
Feel weaker 
but felt that is 
PVFS 
stretching I will modify 
the 
programme 
to do as 
much as 
possible at 
home 
Swimming, 
fencing 
(only 
1/week as 
very tired) 
No I found it 
difficult to 
take part in 
this, wanted 
to continue 
with it but 
was having 
severe pain, 
tiredness 
and 
depression 
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Level of 
exercises 
Group or 
individual 
Length 
of 
session 
Variety of 
exercises 
Alterations 
to the 
programme 
Adverse 
effects 
Amount of 
supervision/ 
instruction 
Location of 
exercise 
Benefits 
noted 
Would you 
continue 
with the 
exercise 
programme? 
If, so which 
components? 
And 
where? 
Other 
physical 
activity? 
Start any 
new 
activities? 
Other 
comments? 
P
3
1
8
 
Usually 
but 
sometimes 
too easy 
Makes no 
difference 
Just 
right 
Good 
variety of 
exercises 
There were 
no 
alterations 
and I liked 
that 
Yes, on 
the double 
leg push. 
My 
hamstrings 
became 
much 
tighter 
than usual 
Just right Own health 
club, staff 
knew me and 
understood 
my needs 
Not really, 
core 
stability and 
balance 
maybe 
slightly 
Yes but only 
1-2 a week 
Strength, 
aerobic 
Continue at 
health club 
Swimming, 
static bike 
No N/A 
P
1
1
 
Usually 
but 
sometimes 
too difficult 
Alone Just 
right 
Good 
variety of 
exercises 
N/A Muscle 
pains 
Just right Local leisure 
centre 
Easier to 
move, felt 
less 
breathless 
N/A All 
components 
I’d like to 
continue 
going to my 
local leisure 
centre 
N/A No N/A 
P
1
2
 
Usually 
but 
sometimes 
too easy 
Group Just 
right 
Good 
variety of 
exercises 
I liked how 
the 
sessions 
were altered 
as I got 
more used 
to the 
exercises 
I had 
minor 
knee pain 
in my first 
few 
sessions 
with the 
program 
Just right Local leisure 
centre 
Increase in 
stamina 
and found it 
easier 
cycling 
Yes All 
components 
Other: I got 
a free gym 
membership 
from college 
Cycling, 
squatting 
Kung fu, 
swimming 
Had a great 
time 
participating 
in this 
program. 
Thanks  
P
1
5
 
Usually 
but 
sometimes 
too difficult 
Group Just 
right 
Good 
variety of 
exercises 
I liked how 
the 
sessions 
were altered 
as I got 
more used 
to the 
exercises 
Muscle 
soreness 
on 
beginning 
Just right Local leisure 
centre 
N/A Yes but only 
1-2 a week 
All 
components 
I’d like to 
continue 
going to my 
local leisure 
centre 
Stretching No This 
program 
was a good 
idea, was 
feeling 
motivated, 
to keep fit , 
more 
happier 
P
1
7
 
Yes Group Just 
right 
Good 
variety of 
exercises 
I liked how 
the 
sessions 
were altered 
as I got 
more used 
to the 
exercises 
Not 
applicable 
Just right I’m a 
member of 
Gullane Gym 
and like 
going there 
Yes. Lost 
some 
weight. 
More 
mobile. A 
bit steadier 
in exercises 
Yes but only 
1-2 a week 
Strength, 
stretching 
Other: 
Gullane 
gym 
Swimming No The 
program 
lasted 
longer than I 
expected, 
and became 
a little 
difficult to fit 
in to my 
routine 
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7.5.4 The outcomes of physical function in the intervention group after 6 
weeks compared to those in a control group 
The repeated-measures ANOVA test showed no statistically significant 
interaction group x time effects at 6 weeks in any of the physical function 
measures. The TUG showed a statistically significant time effect, which 
indicated that at 6 weeks both groups took less time to complete the TUG. The 
GMFM scores also show a statistically significant increase over time (6 weeks). 
The p-values presented in Table 7.8 are based on the participants who had data 
for both sessions, as presented in Table 7.7.  
 
 
Table 7.7 Results of the physical function and gait quality measures after the exercise programme 
(6 weeks) 
Outcome 
measures 
 Baseline (mean)  6 weeks (mean) 
  Exercise n=9 Control n=7  Exercise 
n=9 
Control n=7 
Physical 
function 
TUG(s) 19.0(12.1) 18.5(12.7)  16.7(12.2) 15.8(9.9) 
 10m SRT 8.7(6) 8.7(4)  9.0(6) 9.0(3) 
 Hip 
extension 
(Nm/kg) 
1.04(0.46) 1.32(0.55)  1.09(0.55) 1.52(0.7) 
 Hip 
abduction 
(Nm/kg) 
0.49(0.22) 0.57(0.31)  0.58(0.24) 0.58(0.28) 
 Knee 
extension 
(Nm/kg) 
0.85(0.29) 0.85(0.29)  1.12(0.42) 1.02(0.51) 
 GMFM D & 
E 
69.5(15.9) 70.0(13.4)  71.5(16.4) 70.8(13.8) 
Gait 
quality 
GPS (o) 15.66(5.7) 13.7(4.9)  15.79(5.6) 15.06(5.5) 
TUG: Timed Up and Go test; s:seconds; 10m SRT: 10-metre shuttle run test; Nm/kg: 
NewtonMetre/kilogramme; GMFM D & E: Gross Motor Function Measure Dimensions D 
& E; GPS: Gait Profile Score 
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Table 7.8 Differences between groups and over time (6 weeks) 
Outcome 
measure 
 Group 
effect 
p-
value 
Time 
effect 
p-
value 
Group/time 
interaction 
p-value 
Partial 
Eta 
Squareda 
Cohen’s 
da 
Physical 
function 
TUG 0.86 0.03* 0.57 0.02 0.03 
10m SRT 0.99 0.49 0.93 0.01 0.00 
Hip 
extension  
0.22 0.21 0.44 0.16 0.14 
 Hip 
abduction 
0.77 0.37 0.43 0.05 0.18 
 Knee 
extension 
0.77 0.06 0.64 0.02 0.14 
 GMFM D & 
E 
0.99 0.05 0.33 0.07 0.02 
Gait quality GPS 0.64 0.39 0.48 0.00 0.11 
*significant difference over time p<0.03 
a Group/time interaction 
TUG: Timed Up and Go test; 10m SRT: 10-meter shuttle run test; GMFM D & E: Gross Motor 
Function Measure Dimensions D & E; GPS: Gait Profile Score 
 
 
7.5.5 The outcomes of objective habitual physical activity, self-reported 
function (COPM, FAQ), QoL and self-esteem in the exercise group after 12 
weeks compared to those in a control group 
There was no statistically significant group x time interaction effect at 12 weeks 
in the habitual physical activity, QoL and self-esteem measures. At week 12, the 
self-reported function measured by the COPM increased significantly in both 
groups with p=0.02. The statistical results shown in Table 7.10 are based on 
those participants who had data for both sessions, as presented in Table 7.9. 
The list of activities selected and scored by the participants as those they would 
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like to improve through following the exercise programme (using the COPM) is 
presented in Table 7.11. 
 
Table 7.9 Results of physical activity, self-reported function, QoL and self-esteem after the exercise 
programme (12 weeks) 
Outcome 
measure 
 Baseline (mean)  12 weeks (mean) 
  Exercise  Control  Exercise Control 
HPA Sitting/lying* 
(hour/day) 
20.8(1.4), 
n=5 
21.2(1.6), 
n=5 
 20.2(2.2), 
n=5 
20.5(1.7), 
n=5 
Standing* 
(hour/day 
2.2(0.9), n=5 1.8(1.0), n=5  2.5(1.3), n=5 2.5(1.2), n=5 
Steps/day* 4573(4270), 
n=5 
3883(2138), 
n=5 
 5357(4625), 
n=5 
4998(2628), 
n=5 
Sit to stand* 43 (22), n=5 35(12), n=5  43(14), n=5 37(11), n=5 
Self-
reported 
function  
COPM 
(Performanc
e 0-10) 
3.6(2.1), n=7 3.9(1.2), n=5  5.1(2.0), n=7 4.5(1.1), n=5 
FAQ (0-25) 15(7), n=7 16(9), n=3  16(5), n=7 16(9), n=3 
QoL PCS (34.75-
56.71) 
46.2(9.3), 
n=6 
44.8(7.9), 
n=5 
 44.9(8.2), 
n=6 
43.4(11.1), 
n=5 
MCS (15.37-
62.39) 
47.5(12.7), 
n=6 
52.2(10.9), 
n=5 
 53.0(14.1), 
n=6 
53.7(11.7), 
n=5 
Self-
esteem 
RSES (0-30) 18.4(8), n=5 23.6(4), n=5  19.2(9.7), 
n=5 
24.6(2.6),n=
5 
HPA: habitual physical activity; COPM: Canadian Occupational Performance Measure; FAQ: 
Gillette Functional Assessment Questionnaire; QoL: Quality of life; PCS:Physical Component 
Score; MCS: Mental Component Score; RSES: Rosenberg Self-Esteem Scale 
*derived from four days’ data 
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Table 7.10 Differences between groups and over time (week 12) for physical activity, QoL and self-
esteem 
Outcome 
measure 
 Group 
effect 
p-
value 
Time 
effect 
p-value 
Group/time 
interaction 
p-value 
Partial 
Eta 
Squareda 
Cohen’s 
da 
HPA Sitting/lying  0.77 0.09 0.86 0.00 0.06 
Standing 0.94 0.13 0.77 0.01 0.36 
Steps/day 0.82 0.12 0.77 0.01 0.09 
Sit to stand 0.43 0.90 0.82 0.00 0.13 
Self-
reported 
function 
COPM  0.91 0.02* 0.33 0.10 0.54 
FAQ   0.94 0.33 0.12 0.13 
QoL PCS  0.26 0.26 0.22 0.00 0.01 
MCS  0.94 0.17 0.58 0.11 0.32 
Self-
esteem 
RSES 0.37 0.62 0.47 0.00 0.03 
*significant difference over time p<0.05 
a group/time interaction 
HPA: habitual physical activity; COPM: Canadian Occupational Performance Measure; FAQ: 
Gillette Functional Assessment Questionnaire; QoL: Quality of life; PCS:Physical Component 
Score; MCS: Mental Component Score; RSES: Rosenberg Self-Esteem Scale 
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Table 7.11 List of activities derived from the Canadian Occupational Performance Measure from 
baseline to week 12 
 Activity (ies) Performance score (0-10) 
Baseline 12 weeks 
E
x
e
rc
is
e
 g
ro
u
p
 
P848 
Balance (drying off from shower) 5 5 
Long distance walking 4 5 
Going up stairs 5 5 
Up/down curbs on own 1 1 
Run 3 3 
P449 
Carrying drinks 5 5 
Stairs without a railing 6 7 
Escalators 6 6 
Uneven ground/balance 5 6 
Stamina over long distances 7 8 
P318 
Carrying liquids 1 1 
Standing without hands 3 4 
Escalators 1 1 
Down spiral staircase 2 2 
Dressing in kilt 2 2 
P11 
Swimming 2 2 
Walk less bouncy 1 3 
Walk more than 5 minutes 1 5 
Right hand function 4 4 
P12 
Climbing (indoor) 5 8 
Cycling 7 7 
Sailing 8 8 
P15 More walking without walker 1 6 
P17 
Running (quicker) 5 7 
Swimming (kicking) 0 2 
Climb down from stairs (safer) 7 9 
C
o
n
tr
o
l 
g
ro
u
p
 
P339 
Dressing 8 8 
Transferring chair to walker 7 8 
Holding objects when standing 2 2 
Posture when walking 2 2 
Confidence to take steps without aids 3 2 
P831 
Carrying heavy objects 4 6 
Carrying unbalanced objects 3 7 
In/out of tub 8 8 
Carrying liquids 6 5 
Muscle endurance/stamina 6 4 
P659 
Bath 1 1 
Escalators 1 2 
Long walks 4 5 
Dancing 3 4 
P16 
Cycling (starting) 2 2 
Kneeling 3 3 
Fitness level (more energy) 4 5 
Upper limb strength 3 3 
P210 
Two-wheel bicycle 1 1 
Balance 5 6 
Carrying objects 6 7 
Swimming 3 3 
Walking long distance 6 7 
P14 Walking (distance) 2 2 
 Horse riding 5 7 
 Ride bike 1 1 
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7.5.6 The outcomes of physical function in the exercise group over time (6, 
12, 18 weeks) 
As only a very small number of the participants in the control group attended for 
assessment at weeks 12 and 18, analysis on the effects over time (6, 12, 18 
weeks) was performed for the exercise group only. The physical function and 
gait quality data for the exercise group over time are presented in Table 7.12. 
There was a significant difference in hip extension strength over time in the 
exercise group. However, post-hoc tests with Bonferroni adjustment (p>0.017) 
revealed that no significant change occurred between baseline and 6 weeks 
(p=0.89, d=0.14), baseline and 12 weeks (p=0.09, d=0.76) or baseline and 18 
weeks (p=0.043, d=0.41). There were no statistically significant differences over 
time in other measures in the experimental group (Table 7.13). Hip abductor 
strength showed a continual increase from baseline to week 12, with a moderate 
effect size (d=0.54). Moderate effect sizes were also found for knee extensor 
strength at week 6 and week 18, with d=0.67 and d=0.79, respectively. 
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Table 7.12 The outcome (mean) of physical function and gait quality over time in the experimental 
group 
Outcome measure Baseline n=7 Week 6 n=7 Week 12 n=7 Week 18 n=7 
TUG(s) 17.1(11.4) 15.8(11.1) 15.0(9.8) 16.8(13.3) 
10m SRT  9.1(6.4) 9.4(6.4) 8.3(5.3) 8.8(6.7) 
Hip extension (Nm/kg)  1.04(0.49) 0.97(0.48) 1.46(0.74) 1.28(0.67) 
Hip abduction (Nm/kg)  0.59(0.16) 0.67(0.20) 0.69(0.21) 0.68(0.27) 
Knee extension 
(Nm/kg)  
0.86(0.26) 1.1(0.45) 1.0(0.4) 1.1(0.34) 
GMFM D & E 70.5(16.4) 72.7(17.0) 72.2(17.9) 72.4(17.6) 
GPS (o) 15.66(5.7) 15.79(5.6) 15.78(4.4) 14.33(3.1) 
TUG: Timed Up and Go test; s:seconds; 10m SRT: 10-metre shuttle run test; 
Nm/kg:NewtonMetre/kilogramme; GMFM D & E: Gross Motor Function Measure Dimensions D 
&E; GPS: Gait Profile Score 
 
 
Table 7.13 Differences over time (baseline, week 6, week 12, week 18) for physical function in the 
experimental group (Friedman test) 
Outcome 
measure 
 p-value Post hoc* Effect size  
 
 
   Week 
6 
Week 
12 
Week 
18 
Physical 
function 
TUG 0.18 n/a 0.12 0.2 0.02 
10m SRT 0.41 n/a 0.05 0.14 0.05 
Hip extension  0.03 p=0.89a,0.09b,0.043c 0.14 0.67 0.41 
Hip abduction  0.49 n/a 0.44 0.54 0.41 
Knee 
extension  
0.62 n/a 0.65 0.42 0.79 
GMFM D & E 0.50 n/a 0.13 0.10 0.11 
Gait 
quality 
GPS 0.62 n/a 0.02 0.02 0.29 
*Bonferroni adjustment significant value =p<0.017; TUG: Timed Up and Go test;10m SRT: 10-metre shuttle 
run test; GMFM D & E: Gross Motor Function Measure Dimensions D &E; GPS: Gait Profile Score 
a p-value between baseline and 6 weeks with Bonferroni adjustment (Wilcoxon Ranked Test) 
b p-value between baseline and 12 weeks with Bonferroni adjustment (Wilcoxon Ranked Test) 
c p-value between baseline and 18 weeks with Bonferroni adjustment (Wilcoxon Ranked Test) 
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7.5.7 The outcomes of objective habitual physical activity patterns, self-
reported function, QoL and self-esteem in the exercise group: changes 
over time (12 weeks) 
The outcomes for objective habitual physical activity, self-reported function, QoL 
and self-esteem were explored over time from baseline to week 12 in the 
exercise group and are shown in Table 7.14. There was a statistically significant 
effect of time for self-reported function, as measured by COPM (Table 7.15). 
The current study also found a trend (d=0.36) of improvement in the exercise 
group for time spent sitting/lying and standing using data derived from at least 4 
days’ use of the ActivPALTM from baseline to week 12, but this did not reach 
statistical significance (p=0.3 & 0.5). At week 12, the mean time for sitting/lying 
(sedentary behaviour) was reduced by 0.6 hours and the number of steps per 
day had increased by 949 steps; however, these changes were less than the 
MDC values found in Study 2, Chapter 5, thereby indicating that the changes 
could be due to measurement error. Although no statistical effects of time were 
found in the mental component score (MCS), a trend of improvement was 
observed with a small effect size (d=0.34). 
 
Table 7.14 The outcome (mean) of the objectives habitual physical activity, QoL and self-esteem 
over time in the experimental group 
Outcome measure  Baseline  Week 12 
HPA Sitting/lying (hour/day) 20.9(1.4), n=5 20.3(1.9), n=5 
Standing (hour/day) 2.1(1.0), n=5 2.5(1.2), n=5 
Steps/day 4228(3204), n=5 5177(3552), n=5 
Sit-to-stand transition 39(17), n=5 40(12), n=5 
Self-reported function COPM (Performance 0-10) 2.8(1.9), n=7 4.3(1.8), n=7 
FAQ (0-25) 14.6(5.7), n=7 15.6(3.9), n=7 
QoL PCS (34.75-56.71) 44.1(8.7), n=7 42.1(5.4), n=7 
MCS (15.37-62.39) 48.1(14.0), n=7 53.2(15.8), n=7 
Self-esteem RSES 18.4(8.4), n=7 19.2(9.7), n=7 
HPA: habitual physical activity; COPM: Canadian Occupational Performance Measure; FAQ: Gillette 
Functional Assessment Questionnaire; QoL: Quality of life; PCS:Physical Component Score; MCS: Mental 
Component Score; RSES: Rosenberg Self-Esteem Scale 
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Table 7.15 Differences over time (baseline–week 12) for physical activity, QoL and self-esteem in 
the experimental group (Wilcoxon Rank test) 
Outcome measure  p-value Effect size  
HPA Sitting/lying 0.35 0.36 
Standing  0.50 0.36 
Steps/day 0.50 0.28 
Sit to stand 0.89 0.07 
Self-reported function COPM  0.02* 0.81 
FAQ  0.60 0.20 
QoL PCS  0.75 0.28 
MCS  0.08 0.34 
Self-esteem RSES 0.21 0.09 
*significant difference over time p<0.05; HPA: habitual physical activity; COPM: Canadian Occupational 
Performance Measure; FAQ: Gillette Functional Assessment Questionnaire; QoL: Quality of life; PCS: 
Physical Component Score; MCS: Mental Component Score; RSES: Rosenberg Self-Esteem Scale 
 
 
7.6 Discussion 
7.6.1 Analysis of group x time interaction at 6 weeks (RCT) 
This analysis aimed to compare the results for physical function (TUG, 10m 
SRT, isometric muscle strength, GMFM, COPM, FAQ) and gait quality between 
the intervention (exercise) group following 6 weeks of a pragmatic community 
exercise programme and a control (usual care) group. The results showed no 
significant time x group interaction at 6 weeks for any of the outcome measures. 
Other RCTs that examined the effects of exercise interventions for people with 
CP also failed to reveal between-group differences for some or all of the 
outcome measures (Dodd et al. 2003, Taylor et al. 2013). Dodd et al. (2003) 
reported on the results of an RCT into the effects of a six-week home-based 
strength training programme involving 21 participants with CP aged 8 to 18 
years classified as GMFCS levels I–III, and they also did not find a significant 
group x time interaction for either isometric muscle strength of the hip extensors 
and abductors or for the GMFM dimensions D&E. However, Dodd et al. (2003) 
did report that the exercise group showed a statistically significant increase in 
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combined ankle plantarflexor and knee extensor strength at 6 and 12 weeks 
compared to the control group. Another RCT on 12-week strength training also 
failed to find a difference (i.e. improvement) on GPS and GMFM dimensions D & 
E between the exercise and control groups at the 12-week assessment on 
participants with CP and a mean age of 18.1 years with GMFCS levels II & III 
(Taylor et al. 2013). However, Taylor et al. (2013) did report that the exercise 
group significantly improved on their FAQ, Functional Mobility Scale (at 5m) and 
the strength of their targeted muscle group compared to the control group.  
 
The highest effect size found in the RCT analysis in this study was for the 
COPM, which indicated a moderate effect size of d=0.54 at 12 weeks. Post-hoc 
power analysis revealed that if this effect size of 0.54 were to be maintained, a 
sample size of n=51 in each group would be required for this comparison to 
reach statistical significance (at 80% probability).    
 
7.6.2 Analysis of the effect of time at 6 weeks (both groups) 
This analysis revealed a statistically significant improvement over time in the 
physical function of both groups, as measured by the TUG, and gross motor 
function, as recorded by GMFM 66 dimensions D & E. These results suggest 
that the participants in both groups may have experienced a learning effect in 
these outcome measures. 
 
7.6.3 Analysis of the exercise group (Within group) at 6, 12 and 18 weeks 
The current study found no significant improvement over time (6, 12, 18 weeks) 
in any of the outcome measures within the exercise group. Some of the OMs – 
hip extension strength (d=0.67) and hip abductor strength (d=0.54) – showed 
moderate effect sizes for improvement from baseline to week 12. However, hip 
extension strength decreased from weeks 12 to 18 (d=0.41). The changes in the 
scores appear to be different from the results of the significance testing due to 
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the small sample size. The change in hip extensor strength showed an increase 
from baseline to week 12; however, this change was not statistically significant, 
thus indicating a type I error. 
 
The lack of any statistically significant improvement in isometric muscle strength 
within the experimental group found in the current study is in contrast to the 
findings reported by Eek et al. (2008), who found a significant improvement 
compared to baseline for hip extension and hip abductor strength in participants 
with CP aged 9 to 15 years with GMFCS levels I & II following an 8-week 
strength-training programme carried out three times per week. This discrepancy 
in the results may be due to the fact that Eek et al. (2008) focused on strength 
training only, while the current study combined both aerobic and strength 
training.  
 
There was a lack of effect of the exercise programme on the outcomes of 
walking performance and gait quality. The TUG test and gait quality measured 
by the GPS did not show improvement in any of the assessments (6, 12 and 18 
weeks), as evidenced by the lack of statistical significance and low effect sizes 
(d<0.3). Other CP studies with adolescents reported mixed effects of exercise 
programmes on walking speed and gait kinematics. Unger et al. (2008), in an 
evaluation of an individualised strength programme for 13–18-year-olds, 
reported a decrease in crouch gait but no effect on walking speed and stride 
length. In a different study by Darrah et al. (1995) with participants aged 11–20 
years, significant improvements in strength were reported but no significant 
change in walking speed.  
 
Although there was a clear lack of change in objective physical function 
outcomes over time, there were statistically significant improvements in self-
reported physical function, as measured by the COPM, from baseline to week 
12 in the experimental group, with large effect size (p=0.02, d=0.81). The COPM 
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is a self-reported questionnaire in which participants are asked to list those 
activities (a maximum of five) that they would like to improve by following the 
exercise programme. The participants in the exercise group rated improvement 
in the performance of their selected daily activities, such as distance walked, 
climbing up and down the stairs and swimming, from baseline to week 12 by 
nearly one point more (from 3.6 to 5.1) compared to the control group (3.9 to 
4.5). This result indicates that the exercise programme influenced the 
individuals’ rated performance regarding their performance in their daily 
activities, which perhaps allowed them to participate more in society (McBurney 
et al. 2003). However, the COPM is a very subjective outcome measure and 
thus the positive result could be (partly) due to the fact that the participants 
anticipated an improvement through their following of the exercise programme. 
 
There was no significant difference observed either within group (experimental) 
or between groups with regards to the FAQ scores from baseline to 12 weeks in 
this study. The current finding is consistent with the lack of change reported by 
McNee et al. (2009) in a study of 13 participants with CP aged 6–16 years who 
followed a 10-week plantarflexor strengthening programme. It is possible that 
the FAQ is not sufficiently sensitive to capture relatively small improvements in 
walking function.  
 
There was a trend for improvement in the exercise group in comparison with the 
control on MCS scores over the 12 weeks, with a small effect size (d=0.32). 
Slaman et al. (2014b) found a significant improvement in the MCS (SF36) at the 
week 6 and week 12 assessment following a combination of physical fitness and 
counselling intervention in 57 young people with CP. Previous CP exercise 
studies have measured QoL using population-specific QoL scales such as 
TACQOL (Verschuren et al. 2007) and PedsQoL (Engsberg et al. 2006) and 
generic scales such as SF 36 (a longer version of SF-12) (Slaman et al. 2014b).  
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The RSES was used to evaluate changes in self-esteem in the current study, 
with the current study finding no statistically significant difference between the 
exercise and control groups at week 12. Dorval et al. (1996), in a study on the 
impact of a 10-week aquatic programme on adolescents with CP, also revealed 
no significant difference in self-esteem measured by the RSES in the 
experimental group (aquatic programme) compared with the control group 
following the training and nine-month follow-up. There are other examples of 
exercise programmes having a positive effect on self-perception in CP (Dodd et 
al. 2004, Unger et al. 2006). High self-esteem can lead to positive qualities such 
as life satisfaction, positive social adjustment, independence, adaptability and 
resilience to stress (Biddle et al. 2003) and has therefore emerged as a strong 
predictor of mental well-being and quality of life (Diener 1994).  
 
7.6.4 Recruitment, adherence, attrition 
While RCTs provide the most reliable evidence for evaluating health care 
interventions (Barton 2000, Sackett et al. 1996), they are often hindered by 
recruitment difficulties (Lovato et al. 1997). The recruitment rate in the current 
study was low (6%) (Figure 7.3) and, as a result, did not achieve the sample 
size required for an appropriately powered trial. The effects of insufficient 
recruitment include 1) reduced power to detect significant intervention effects 
(Swanson and Ward 1995), and 2) generalisability of the results (Easterbrook 
and Matthews 1992). A systematic review suggested two strategies for 
increasing recruitment in RCTs. Firstly, engaging participants in learning about 
the health problem being studied and its impact on their health, or else inform 
participants of the intervention they have been randomised to receive (non-blind 
trial design) (Caldwell et al. 2010). This strategy has been applied in our 
recruitment as the information on the exercise programme was embedded in the 
invitation package. In addition, the invitation package was revised prior to the 
current study taking place. In particular, the patient information sheet (PIS) 
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(Appendix 13) was reviewed (informally, unstructured) by several people with 
CP aged 16–25 who were attending the Craigalbert Centre (Appendix 14), and 
this informal discussion does not form part of the thesis. These young people 
commented on several issues, such as the mentioning of pain in the PIS, which 
may put some potential participants off. Consequently, the PIS was amended 
after taking into account their written and verbal comments to the Craigalbert 
Centre’s physiotherapist. Secondly, Caldwell et al. (2010) also suggested the 
use of monetary incentives. Due to financial restrictions, the current study did 
not offer these incentives to its participants, although travel expenses from the 
participants’ homes to the assessment venue, and vice versa, were covered. In 
addition, the participants in the exercise group (as well as the participants in the 
control group who wished to take part in the exercise programme) received five 
months’ membership of the leisure centre with unlimited access. Future multi-
centre trials may improve on the number of participants recruited in comparison 
to single-centre studies such as the current study. 
 
Adherence was monitored using the exercise logbook. It should be noted that 
adherence to the programme increased from 86% to 90.6% between Block 1 (0–
6 weeks) and Block 2 (7–12 weeks), thereby suggesting that the majority of the 
participants preferred to exercise twice weekly rather than thrice weekly. This 
was also supported by the feedback questionnaire, which was returned by nine 
of the participants upon completion of the exercise programme. Four of the 
participants stated that they would like to continue to exercise on their own after 
the programme, but only for 1 to 2 sessions per week. On the other hand, three 
of the participants answered ‘yes’ but did not specify a frequency. One 
participant stated they would like to continue exercising with a different 
programme, and one participant did not answer. Exit/follow-up questionnaires in 
future studies should obtain more specific feedback regarding the participants’ 
preferred exercise frequency.  
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As described above, the majority of the participants exercised at the prescribed 
frequencies in Block 1 (3x/week) and Block 2 (2x/week), indicating good 
adherence. However, during Block 3, when physiotherapist input was mostly 
absent, the average frequency of gym attendance decreased to once per week, 
thus demonstrating that long-term adherence may not have been achieved for 
five of the participants; one of the participants did not attend the gym at all and 
four of the participants attended less than 2/3x per week. Adherence to an 
exercise programme is multifactorial and there are many age-specific 
(perceived) barriers to attending the gym (Verschuren et al. 2012, Heller et al. 
2002, Shields et al. 2012) (refer to Chapter 8 for further discussion on this). For 
example, in Block 3, one of the participants was on work placement for three 
months and therefore could not attend gym sessions at all during these weeks. 
 
Apart from adherence, study attrition was another problem within this study. Five 
of the participants withdrew over the course of the 18 weeks (at different time 
points, Figure 7.3). Of those five, two participants were in the exercise group 
and three participants were in the control group. The attrition rate (29%) in this 
study is comparable with that seen in previous CP exercise studies (McNee et 
al. 2009). McNee et al. (2009), in a study of 10-week strength training with 
frequencies of exercise 4 x/week, had 13 participants complete the programme 
with an attrition rate of 35%. Since this study has an attrition greater than 20%, 
this indicates that the results have a high risk of bias; as such, the results should 
be treated with caution (Dumville et al. 2006). 
 
7.6.5 Fidelity 
While the frequency, repetitions and progressive nature of the exercises in the 
training programme could be quantified through the exercise logbook, the 
participants’ fidelity was not formally measured. The frequency and quality 
(whether the participants did the exercise as outlined) of training should be 
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captured and linked to the programme outcomes, to provide stronger evidence 
on the exercise programme (Fortington et al. 2015). Ideally, to maximise the 
intervention fidelity, it is recommended that an independent assessor observe 
the exercise session at random intervals and monitor the consistency of the 
exercise content using a checklist based on the explicit components of the 
exercise intervention protocol. However, in practice this might not be practical; 
hence, the current study used the exercise logbook to monitor the number of 
repetitions and the progressiveness of the exercise.  
7.6.6 Exercise progression and preferences and exercise characteristics 
The current study aimed to progress the strength training every 2 weeks when 
the participants were able to comfortably achieve 12 repetitions with a particular 
resistance. For aerobic exercise, the aim was to progress the intensity and/or 
duration whilst keeping the Borg Rating of Perceived Exertion (RPE) scale at 
‘13’ using a static bicycle, cross trainer, treadmill or rowing machine as 
appropriate, preferably by the participants themselves in line with advice from an 
experienced physiotherapist. The entries in the exercise logbooks showed that 
all of the participants followed the progression as mentioned above. The 
feedback questionnaire did not record any complaints that either the dosage or 
intensity of the exercise programme were too high, thus suggesting progression 
was well tolerated. The results of the feedback questionnaire also showed that a 
majority (7 of 9) of the participants would like to continue the exercise 
programme with strengthening, aerobic and stretching components, with another 
two participants stating they would prefer to continue with the stretching 
component only. During the programme the exercise bikes were utilised most. 
One participant utilised the cross trainer and one utilised the Motomed. 
 
7.6.7 Outcome measures 
Despite the large number of outcome measures (13) repeated at four time points 
with between 2 and 3 hours for each visit, the assessment was shown to be 
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feasible and did not discourage participation for those who volunteered to 
participate in the study. No complaints were received regarding the duration of 
the assessment, but this may be due to the fact that the participants wanted to 
please the researcher and were eager to find out their performance and any 
improvement they had made. However, the current study did not ask for 
feedback regarding the length of the assessment in the exit questionnaire 
(feedback questionnaire), which was focused on the characteristics of the 
exercise programme and not the study itself. 
 
It is possible, however, that the potential participants who were invited to 
participate in the study decided not to participate due to the requirement to 
commit to relatively frequent and long assessments, thus partly resulting in the 
low recruitment rate. The duration of the assessment in relation to the 
recruitment rates should therefore also be examined as this study had a very 
low recruitment rate (6%), and this is something that could be explored in future 
studies through a survey or follow-up call. The duration of assessment could 
potentially be reduced in future studies by performing fewer outcome measures 
during each visit. But, as discussed in Chapters 2 and 5, the psychometric 
properties of the outcome measures should be important criteria to consider 
when choosing a tool to measure outcomes following exercise intervention.  
 
7.6.8 Limitations 
In the current study, the target sample size was not achieved due to low 
recruitment rates and attrition of 29%; hence, the study was underpowered and 
therefore at risk of type-2 error. As discussed above, the low number of 
participants may have been due to the requirement to commit to an 18-week, 
thrice-/twice-weekly exercise programme and the high number of outcome 
measures assessed (2–3 hour assessments, 4 times). Interestingly, the number 
of participants in the current study is comparable to those in many similar 
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studies (Damiano et al. 1995a, McPhail and Kramer 1995, Dodd et al. 2004, 
Eagleton et al. 2004, Engsberg et al. 2006, Unnithan et al. 2007, McBurney et 
al. 2003, McNee et al. 2009, Eek et al. 2008, Auld et al. 2014), thus indicating 
that small sample size is a common problem in exercise studies in the CP 
population, which is something that needs to be addressed. 
 
The fidelity of the exercise programme was not formally assessed over the 
duration of the programme. As discussed earlier, having an independent 
assessor to assess whether the programme was conducted as planned (i.e. 
progression of the exercise, RPE) would have been preferable. However, the 
aim of this study was to assess the effects of a pragmatic community exercise 
programme and not those of a highly structured and supervised programme in a 
university or hospital setting. 
 
7.7 Conclusion 
The RCT did not result in any statistically significant findings; however, 
moderate effect was found on the COPM, thereby indicating that there was a 
trend of improvement from baseline to 12 weeks in self-reported physical 
function. Analysis within the experimental group detected a statistically 
significant improvement on the COPM at 12 weeks. Moderate effect sizes 
indicating a trend for improvement in isometric muscle strength (i.e. hip 
extension, hip abductor) were also observed at either 6, 12 or 18 weeks. Small 
effect sizes were detected in time spent sitting/lying, standing and MCS. A 
single-centre study rarely provides sufficient evidence to guide clinical and 
research practice; nevertheless, the results of this study do add to the findings of 
other previous CP exercise studies. It is clear that further, appropriately powered 
research is warranted. 
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CHAPTER 8 FINAL DISCUSSION 
 
8.1 Introduction 
The primary aim of this thesis was to investigate the effects of an 18-week 
exercise programme on the physical function, gait quality, habitual physical 
activity, quality of life and self-esteem of adolescents and young adults with CP 
through a single-blind randomised controlled trial (Study 3, Chapter 7). The 
study’s secondary objectives were to evaluate (a) the methodological quality and 
strength of evidence of the published articles that reported the psychometric 
properties of gait quality and walking performance in adolescents and young 
adults with CP using a standardised quality checklist (COSMIN) (Study 1, 
Chapter 4), and (b) the reliability of physical function, habitual physical activity, 
quality of life and self-esteem outcome measures in adolescents and young 
adults with CP, using a test-retest study design (Study 2, Chapter 5). 
 
The key findings from the preceding chapters are summarised in Table 8.1. In 
each of the preceding four chapters the empirical studies have been discussed 
independently of one another. The purpose of this chapter is therefore to 
synthesise and integrate these chapter-specific findings and to discuss these in 
the broader context of the existing literature. The implications for clinical and 
research contexts are discussed along with an identification of the limitations of 
this study and feasibility issues that will inform future work. 
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Table 8.1 Key findings from the preceding four chapters 
Chapter Key findings 
Chapter 4: Psychometric 
properties of measures of gait 
quality and walking performance 
in young people with cerebral 
palsy: A systematic review 
 Fourteen OMs for measuring gait quality and walking performance were identified. 
Strong and moderate levels of evidence were found for the reliability of FMS and 
validity of GPS, respectively. 
 No evidence was found for responsiveness and measurement error for any OMs.  
Chapter 5: Reliability of physical 
function, habitual physical 
activity, quality of life and self-
esteem outcome measures in 
young people with cerebral palsy 
and age-matched controls 
 The ICC values for participants with CP were: TUG (0.95, 95% CI 0.77–0.99), 10m 
SRT (0.86, 95% CI 0.44–0.97), isometric hip extensor strength (0.89, 95% CI 0.56–
0.98) and HPA (sedentary behaviour, standing, stepping, step counts, sit to stand) 
measured by an activity monitor (ActivPALTM) (0.76–0.86, 95% CI 0.02–0.98) when 
assessed 6 weeks apart in adolescents and young adults with CP with GMFCS 
level I–III. Moderate reliability was found for the SF-12 physical component score 
(ICC=0.74, 95% CI -0.03–0.96). The ICC for the SF-12 mental component score 
was 0.45 (95% CI -0.45–0.90) and for the RSES was 0.13 (95% CI -0.69–0.81), 
indicating poor reliability. 
 The ICC values for the healthy controls were: TUG (0.80, 95% CI 0.48–0.93), 10m 
SRT (0.92, 95% CI 0.77–0.97) and RSES (0.96, 95% CI 0.89–0.99). Moderate 
reliability was found for hip abductor strength (0.57, 95% CI 0.08–0.84), PCS (0.53, 
95% CI 0.03–0.82) and MCS (0.57, 95% CI 0.08–0.84). Poor reliability was found 
for hip extensor strength (0.36, 95% CI -0.19–0.74), knee extensor strength (0.16, 
95% CI -0.39–0.62) and HPA (0.24-0.50, 95%CI -0.39–0.84). 
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Chapter Key findings 
 The MDC95 and MDC% for OMs of physical function, habitual physical activity, 
quality of life and self-esteem in adolescents and young adults with CP and age-
matched controls were established. 
Chapter 6: Physical function, 
habitual physical activity, quality 
of life and self-esteem in young 
people with cerebral palsy and 
age-matched controls: A cohort 
study 
 This study confirms that the young people with CP in our study had significantly 
lower physical function, lower habitual physical activity and reported a lower 
physical component of QoL than their age-matched peers. However, the mental 
component score and self-esteem were not significantly different between the CP 
group and healthy controls.  
Chapter 7: Effects of an 18-week 
pragmatic community exercise 
programme on physical function, 
gait quality, habitual physical 
activity, quality of life and self-
esteem of young people with CP: 
a single-blind RCT 
 No significant time x group interaction for any outcome measures at either 6 weeks 
(for physical function) or 12 weeks (for HPA, SF-12, RSES, COPM, FAQ); small 
effect size found in the COPM (d=0.54) at 12 weeks. 
 Considering the experimental group only: statistically significant improvement in the 
COPM at 12 weeks (p=0.02, d=0.81) and trends indicating increased isometric 
strength of hip extensor (d=0.67) and abductor muscle (d=0.54), decreased time 
spent sitting/lying (d=0.36), increased time spent standing (d=0.36) and increased 
SF-12 MCS (d=0.34) at 12 weeks. No statistically significant changes in gait quality 
(p=0.62, d=0.29), step count (p=0.5, d=0.28), sit to stand (p=0.9, d=0.07), SF-12 
PCS (p=0.8, d=0.28) and self-esteem (p=0.2, d=0.09) over time. 
FMS: Functional Mobility Scale; GPS; Gait Profile Score; 3DGA: Three-Dimensional Gait Analysis; OMs: Outcome Measures; ICC: Intraclass Correlation Coefficient; TUG: 
Timed Up And Go Test; 10m SRT: 10-metre Shuttle Run Test; HPA: Habitual Physical Activity; GMFCS: Gross Motor Function Classification Score; MDC: Minimal Detectable 
Change; COPM: Canadian Occupational Performance Measure; d: Cohen’s d effect size; GMFM: Gross Motor Function Measure; QoL: Quality of Life; PCS: Physical 
Component Score; MCS: Mental Component Score; SF-12: Short Form 12 
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8.2 Current psychometric evidence supporting outcome measures of 
gait and walking performance in young people with CP 
Clinicians and researchers should be looking for evidence from high-quality 
psychometric studies to reassure them of the validity, reliability and 
responsiveness of the outcome measure(s) they decide to use. However, Study 
1 (Chapter 4) showed that there is a lack of such high-quality studies reporting 
the psychometric properties of gait quality and walking performance outcome 
measures used in young people with CP. As a result, the systematic review in 
Chapter 4 concluded that only the reliability (consistency) of the Functional 
Mobility Scale (FMS) has a ‘strong’ level of evidence and the construct validity of 
the Gait Profile Score (GPS) derived from the 3DGA has a ‘moderate’ level of 
evidence. The rating of the methodological quality in many studies was reduced 
from ‘excellent’ to ‘good’/’fair’, often due to poor choices for the statistical 
analysis. The results from Study 1 also demonstrated that the evidence for 14 
OMs with regard to responsiveness and measurement error, including for FMS 
and GPS, remains unknown. 
 
Responsiveness was reported in only three of the studies included in the 
systematic review (Chapter 4), and the methodological quality of all three was 
rated as ‘poor’ for the reason of not including a comparator outcome measure. 
Moreover, none of these three studies reported Minimal Clinically Important 
Change (MCID) values. The limited choice of outcome measures with robust 
psychometric properties, especially pertaining to responsiveness, is of concern 
as any ability to assess changes in gait quality and walking performance in 
patients following an exercise intervention requires outcome measures that are 
responsive to change. In addition, it was concluded that there is a lack of studies 
reporting measurement error (e.g. MDC). 
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Concern about the lack of or unknown evidence, especially with regard to 
responsiveness, was identified not just in the current review but also in previous 
systematic reviews with CP populations (Ketalaar et al. 1998, Harvey et al. 
2008, Carlon et al. 2010). In their systematic review of functional motor abilities 
outcome measures, Ketalaar et al. (1998) suggested that there is an urgent 
need to explore measures that can evaluate change in functional abilities in 
children with CP. Harvey et al. (2008) suggested that more studies on the 
responsiveness of activity limitation outcome measures are needed for children 
with CP. Another systematic review by Carlon et al. (2010) on the quality-of-life 
measures for school-aged children with CP also recommended more work on 
data for sensitivity to change. In addition, Carlon et al. (2010) also commented 
on the lack of available data on measurement error despite the fact that the 
methodological quality of studies assessing validity and reliability with regard to 
consistency is improving. 
 
The clinical significance of a difference in a certain measure after treatment is 
represented by the MDC and MCID (de Vet et al. 2006). MDC is defined as the 
smallest change beyond measurement error, and any change higher than the 
MDC can thus be regarded as a true difference (de Vet al. 2006). MCID is 
defined as the smallest change in an OM that is perceived to be effective by the 
patient or clinician (de Vet et al. 2006, Guyatt et al. 2002, Jaeschke et al. 1989). 
The MDC is derived from test-retest reliability studies while the MCID is derived 
from the results of a longitudinal study where outcomes are expected to change 
over time as a result of a certain intervention. Therefore, the values for MDC and 
MCID provide clinicians with the information they need for effective clinical 
decision-making when interpreting score changes following a certain 
intervention. While this thesis presents the MDC values for all of the OMs 
included in Study 2, the values for the MCIDs were not derived. There were two 
reasons for this. Firstly, it is not recommended to combine a study on the 
responsiveness of outcome measures with an intervention study, as it is not 
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known whether the intervention actually brings about a change in outcome. 
Secondly, there are methodological issues regarding the way in which MCID is 
derived. The anchor approach has been recommended to calculate MCID 
(Copay et al. 2007, Haley and Fragala-Pinkham 2006b) compared to the 
distribution approach. However, as there is a lack of a gold standard in the area 
of health care and rehabilitation, the anchor is often a patient or clinician rating 
scale such as the Global Rating Scale (Kamper 2009), and the evidence 
regarding the validity of such a rating scales is currently conflicting (Kamper 
2009). 
 
8.3 Reporting standards of clinical studies 
Several standards are currently available to help with the reporting of research 
and clinical studies, including 1) Preferred Reporting Items for Systematic 
Reviews and Meta-analyses (PRISMA) (Moher et al. 2016, Moher et al. 2015), 
2) Consolidated Standards for Reporting Trials (CONSORT) (Schulz et al. 
2015), and 3) Revised Standards for Quality Improvement Reporting Excellence 
(SQUIRE 2.0). More details on these and other guidelines can be found in the 
EQUATOR (Enhancing the QUAlity and Transparency Of health Research) 
website (http://www.equator-network.org). These standardised checklists guide 
the author on the reporting or designing (i.e. methodological aspects) of 
intervention studies but not of psychometric studies. The COSMIN checklist, as 
detailed in Chapter 4, is a specific checklist concerned with the methodological 
quality of psychometric studies. It incorporates a multi-level grading system for 
each measurement property, thus giving detailed information on the quality of 
outcome measures as well as the appropriate usage of statistical analysis for 
specific measurement properties. The COSMIN checklist is therefore also aimed 
at informing clinicians and researchers with regard to the reporting and design of 
psychometric studies. 
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The COSMIN checklist was originally developed to rate the methodological 
quality of health-related quality of life surveys. However, in the systematic review 
in this thesis and many other systematic reviews, the methodological quality of 
non-questionnaire-based outcome measures has been rated using the COSMIN 
checklist, and this is regarded as a limitation by some researchers. Although 
another standard assessment to rate studies on the measurement properties of 
outcome measures has been published by Brink and Louw (2012), this was not 
developed for use in systematic reviews. The COSMIN checklist was developed 
for non-questionnaire-based outcome measures; as such, there were items in 
the checklists which were not applicable to the current review, such as missing 
items. Internal consistency and content validity were not rated/not applicable. 
This was discussed in Chapter 4. Apart from that, all other boxes (measurement 
properties) and items on the COSMIN checklist are applicable for all types of 
outcome measures. 
 
8.4 Contribution of this thesis to psychometric evidence for 
outcomes of physical function and physical activity, QoL and self-
esteem in young people with CP 
To address some of the gaps in the evidence regarding the lack of data on 
measurement error in commonly used outcome measures identified in the 
systematic review (Chapter 4) and previous systematic reviews, Study 2 
(Chapter 5) was performed. In this study the reliability (both consistency and 
agreement/measurement error) of outcomes of physical function (TUG, 10m 
SRT, isometric muscle strength, habitual physical activity (ActivPALTM), QoL and 
self-esteem outcome measures in adolescents and young adults with CP were 
determined through a test-retest design with a 6-week interval. It was found that 
the ICC of the TUG was 0.95 (95% CI 0.77–0.99), that of the 10m SRT was 0.86 
(95% CI 0.44–0.97) and there was an ICC of 0.89 (95%CI 0.56–0.98) for 
isometric hip extensors. The ICCs for the isometric hip abductors and habitual 
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physical activity were between 0.75 and 0.86 (95% CI 0.02–0.98), indicating 
good reliability (‘consistency’). The physical component scores of the SF 12 
were found to have moderate reliability (ICC=0.74, 95% CI -0.03–0.96). These 
findings are supported by other studies, which found good reliability of the TUG 
(Dhote et al. 2012, Williams et al. 2012, Gan et al. 2008), 10m SRT (Verschuren 
et al. 2006, Verschuren et al. 2011), isometric hip extensor strength (Seniorou et 
al. 2002) and ActivPALTM (Bania 2004) in the CP population. However, the 
majority of these previous studies used an interval of less than 6 weeks, with the 
majority having a one-week gap between tests. The 6-week interval in our study 
was selected as this interval is often selected in exercise intervention studies 
since it is often believed that around 6 weeks is sufficient for an exercise 
intervention to induce changes in physical fitness (Taylor et al. 2013). 
 
Therefore, our findings contribute to the evidence in the literature regarding the 
reliability (consistency) of the physical function, isometric muscle strength and 
ActivPALTM in young people with CP. However, the ICCs of the mental 
component score of the SF-12 and self-esteem measured by the RSES were 
0.45 (95%CI -0.45–0.90) and 0.13 (95%CI -0.69–0.81) respectively, thereby 
indicating poor reliability. Nevertheless, the current study provides the MDC 
values for SF-12 and RSES, and this could help clinicians or researchers to 
interpret the changes (i.e. a true change or measurement error). No previous 
studies have examined the reliability of SF-12 and RSES in adolescents and 
young adults with CP; hence, future studies are needed to confirm our results.   
 
In addition to the consistency aspect of reliability, the current study also reported 
the MDC95 values (i.e. ‘agreement aspect of reliability’) for all of the outcome 
measures included in Study 2, Chapter 5. The MDC95 values found in Study 2 in 
relation to the changes found in the exercise study (Study 3, Chapter 7) are 
shown in Table 8.2. None of the average changes found in Study 3 were beyond 
the MDC95 values reported in Study 2. This may indicate that the changes found 
199 
  
in Study 3 were possibly due to measurement error and do not reflect a true 
change as a result of the exercise programme. On an individual level, however, 
a few of the participants exceeded the MDC95 values in different outcome 
measures (Table 8.2).  
 
With regard to the step counts, the MDC95 reported in Study 2 was 2667 
steps/day, and this value is quite high in comparison to that for other populations 
using the same activity monitor, i.e. ActivPALTM. Van der Linden et al. (2013) 
found the MDC95 for step counts in people with multiple sclerosis was 1741 
steps/day. So far, no study has reported the MDC of habitual physical activity 
pattern using ActivPALTM in the CP population. A possible explanation for this 
high measurement error may be that habitual physical activity is complex and is 
related to psychological, social or environmental factors and physical factors 
(Palisano et al. 2011, Bania et al. 2011, Anderson-Bill et al. 2011, Conchar et al. 
2016), meaning that daily step count, even when averaged over a period of 4 to 
7 days, can vary considerably from week to week. 
 
In summary, Study 1 (Chapter 4) identified a lack of studies reporting the MDC 
of measurements used in the population with CP, while Study 2 was the first to 
report the absolute and relative MDC values of measures of physical function, 
habitual physical activity patterns, quality of life and self-esteem in young people 
with CP. The results from Study 2 can be used as a reference for the 
measurement error of measures of physical function (i.e. TUG, 10m SRT, 
isometric muscle strength) and habitual physical activity patterns (i.e. activity 
monitor ActivPALTM) to help clinicians and researchers determine the ‘true’ 
change between two assessments.  
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Table 8.2 The minimal detectable change values reported in Study 2 and Study 3 
Outcome 
measures 
MDC95 values in Study 2, 
Chapter 5 with 6-week 
interval 
Mean (SD) changes  
found in Study 3, 
Chapter 7 
(experimental group) 
Number of 
participants in the 
exercise group 
exceeding the MDC  
TUG(s) 6.88 2.3a 1/9 
10m SRT (nr of  
shuttles) 
3.6 0.3a 1/9 
Hip extensor 
(Nm/Kg) 
0.6 0.05a 1/9 
Hip abductor 
(Nm/Kg) 
0.44 0.09a 0/9 
Knee extensor 
(Nm/Kg) 
0.74 0.27a 1/9 
GMFM 66 
Dimension D&E 
3.62 2a 2/9 
GPS (o)¥ 5.6 0.13b 0/9 
Sitting/lying* 
(hours/day) 
1.8 0.6b 1/5 
Steps/day* 2667 784b 1/5 
Sit to stand* 
(number/day) 
13.6 0b 2/6 
COPM 
(Performance 0-
10) 
1 1.5b 2/7 
FAQ (0-25) 3 1b 1/7 
PCS (34.75-
56.71)µ 
13.21 1.3b 0/4 
MCS (15.37-
62.39)µ 
22.26 5.5b ¼ 
RSES (0-30) 7.56 0.8b 0/4 
MDC, Minimal Detectable Change; TUG, Time Up and Go test; 10m SRT, 10-metre shuttle run 
test; GMFM, Gross Motor Function Measure; GPS, Gait Profile Score; COPM, Canadian 
Occupational Performance Measure; FAQ, Gillette Functional Assessment Questionnaire; PCS, 
Physical Component Score; MCS, Mental Component Score; RSES, Rosenberg Self-Esteem 
Scale;¥derived from kinematics data from three-dimensional gait (3DGA) analysis; *derived from 
activity monitor known as ActivPALTM ; µderived from Short Form 12 version 2 (SF-12); a 6-week 
interval; b 12-week interval 
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8.5 Exercise programme for adolescents and young adults with CP 
Study 3 (Chapter 7) was conducted in response to the paucity of research with 
scientifically robust designs that investigated exercise interventions in 
adolescents and young adults with CP. This is unfortunate since adolescence 
and early adulthood seems to be a crucial time at which to implement this type 
of management strategy. This stage of life appears to mark the beginning of 
functional decline and greater social isolation for people with CP (Ng et al. 2003, 
Stevenson et al. 1997, Jahnsen et al. 2004, Liptak 2008). Additionally, it is 
during this time that people with CP must begin the transition from child health 
care to adult health care. Introducing adolescents and young adults with CP to 
an exercise programme would perhaps provide them with a means of self- 
managing their health and well-being throughout their adult life, when the 
provision of physiotherapy is rare and often absent. Therefore, the main aim of 
this study was to evaluate the feasibility and effectiveness of an 18-week 
exercise programme on physical function, gait quality, habitual physical activity, 
quality of life and self-esteem in adolescents and young adults with CP.  
 
Four hundred and thirty ambulant young people with CP aged 16 to 25 years 
were invited to participate in this study. However, only 19 adolescents and 
young adults with CP were randomly allocated to either the exercise (n=10) or 
control groups (n=9) and assessed at baseline. At the 6-week assessment, nine 
participants in the exercise group and seven participants in the control group 
were available for analysis; by the 12-week assessment this had fallen to seven 
and five participants, and at 18 weeks the numbers were seven and one for the 
exercise and control groups, respectively. Due to the recruitment and retention 
of the participants in the study being lower than anticipated, analysis of the RCT 
was performed for the baseline and 6-week assessments. The results of the 12- 
and 18-week assessments were explored using a within-group analysis for the 
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experimental group only. The results showed no statistically significant effects 
for the group x time interaction in the analysis of the RCT at 6 weeks. Within-
group analysis of the experimental group showed a statistically significant 
improvement for only the self-reported function (COPM) (p=0.02) at 12 weeks 
compared to the baseline.  
 
8.5.1 Physical function, physical activity, QoL and self-esteem in young 
people with CP compared to age-matched healthy peers 
In Chapter 6, the baseline of all OMs between the CP group (both exercise and 
control groups) and healthy controls was explored. Statistical analysis (Mann-
Whitney test) showed that the CP group was significantly weaker, walked 
slower, had a lower level of aerobic fitness and a lower level of habitual physical 
activity than their healthy age-matched peers. 
 
In order to put any changes due to the exercise programme into perspective, 
Figures 8.1–8.3 show the outcome measures of the exercise group (baseline 
and 6- & 12-week assessments, post exercise) and those of the healthy age-
matched peers. Not surprisingly, regarding the lack of exercise-induced effects, 
none of the physical function measures of the exercise group post exercise 
reached the values of the healthy group. Knee extensor strength at week 6 in 
the exercise group was the closest to the healthy group compared to other 
measures of physical function. Similarly, none of the post-exercise programme 
measures of habitual physical activity in the exercise group reached those of the 
healthy controls.  
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Figure 8.1 Comparison of the physical function measures between the exercise group (pre and post 
exercise) and healthy participants 
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Figure 8.2 Comparison of the habitual physical activity pattern measures between the exercise 
group (pre and post exercise) and healthy participants 
205 
  
 
 
Figure 8.3 Comparison of the QoL and self-esteem measures between the exercise group (pre and 
post exercise) and healthy participants 
 
8.5.2 Habitual Physical Activity 
Habitual physical activity is an important outcome for any study seeking to 
explore the effects of an exercise programme. Increasing the levels of physical 
activity in people with CP is imperative as it may potentially reduce the risk of 
secondary health problems such as cardiovascular disease, obesity and 
osteoporosis (Kokkinos 2012). In addition, increasing physical activity levels 
may also decrease some of the problems commonly associated with CP such as 
muscle weakness, stiffness and decreased mobility (Thompson et al. 2011, Kerr 
et al. 2011). The evidence suggests that participating in an exercise programme 
can increase the daily physical activity of people with CP (Bania et al. 2011, Van 
den Berg-Emons et al. 1998). 
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Habitual physical activity in this study was captured using an activity monitor 
known as ActivPALTM. From this monitor, the time that the participants spent 1) 
sitting/lying and 2) ‘stepping’ (standing and walking), plus 3) number of step 
counts, and 4) the number of standing-to-sitting transitions per day between four 
and seven days were derived. Study 3 revealed that there was no statistically 
significant interaction between group and time in any of the measures of habitual 
physical activity, and this result is consistent with that obtained in a study by 
Bania et al. (2016) on participants with CP aged between 14 and 22 years. A 
possible explanation for this lack of an increase in habitual physical activity in 
the intervention group is the phenomenon of resting after a bout of exercise, as 
described by (Rowland 1998). Participants may have felt they had worked hard 
during their weekly training sessions and thus on their non-gym days they felt 
they deserved or needed more rest. Informal anecdotal feedback from the carer 
of one of the participants indicated that her daughter spent most of her time 
sitting on the couch watching television (on non-exercise days) because she felt 
too tired after spending time at the gymnasium 2 to 3 times per week.  
 
Another issue associated with using habitual physical activity as an outcome 
measure in exercise studies is the high day-to-day or even week-to-week 
variability in this measure, as was found in Study 2, which confirmed the results 
of previous studies (Bania et al. 2016, van der Linden et al. 2014). The high 
measurement error was also shown by an MDC of 2667 steps/day in Study 2 
and 1741 steps/day in a study of people with multiple sclerosis (van der Linden 
et al. 2014).  
 
Further, addressing lower limb strength and aerobic capacity alone, without 
addressing any psychological, social or environmental factors, may not have 
been sufficient to elevate the habitual physical activity measures and reduce 
sedentary time in people with CP. Combining the exercise training and patient 
education and/or counselling on physical activity participation may be more 
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effective in changing an individual’s physical activity behaviour (van der Ploeg et 
al. 2006, Slaman et al. 2010, Van der Ploeg, Hidde et al. 2007). A recent multi-
centre RCT with 57 participants with CP aged 16–25 years revealed significant 
improvement in self-reported physical activity measured using the Physical 
Activity Scale for Individuals with Physical Disabilities following a six-month 
lifestyle intervention consisting of physical fitness training combined with 
counselling sessions that focused on physical behaviour and sports participation 
(Slaman et al. 2015). However, this effect was not maintained in the long-term 
follow-up (12 months), and no significant improvement was found in the 
objective habitual physical activity measured using an accelerometer. Whilst a 
combination of exercise training and patient education seems promising with 
regard to improving the level of physical activity among the CP population, 
further studies are clearly needed to confirm this. 
 
8.5.3 Sustainability/maintenance of exercise-induced effects and exercise 
behaviour 
The short-term effects of an exercise programme with regard to physical activity 
have been explored in both this thesis and previous CP exercise studies 
(Slaman et al. 2015, Bania et al. 2016). However, the long-term effects of such 
programmes remain unknown. One of the long-term aims of an exercise 
programme is the achievement of a behavioural change towards a more active 
lifestyle. The aim of the design of the current study, with a reduction in the 
prescribed number of weekly exercise sessions over the three 6-week blocks, 
was to induce exercise behaviour that would be maintained beyond the duration 
of the 18-week programme.   
 
Although a long-term (>12 months), formal assessment of any possible 
exercise-induced effects was beyond the scope of this thesis (i.e. it was not 
possible within the 3-year PhD programme), an informal follow-up (i.e. telephone 
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and email) at approximately 2 months following the completion of the 18-week 
programme was carried out. Former participants were asked whether they were 
still engaged in any exercise or physical activity after completion of the 
programme. Due to problems with reaching the participants via telephone and 
email, only two participants out of four (from the 2015–2016 batch) provided 
feedback. One participant reported cycling to college 3x/week and doing sports 
activity, i.e. indoor/outdoor climbing, while another participant replied that she 
only took part in physical education at school. The current study did not provide 
an objective measure of habitual physical activity patterns to identify the long-
term effects of the programme. Direct observation through activity monitoring is 
probably the most appropriate and practical measure of assessing habitual 
physical activity patterns (Sirard and Pate 2001) in order to capture the long-
term effects of an exercise programme in people with CP and should therefore 
be considered for future research. 
 
8.5.4 Feasibility issues 
8.5.4.1 Recruitment and participant retention 
A total of 430 ambulant young people with CP aged 16 to 25 were invited to 
participate in this study, resulting in a total of 28 individuals initially expressing 
an interest in participating. However, only 19 adolescents and young adults with 
CP were randomly allocated to either the exercise (n=10) or control groups 
(n=9) and assessed at baseline. At the 12-week assessment, seven participants 
in the exercise group and five participants in the control group were available for 
analysis. 
 
This very low recruitment rate is not unique to either the current study or the 
wider CP population and has also been reported in previous exercise studies 
conducted with this age group in the general population or other patient groups 
(Rooks et al. 2006, Fairey et al. 2005, Heinrichs et al. 2005). 
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There were probably two issues with the low recruitment. Firstly, there was the 
issue of the participants’ willingness to take part in a research study which 
required four assessments, each of 2 to 3 hours in duration, over a period of 18 
weeks. Although no further survey was carried out enquiring as to the reasons 
for the low recruitment, one participant who withdrew prior to the baseline 
assessment taking place informed that it was due to his limitations in terms of 
the session scheduling and location (i.e. for assessments) rather than an 
inability to participate in the exercise programme. The use of simple, quick and 
easy measurement tools for walking performance may thus have helped to 
partially overcome this barrier to taking part in exercise studies (Himuro et al. 
2015). The measurement tools recommended by Himuro et al. (2015) are TUG, 
the one-minute walk test, FAQ, ABILOCO-Kids and FMS; however, the 
measurement error and responsiveness are yet to be confirmed for these 
measures. 
 
The second issue was the participants’ willingness to take part in a gym-based 
exercise programme. To promote an active lifestyle in this population, it is 
crucial to understand the perceived barriers to physical activity in people with 
CP. Some of the barriers to participation in physical activity in children and 
adolescents with CP have been reported as being challenges with transportation 
to the sports club (Verschuren et al. 2012, Lawlor et al. 2006), the attitudes of 
strangers and staff in public places, the presence of stairs (Lawlor et al. 2006) 
and financial constraints (Verschuren et al. 2012). Other studies with young and 
older adults aged 18 to 40 years with physical disabilities reported perceived 
barriers to participate in physical activity such as time constraints, lack of 
energy, fear of injuries and too much effort required (Buffart et al. 2009, Rimmer 
et al. 2004). 
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8.5.4.2 Dropout in the exercise group 
Two participants dropped out of the programme, one due to depression and one 
due to chronic fatigue syndrome. It was noted at the baseline assessment that 
the latter participant had suffered from fatigue over the course of past few years. 
Notes in the exercise logbook also showed that the participant felt tired from the 
second week of the programme onwards. The participant had been exercising 
prior to the study, comprising mainly swimming at the leisure centre. As the 
exercise programme in the study prescribed an aerobic, land-based form of 
exercise, the participant had to travel a few miles further to use a Motomed 
exercise bike, as she was not able to use the usual aerobic equipment 
(recumbent bike, rower, treadmill) at her local leisure centre. It is possible that 
this change to a less convenient venue was more demanding than her usual 
exercise routine.  
 
Optimal participant retention is an important factor to consider in the feasibility of 
an RCT. Excessive attrition can limit the meaningful interpretation of results. In 
this study, two of the participants in the exercise group and three of the 
participants in the control group withdrew from the programme (at different time 
points, refer to Figure 7.3), resulting in an attrition rate of 29%. Dropout in 
previous CP exercise studies ranged from 4% to 35% (McNee et al. 2009, 
Taylor et al. 2013, Bania et al. 2014, Slaman et al. 2015). Its attrition of greater 
than 20% indicates that the results of this study have a high risk of bias and 
should therefore be treated with caution (Dumville et al. 2006). 
 
8.5.4.3 Adherence to the exercise programme 
Adherence to a thrice-weekly followed by a twice-weekly exercise programme 
was confirmed by the excellent compliance with the thrice-weekly sessions 
during the first six weeks (86%) and in the second block of two weekly sessions 
(90.6%). The majority of the participants (n=7 out of 9) continued with exercise 
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sessions in the last six weeks (12–18 weeks), where there was no prescribed 
number of sessions. However, gymnasium attendance fell considerably, with 
some of the participants failing to attend the gym at all in those weeks. 
 
The reduced gymnasium attendance in weeks 12–18 could be partly due to the 
lack of input from the physiotherapist. Evidence shows that people with a 
disability feel safer and more confident when exercising with the involvement of 
a physiotherapist (Lennon et al. 2013, Simpson et al. 2011). In addition, one 
participant commented, ‘…..GM (physiotherapist) was a great support’ in the 
feedback questionnaire, thus indicating that the input of a physiotherapist is an 
important factor influencing the success (adherence, fidelity) of the exercise 
programme. Future studies may perhaps wish to consider the inclusion of 
contact with a physiotherapist for their participants at least once during weeks 
12 to 18.  
 
8.5.4.4 Perception of the exercise programme  
Despite the lack of statistically significant effects both between groups (in the 6-
week RCT) and within the experimental group at 6, 12 and 18 weeks in all OMs 
except the COPM, the exercise programme feedback questionnaire showed a 
positive response with regard to the programme, as shown in Table 7.5 (Chapter 
7). In particular, one participant commented on the feedback questionnaire as 
follows: ‘This programme was a good idea. I was feeling motivated, to keep 
myself fit, happier.’ Durstine et al. (2000) suggested that enjoyment is an 
important element when seeking to implement an exercise programme. Previous 
CP exercise studies also found significant increases in their participants’ self-
perception (Verschuren et al. 2007, Unger et al. 2006, Dodd et al. 2004), as well 
as them expressing enjoyment and feeling more confident by participating in the 
exercise programme (Mc Burney et al. 2003, Allen et al. 2004, Morton et al. 
2005). Further, enjoyment of the exercise programme is an important factor for 
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young adults in terms of them deciding whether or not to continue with the 
exercise programme on a regular basis in the future. According to previous 
studies (Allenet al. 2004, McBurney et al. 2003, Lee et al. 2008, Unger et al. 
2006), future exercise studies should consider incorporating a qualitative 
analysis (i.e. interview or focus group) when determining the effectiveness of 
such a programme and the factors determining effectiveness. 
 
8.5.4.5 Selection of outcome measures  
The selection of the range of outcome measures used in this study was justified 
through their psychometric properties (validity and reliability), their feasibility 
(practicality) and the fact that the OMs represented all three of the domains 
described in the ICF framework (as discussed in Chapter 2). It is possible, 
however, that other measures may have been more appropriate to reflect any 
improvements induced by the exercise programme and that such measures 
should be considered in future research. For example, to assess quality of life, a 
disease-specific questionnaire (i.e. TACQOL) may be more effective for 
assessing those areas of life that may be most affected by the specific disease 
or condition. However, generic questionnaires give a broad assessment of 
health status and allow for the comparison of health-related QoL between 
groups of patients with different conditions. Ideally, it is recommended to 
combine both generic and disease-specific tools. Regarding the low reliability of 
SF-12 and RSES, this is indeed a limitation of the thesis, as the reliability study 
was conducted after the first batch of the intervention study. Using the myometer 
to measure isometric muscle strength in individuals with CP, the effects of their 
spasticity probably affected the participants’ strength measures, although 
spasticity has been found to be independent of strength (Ross and Engsberg 
2002). Despite this, strength testing has demonstrated good reliability 
(consistency) with a high measurement error in this population, as shown in 
Study 2. Instead of TUG, the 6-minute or 2-minute walk tests are probably better 
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tools to use to evaluate walking, since in the list of activities in the COPM that 
participants wanted to improve, seven of the sixteen participants indicated that 
they would like to improve their walking distance. So while the studies in this 
thesis did not intend to present an exhaustive list of possible measures, they do 
provide examples of how clinical measures that are appropriate to the research 
setting (i.e. laboratory) relevant to adolescents and young adults with CP can be 
considered in the context of the ICF model. 
 
As discussed in previous sections, such alternative measures should have been 
reliable and responsive to change. In particular, it is recommend that the 
responsiveness and in particular the MCID of these outcome measures are 
established. Table 8.3 summarises the limitations identified in the current study 
and some potential solutions for use in future research. 
214 
  
Table 8.3 Main limitations identified throughout the thesis 
Limitations Recommendations 
The sample size in the exercise study was 
small 
 Multi-centre trial 
 Decrease assessment burden to improve recruitment. Reduce 
barriers and reinforce facilitators to exercise.  
Responsiveness (MCID) was not explored   A responsiveness study with appropriate methodology design 
and statistical analysis should be conducted to inform clinicians 
of the clinically important change. 
No measurement of physical activity in 
medium-/long-term follow-up 
 Follow up at 24 weeks & 12 months with ActivPALTM to 
determine habitual physical activity.  
Exercise programme solely focused on 
improving physical fitness and habitual 
physical activity   
 Apart from the exercise programme, future studies could 
perhaps incorporate counselling/patient education on physical 
activity or participation in sports on an individual basis.  
MCID: minimal clinically important change
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8.6 Conclusion 
The need to use outcome measures that have robust psychometric 
properties to evaluate the effectiveness of interventions such as strength and 
aerobic training is well recognised. However, only two of the outcome 
measures currently being used to measure gait quality and walking 
performance in young people with CP were found have strong to moderate 
evidence in terms of their reliability and validity, with very limited information 
and evidence available on their responsiveness and measurement error 
(Chapter 4). 
 
The results from the reliability study (Chapter 5) add to the evidence base for 
the psychometric properties (i.e. consistency and agreement) for the 
outcome measures used to measure physical function and habitual physical 
activity; however, more studies are needed to investigate these psychometric 
properties for the different QoL and self-esteem outcome measures used for 
young people with CP. 
 
The exercise study (Chapter 7) explored the feasibility of an 18-week 
exercise programme in young people with CP. In addition, the effect on 
physical function, gait quality, habitual physical activity, QoL and self-esteem 
following the exercise programme was explored with inferential analysis, and 
the effect sizes for each outcome measure were reported. Further work is still 
required to confirm these findings in a larger sample. Other limitations, as 
well as recommendations, have been presented for both clinicians and 
researchers for future direction, as presented in Table 8.3. 
 
In conclusion, the series of studies in this thesis has served to answer some 
of the questions related to the level of evidence for gait quality and walking 
performance outcome measures, the psychometric properties (i.e. reliability) 
of the OMs used in exercise studies and the effects as well as the feasibility 
of an 18-week exercise programme on adolescents and young people with 
CP. These studies have also generated directions for further exploration in 
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CP research; in particular, investigations on the responsiveness (MCID) and 
the integration of patient education in the exercise programme, in addition to 
the need to follow up (i.e. over the medium and long terms) in order to gain 
information on the sustainability of increases in the physical activity levels of 
people with CP. 
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Appendices 
 
Appendix 1 GMFM scoring instruction 
 
Test should be performed  without shoes on 
Participant gets a max of 3 attempts for each item and best performance is scored – test 
trials can be used 
 
STANDING 
 
52.On the Floor: Pulls to stand 
Starting position: any on floor other than standing 
Ending: can be leaning on bench 
 
0 = does not initiate standing 
1 = initiates pulling to stand 
2 = partially pulls to stand 
3 = pulls to stand 
 
53.Standing: Maintains, arms free, 3 sec 
0 = does not maintain standing, 
1 = maintains, 2 hands holding on, 3 sec 
2 = maintains, 1 hand holding on, 3 sec 
3 = maintains, arms free, 3 sec 
 
54/55.Standing: Holding on to large bench with 
one hand, lifts right/left foot, 3 seconds 
0 = does not initiate lifting right/left foot 
1 = holding bench 2 hands, lifts right/left foot, <3 s 
2 = holding bench 2 hands, lifts right/left foot, 3 s 
3 = holding bench 1 hand, lifts right/left foot, 3 sec 
 
For 3 must begin holding with only one hand 
 
56.Standing: Maintains, arms free, 20 seconds 
0 = does not maintain standing, arms free 
1 = maintains, arms free, <3 sec 
2 = maintains, arms free, 3-19 sec  
3 = maintains, arms free, 20 sec 
 
57/58.Standing: Lifts left/right foot, arms free, 
10 seconds 
0 = does not lift left foot, arms free  
1 = lifts left foot, arms free, <3 sec 
2 = lifts left foot, arms free, 3-9 sec  
3 = lifts left foot, arms free, 10 sec 
 
59.Sitting on small bench: Attains standing 
without using arms 
Starting: feet flat on floor, knees approx. 90° 
 
0 = does not initiate standing 
1 = initiates standing 
2 = attains standing using arms 
3 = attains standing without using arms (on body or 
bench) 
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60/61.high kneeling: attains standing through 
half kneeling on right/left knee, no arms 
Starting: high kneeling – weight bearing on knees, 
buttocks clear of lower legs 
 
0 = does not initiate standing 
1 = initiates standing 
2 = attains standing using arms (start from high 
kneel, but not necessarily through half knee) 
3 = attains standing through half kneeling on 
right/left knee, without arms (on body or ground) 
 
62.Standing: Lowers to sitting on floor with 
control, arms free 
Starting : must start standing free, if hold on to 
lower must only be once movement is initiated 
 
0 = does not lower 
1 = lowers to sit on floor, but ‘crashes’ down 
2 = lowers to sit on floor with control, uses arms or 
holds on 
3 = lowers to sitting on floor with control, arms free 
 
63.Standing: Attains squat, arms free 
Starting : must start standing free, if hold on to 
lower must only be once movement is initiated 
 
0 = does not initiate squat 
1 = initiates squat 
2 = attains squat, using arms or holding on 
3 = attains squat, arms free 
 
Squat = crouching close to ground with hips and 
knees flexed at least 90° 
 
64.Standing: Attains squat, arms free 
0 = does not initiate picking up object 
1 = initiates picking up object 
2 = picks up object, using arms or holding on 
(includes leaning on floor) 
3 = picks up object, arms free, returns to standing
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WALKING RUNNING & JUMPING 
 
65/66. Standing two hands on bench: Cruises five steps to the right/left 
Starting: weight should be taken through arms and legs (not torso leaning on bench) 
 
0 = does not initiate cruising to right/left 
1 = initiate cruising, < 1 complete step to right/left 
2 = cruises 1 – 4 steps to right/left 
3 = cruises 5 steps to right/left 
 
Cruising one step = movement sideways of both legs 
 
67/68. Standing two/one hand(s) held: Walks forward 10 steps 
0 = does not initiate walking forward 
1 = walks forward < 3 steps 
2 = walks forward 1 – 9 steps 
3 = walks forward 10 steps 
 
One step is push off to contact of one leg 
Steps must be consecutive, short break of 1-2 sec allowed 
 
69. Standing: Walks forward 10 steps 
Starting: must stand arms free. Can hold on beforehand but must balance in arms free before starting walk 
 
0 = does not initiate walking forward 
1 = walks forward < 3 steps 
2 = walks forward 1 – 9 steps 
3 = walks forward 10 steps 
 
70 .Standing: Walks forward 10 steps, stops, turns 180°, returns 
Starting: must stand arms free. Can hold on beforehand but must balance in arms free before starting walk 
 
0 = walks forward 10 steps, does not stop without falling 
1 = walks forward 10 steps, stops, does not initiate turn 
2 = walks forward 10 steps, stops, turns < 180° 
3 = walks forward 10 steps, stops, turns 180°, returns 
 
Must make full stop before turning 
71. Standing: Walks backwards 10 steps 
Starting: must stand arms free. Can hold on beforehand but must balance in arms free before starting walk 
 
0 = does not initiate walking backwards 
1 = walks backwards < 3 steps 
2 = walks backwards 1 – 9 steps 
3 = walks backwards 10 steps 
 
72. Standing: Walks forward 10 steps carrying large object with two hands 
0 = does not initiate walking, carrying large object 
1 = walks forward 10 steps carrying a small object with one hand 
2 = walks forward 10 steps, carrying a small object with two hands 
3 = walks forward 10 steps, carrying a large object with two hands 
 
73. Standing: Walks forward 10 consecutive steps between parallel lines 20 cm apart 
0 = does not initiate walking 
1 = walks forward < 3 consec. steps between lines 
2 = walks forward 3-9 consec. steps between lines 
3 = walks forward 10 consec. steps between lines 
 
Part of the foot may touch line but not go over it. 
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74. Standing: Walks forward 10 consecutive steps on a straight line 2 cm wide 
0 = does not initiate walking 
1 = walks forward < 3 consecutive steps on line 
2 = walks forward 3-9 consecutive steps on line 
3 = walks forward 10 consecutive steps on line 
 
Part of the foot must stay on the line 
 
75/76. Standing: Steps over a stick at knee level, right/left foot leading 
0 = does not initiate stepping over stick 
1 = steps over stick 5-7.5 cm high 
2 = steps over stick at mid-calf level 
3 = steps over stick at knee level, right/left foot leading 
 
Must finish without falling 
 
 
 
77. Standing: Runs 4.5 m, stops and returns 
0 = does not initiate running 
1 = initiates running by walking quickly 
2 = runs <4.5 m 
3 = runs 4.5 m, stops and returns 
 
For running both feet must be off the floor at some point 
 
75/76. Standing: Kicks ball with right/left foot 
0 = does not initiate kicking 
1 = lifts right foot, does not kick 
2 = kicks ball with right foot, but falls 
3 = kicks ball with right foot 
 
Kick: foot must clear the floor when ball is contacted and ball must move from the impact 
 
80. Standing: Jumps 30 cm high, both feet simultaneously 
0 = does not initiate jump 
1 = jumps < 5 cm high, both feet simultaneously 
2 = jumps 5-28 cm high, both feet simultaneously 
3 = jumps 30 cm high, both feet simultaneously 
 
Both feet must be off the floor at the same time, but not necessarily land or take off at the same time 
Must land, arms free, without falling to get any score 
 
81. Standing: Jumps forward 30 cm, both feet simultaneously 
0 = does not initiate jump 
1 = jumps forward < 5 cm, both feet simultaneously  
2 = jumps forward 5-28 cm, both feet simultaneously 
3 = jumps forward 30 cm, both feet simultaneously 
 
Both feet must be off the floor at the same time, but not necessarily land or take off at the same time 
Must land, arms free, without falling to get any score 
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82/83. Standing: Hops on right/left foot 10 times within a 60 cm circle 
0 = does not initiate hopping on right/left foot 
1 = hops on right/left foot < 3 times within a 60 cm circle  
2 = hops on right/left foot 3-9 times within a 60 cm circle  
3 = hops on right/left foot 10 times within a 60 cm circle 
 
Part of the foot must stay in the circle 
Hopping foot must clear the floor and other foot must not touch floor 
Not pause more than 2 sec between hops 
 
84/85. Standing holding one rail: Walks up/down four steps, alternating feet, holding one rail 
0 = does not initiate walking up steps, holding rail 
1 = walks up/down 2 steps, holding rail, same foot leads 
2 = walks up/down 4 steps, holding rail, alternating feet inconsistently 
3 = walks up/down 4 steps, holding rail, alternating feet 
 
86/87. Standing: Walks up/down four steps, alternating feet 
0 = does not initiate walking up steps 
1 = walks up/down 2 steps, same foot leads 
2 = walks up/down 4 steps, alternating feet inconsistently 
3 = walks up/down 4 steps, alternating feet 
 
88. Standing on 15 cm step: Jumps off, both feet simultaneously 
0 = does not initiate jumping off step 
1 = jumps off, both feet simultaneously, but falls 
2 = jumps off, both feet simultaneously, but uses hand to avoid falling 
3 = jumps off, both feet simultaneously 
 
Both feet simultaneously: both feet of ground at same time, but not necessarily leaving floor or landing at 
same time 
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Appendix 2FAQ 
Functional Assessment Questionnaire 
 
Mobility Levels 
Choose the one answer below that best describes your typical walking ability (with the use of any needed 
assistive devices).  
I... 
1. Cannot take any steps at all. 
2. Can do some stepping on my own with the help of another person.  Do not take full weight on feet; 
do not walk on a routine basis.   
3. Walk for exercise in therapy and less than typical household distances.  Usually require assistance 
from another person.  
4. Walk for household distances, but make slow progress.  Do not use walking at home as preferred 
mobility (primarily walk in therapy).   
5. Walk more than 15-50 feet but only indoors (walk for household distances).   
6. Walk more than 15-50 feet outside the home, but usually use a wheelchair or buggy for community 
distances or in congested areas.  
7. Walk outside the home for community distances, but only on level surfaces (cannot manage kerbs, 
uneven ground, or stairs without assistance of another person).  
8. Walk outside the home for community distances, able to manage kerbs and uneven ground in 
addition to level surfaces, but usually require minimal assistance or supervision for safety.    
9. Walk outside the home for community distances, easily get around on level surfaces, kerbs, and 
uneven ground, but have difficulty or require minimal assistance with running, climbing, and/or 
stairs. 
10. Walk, run and climb on level and uneven ground without difficulty or assistance.   
 
 
Higher Level Mobility Skills 
Please tick all the things you are able to do: 
 
 Walk carrying an object 
  
 Walk carrying a fragile object or a glass of liquid 
  
 Walk up and downstairs using the banister 
  
 Walk up and downstairs without using the banister 
  
 Step up and down a kerb independently 
  
 Run 
  
 Run well including around a corner with good control 
  
 Take steps backwards 
  
 Manoeuvre in tight areas 
  
 Get on/off the bus independently 
  
 Hop on the right foot 
  
 Hop on the left foot 
  
 Step over an object right foot first 
  
 Step over an object left foot first 
  
 Ride an escalator, stepping on/off by yourself 
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Appendix 3Canadian Occupational Performance Measure 
2ND EDITION 
authors: Mary Law, Sue Baptiste, Anne Carswell, Mary Ann McColl, Helene Polatajko, Nancy 
Pollock 
The Canadian Occupational Performance Measure (COPM) is an individualized measure 
designed for use by occupational therapists to detect self-perceived change in occupational 
performance problems over time.  
Step 1: IDENTIFICATION OF OCCUPATIONAL PERFORMANCE ISSUES 
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Appendix 4SF-12 version 2 
 
 
 
Your Health and Well-Being 
 
 
 
This survey asks for your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual activities. 
Thank you for completing this survey! 
 
For each of the following questions, please tick the one box that best describes 
your answer. 
 
1. In general, would you say your health is: 
2. The following questions are about activities you might do during a 
typical day.  Does your health now limit you in these activities?  If 
so, how much? 
 Yes, 
limited 
a lot 
Yes, 
limited 
a little 
No, not 
limited 
at all 
    
 a Moderate activities, such as moving a table, pushing  
a vacuum cleaner, bowling, or playing golf .......................... 1 ............... 2 ............... 3 
 b Climbing several flights of stairs ........................................... 1 ............... 2 ............... 3 
Excellent Very good Good Fair Poor 
     
1 2 3 4 5 
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3. During the past 4 weeks, how much of the time have you had any 
of the following problems with your work or other regular daily 
activities as a result of your physical health?  
4. During the past 4 weeks, how much of the time have you had any 
of the following problems with your work or other regular daily 
activities as a result of any emotional problems (such as feeling 
depressed or anxious)? 
5. During the past 4 weeks, how much did pain interfere with your 
normal work (including both work outside the home and 
housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
 All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
      
 a Accomplished less than you  
  would like ..................................... 1 2 ........ 3 .............. 4 .............. 5 
 b Were limited in the kind of  
  work or other activities ................. 1 2 ........ 3 .............. 4 .............. 5 
 All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
      
 a Accomplished less than you  
  would like ..................................... 1 2 ........ 3 .............. 4 .............. 5 
 b Did work or other activities 
  less carefully than usual ................ 1 2 ........ 3 .............. 4 .............. 5 
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1 2 3 4 5 
6. These questions are about how you feel and how things have been 
with you during the past 4 weeks.  For each question, please give 
the one answer that comes closest to the way you have been 
feeling.  How much of the time during the past 4 weeks… 
7. During the past 4 weeks, how much of the time has your physical 
health or emotional problems interfered with your social activities 
(like visiting with friends, relatives, etc.)? 
 
 All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
      
 a Have you felt calm and   
peaceful? ....................................... 1 2 ........ 3 .............. 4 .............. 5 
 b Did you have a lot of energy? ....... 1 2 ........ 3 .............. 4 .............. 5 
 c Have you felt downhearted   
and low? ........................................ 1 2 ........ 3 .............. 4 .............. 5 
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Appendix 5 Rosenberg Self-Esteem Scale 
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Rosenberg Self-Esteem scoring 
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Appendix 6 Search strategies study 1 (systematic review, Chapter 4) 
 
Database search(last updated 14th January 2016) 
 
PubMed  
 
#1 (‘cerebral palsy’)   
“Cerebral Palsy”[mesh] OR "cerebral palsy" [tiab] OR "cerebral palsies" [tiab] OR "little disease"[tiab] OR 
"little's disease"[tiab] OR "spastic diplegias"[tiab] OR "spastic diplegia"[tiab] 
 
#2 (‘gait’) 
gait[tiab OR walk [tiab] OR “gait quality”[tiab] OR “walk test”[tiab] OR “walking performance”[tiab]  
 
#3 (‘outcome measure’)  
(test[ti] OR tests[ti] OR tool[ti] OR tools[ti] OR instrument[ti] OR instruments[ti] OR scale[ti]) AND 
(analys*[tiab] OR assess*[tiab] OR determin*[tiab] OR evaluat*[tiab] OR measure*[tiab] OR 
quantif*[tiab] OR score*[tiab]) or Analy*[ti] OR assessment*[tiab] OR assessing[tiab] OR evaluat*[ti] OR 
instrument[tiab] OR instruments[tiab] OR measure[tiab] OR measurement*[tiab] OR measures[tiab] OR 
quantifying[tiab] OR quantification[tiab] OR questionnaire*[tw] OR scale[tiab] OR scales[tiab] OR 
score[tiab] OR scores[tiab] OR screening[tiab] OR subtest*[tiab] OR test[tiab] OR tests[tiab] OR 
testing[tiab] OR tool[tiab] OR tools[tiab] 
 
#4 (‘sensitive filter for measurement properties’) (Terwee et al 2009) 
(instrumentation[sh] OR methods[sh] OR Validation Studies[pt] OR Comparative Study[pt] OR 
psychometrics [MeSH] OR psychometr*[tiab] OR clinimetr*[tw] OR clinometr*[tw] OR ‘‘outcome 
assessment (health care)’’[MeSH] OR outcome assessment[tiab] OR outcome measure*[tw] ‘‘observer 
variation’’[MeSH] OR observer variation[tiab] OR ‘‘Health Status Indicators’’[Mesh] OR ‘‘reproducibility 
of results’’[MeSH] OR reproducib*[tiab] OR ‘‘discriminant analysis’’[MeSH] OR reliab*[tiab] OR 
unreliab*[tiab] OR valid*[tiab] OR coefficient[tiab] OR homogeneity[tiab] OR homogeneous[tiab] OR 
‘‘internal consistency’’[tiab] OR (cronbach*[tiab] AND (alpha[tiab] OR alphas[tiab])) OR (item[tiab] AND 
(correlation*[tiab] OR selection*[tiab] OR reduction*[tiab])) OR agreement[tiab] OR precision[tiab] OR 
imprecision[tiab] OR ‘‘precise values’’[tiab] OR test-retest[tiab] OR (test[tiab] AND retest[tiab]) OR 
(reliab*[tiab] AND (test[tiab] OR retest[tiab])) OR stability[tiab] OR interrater[tiab] OR inter-rater[tiab] 
OR intrarater[tiab] OR intra-rater[tiab] OR intertester[tiab] OR inter-tester[tiab] OR intratester[tiab] OR 
intra-tester[tiab] OR interobserver[tiab] OR inter-observer[tiab] OR intraobserver[tiab] OR 
intraobserver[tiab] OR intertechnician[tiab] OR inter-technician[tiab] OR intratechnician[tiab] OR intra-
technician[tiab] OR interexaminer[tiab] OR inter-examiner[tiab] OR intraexaminer[tiab] OR intra-
examiner[tiab] OR interassay[tiab] ORinter-assay[tiab] OR intraassay[tiab] OR intra-assay[tiab] OR 
interindividual[tiab] OR inter-individual[tiab] OR intraindividual[tiab] OR intra-individual[tiab] OR 
interparticipant[tiab] OR inter-participant[tiab] OR intraparticipant[tiab] OR intra-participant[tiab] OR 
kappa[tiab] OR kappa’s[tiab] OR kappas[tiab] OR repeatab*[tiab] OR ((replicab*[tiab] 
OR repeated[tiab]) AND (measure[tiab] OR measures[tiab] OR findings[tiab] OR result[tiab] OR 
results[tiab] OR test[-tiab] OR tests[tiab])) OR generaliza*[tiab] OR generalisa*[tiab] OR 
concordance[tiab] OR (intraclass[tiab] AND correlation*[tiab]) OR discriminative[tiab] OR ‘‘known 
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group’’[tiab] OR factor analysis[tiab] OR factor analyses[tiab] OR dimension*[tiab] OR subscale*[tiab] OR 
(multitrait[tiab] AND scaling[tiab] AND (analysis[tiab] OR analyses[tiab])) OR item discriminant[tiab] OR 
interscale correlation*[tiab] OR error[tiab] OR errors[tiab] OR ‘‘individual variability’’[tiab] OR 
(variability[tiab] AND (analysis[tiab] OR values[tiab])) OR (uncertainty[tiab] AND (measurement[tiab] OR 
measuring[tiab])) OR ‘‘standard error of measurement’’[tiab] OR sensitiv*[tiab] OR responsive*[tiab] OR 
((minimal[tiab] OR minimally[tiab] OR clinical[tiab] OR clinically[tiab]) AND (important[tiab] OR 
significant[tiab] 
OR detectable[tiab])AND(change[tiab]ORdifference[tiab])) OR (small*[tiab] AND (real[tiab] OR 
detectable[tiab]) AND (change[tiab] OR difference[tiab])) OR meaningful change[tiab] OR ‘‘ceiling 
effect’’[tiab] OR ‘‘floor effect’’[tiab] OR ‘‘Item response model’’[tiab] OR IRT[tiab] OR Rasch[tiab] OR 
‘‘Differential item functioning’’[tiab] OR DIF[tiab] OR ‘‘computer adaptive testing’’[tiab] OR ‘‘item 
bank’’[tiab] OR ‘‘cross-cultural equivalence’’[tiab]) 
 
#6 (‘exclusion filter’) (Terwee et al 2009) 
(addresses OR biography OR case reports OR comment OR directory OR editorial OR festschrift OR 
interview OR lectures OR legal cases OR legislation OR letter OR news OR newspaper article OR patient 
education handout OR popular works OR congresses OR consensus development conference OR 
consensus development conference OR practice guideline) NOT (‘‘animals’’[MeSH Terms] NOT 
‘‘humans’’[MeSH Terms]) 
 
Combination search 
#1 AND #2 and #3 AND #4 = #5 
#5 NOT #6 
 
Medline 
 
#1 (‘cerebral palsy’)   
AB “Cerebral Palsy” OR AB "cerebral palsy" OR AB "cerebral palsies" OR "little's disease" OR AB "spastic 
diplegias" OR AB "spastic diplegia" 
 
#2 (‘gait’) 
AB gait OR AB walk OR AB “gait quality” OR AB “walk test” OR AB “walking performance”  
 
#3 (‘outcome measure’)  
AB test OR AB tests OR AB tool OR AB tools OR AB instrument OR AB instruments OR AB scale OR AB 
analys* OR AB assess* OR AB determin* OR AB evaluat* OR AB measure* OR AB quantif*[tiab] OR AB 
score*or AB Analy* OR AB assessment* OR AB assessing OR AB evaluat* OR AB instrument OR AB 
instruments OR AB measure OR AB measurement* OR AB measures OR AB quantifying OR AB 
quantification OR AB questionnaire* OR AB scale OR AB scales OR AB score OR AB scores OR AB 
screening OR AB subtest* OR AB test OR AB tests OR AB testing OR AB tool OR AB tools 
 
#4 (‘properties’)  
AB accuracy OR AB accurate OR AB clinimetr* OR AB coefficient* OR AB consisten* OR AB correlated OR 
AB correlation* OR AB cronbach OR AB discrimina* OR AB interrater OR AB inter-rater OR AB 
intersession OR AB inter-session OR AB intertester OR AB inter-tester OR AB Intrarater OR AB intra-rater 
OR AB intratester OR AB intra-tester OR AB kappa OR AB Observer variationOR AB predictiv* OR AB 
propert* OR AB Psychometrics OR AB psychometr* OR AB reliab* OR AB repeatable OR AB repeatability 
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OR AB "Reproducibility of Results" OR AB reproducible OR AB reproducibility OR AB responsive* OR AB 
"Sensitivity and Specificity" OR AB sensitive OR AB sensitivity OR AB spearman* OR AB specific OR AB 
specificity OR AB spearman OR AB subscale* OR AB suitable OR AB suitability OR AB "test development" 
OR AB test-retest OR AB useful* OR AB utility OR AB valid OR AB validity OR AB validat* OR AB 
“Validation studies”  
 
#6 (‘exclusion filter’) 
AB biography OR AB case reports OR AB comment OR AB directory OR AB editorial OR AB interview OR 
AB lectures OR AB legal cases OR AB legislation OR AB letter OR AB news OR AB newspaper article OR AB 
patient education handout OR popular works OR congresses OR consensus development conference OR 
consensus development conference OR practice guideline) OR AB Stroke OR AB Parkinson disease OR AB 
stroke OR AB parkinson* NOT (‘‘animals’’) 
 
Combination search 
#1 AND #2 AND #3 AND #4 = #5 
#5 NOT #6 
 
CINAHL  
 
#1 (‘cerebral palsy’)   
AB “Cerebral Palsy” OR AB "cerebral palsy" OR AB "cerebral palsies" OR "little's disease" OR AB "spastic 
diplegias" OR AB "spastic diplegia" 
 
#2 (‘gait’) 
AB gait OR AB walk OR AB “gait quality” OR AB “walk test” OR AB “walking performance”  
 
#3 (‘outcome measure’)  
AB test OR AB tests OR AB tool OR AB tools OR AB instrument OR AB instruments OR AB scale OR AB 
analys* OR AB assess* OR AB determin* OR AB evaluat* OR AB measure* OR AB quantif*[tiab] OR AB 
score*or AB Analy* OR AB assessment* OR AB assessing OR AB evaluat* OR AB instrument OR AB 
instruments OR AB measure OR AB measurement* OR AB measures OR AB quantifying OR AB 
quantification OR AB questionnaire* OR AB scale OR AB scales OR AB score OR AB scores OR AB 
screening OR AB subtest* OR AB test OR AB tests OR AB testing OR AB tool OR AB tools 
 
#4 (‘properties’)  
AB accuracy OR AB accurate OR AB clinimetr* OR AB coefficient* OR AB consisten* OR AB correlated OR 
AB correlation* OR AB cronbach OR AB discrimina* OR AB interrater OR AB inter-rater OR AB 
intersession OR AB inter-session OR AB intertester OR AB inter-tester OR AB Intrarater OR AB intra-rater 
OR AB intratester OR AB intra-tester OR AB kappa OR AB Observer variationOR AB predictiv* OR AB 
propert* OR AB Psychometrics OR AB psychometr* OR AB reliab* OR AB repeatable OR AB repeatability 
OR AB "Reproducibility of Results" OR AB reproducible OR AB reproducibility OR AB responsive* OR AB 
"Sensitivity and Specificity" OR AB sensitive OR AB sensitivity OR AB spearman* OR AB specific OR AB 
specificity OR AB spearman OR AB subscale* OR AB suitable OR AB suitability OR AB "test development" 
OR AB test-retest OR AB useful* OR AB utility OR AB valid OR AB validity OR AB validat* OR AB 
“Validation studies”  
 
#6 (‘exclusion filter’) 
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AB biography OR AB case reports OR AB comment OR AB directory OR AB editorial OR AB interview OR 
AB lectures OR AB legal cases OR AB legislation OR AB letter OR AB news OR AB newspaper article OR AB 
patient education handout OR popular works OR congresses OR consensus development conference OR 
consensus development conference OR practice guideline) OR AB Stroke OR AB Parkinson disease OR AB 
stroke OR AB parkinson* NOT (‘‘animals’’) 
 
Combination search 
#1 AND #2 AND #3 AND #4 = #5 
#5 NOT #6 
 
Scopus 
 
#1 (‘cerebral palsy’)   
(TITLE-ABS-KEY ( cerebral palsy ) OR ( cerebral palsies ) OR ( spastic diplegias )OR ( spastic diplegia ) ) 
 
#2 (‘gait’) 
(TITLE-ABS-KEY ( gait ) OR TITLE-ABS-KEY ( walk ) TITLE-ABS-KEY ( gait quality* ) OR TITLE-ABS-KEY ( walk 
test* ) OR TITLE-ABS-KEY ( walking performance ) ) 
 
#3 (‘outcome measure’)  
(TITLE-ABS-KEY( test ) OR TITLE-ABS-KEY ( tests ) OR TITLE-ABS-KEY ( tool ) OR TITLE-ABS-KEY ( tools ) OR 
TITLE-ABS-KEY ( instrument ) OR TITLE-ABS-KEY  ( instruments ) OR TITLE-ABS-KEY ( scale) OR TITLE-ABS-
KEY (analys* ) OR TITLE-ABS-KEY ( assess* ) OR TITLE-ABS-KEY  ( determin* ) OR TITLE-ABS-KEY ( evaluat* 
) OR  TITLE-ABS-KEY  ( measure* ) OR TITLE-ABS-KEY ( quantif* ) OR TITLE-ABS-KEY score*) OR TITLE-ABS-
KEY ( Analy* ) OR TITLE-ABS-KEY ( assessment* ) OR TITLE-ABS-KEY ( assessing ) OR TITLE-ABS-KEY ( 
evaluat* ) OR TITLE-ABS-KEY  ( instrument ) OR TITLE-ABS-KEY ( instruments ) OR TITLE-ABS-KEY ( 
measure ) OR TITLE-ABS-KEY ( measurement* ) OR TITLE-ABS-KEY ( measures ) OR TITLE-ABS-KEY ( 
quantifying ) OR TITLE-ABS-KEY ( quantification ) OR TITLE-ABS-KEY ( questionnaire* ) OR TITLE-ABS-KEY  ( 
scale ) OR TITLE-ABS-KEY  ( scales ) OR TITLE-ABS-KEY ( score ) OR TITLE-ABS-KEY ( scores ) OR TITLE-ABS-
KEY ( screening ) OR TITLE-ABS-KEY ( subtest* ) OR TITLE-ABS-KEY ( test ) OR TITLE-ABS-KEY ( tests ) OR 
TITLE-ABS-KEY ( testing ) OR TITLE-ABS-KEY ( tool ) OR TITLE-ABS-KEY ( tools ) ) 
 
Combination search 
#1 AND #2 AND #3 
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Appendix 7 COSMIN checklist 
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Appendix 8 NHS & QMU ethics 
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DIVISION OF DIETETICS, NUTRITION, BIOLOGICAL SCIENCES, PHYSIOTHERAPY, PODIATRY and 
RADIOGRAPHY 
PROJECT RELEASE FORM resubmission 
This form is designed to notify students and staff of the DivREC response to individual research 
project proposals and Dissertation Proposals.  A copy of the form will also be retained by the 
Committee to record each decision and to monitor resource requirements.Students must 
complete sections a – e below, otherwise you will be asked to re-submit: 
a. PROJECT TITLE: Identification of the reliability of physical function outcome measures in 
young people with CP and age-matched healthy controls, through a test-retest study 
design 
b. STUDENT(S): Asfarina Zanudin 09004220 
Please add in all names and matriculation numbers for group projects 
c. SUPERVISOR: Dr Marietta van der Linden  
 
d. SITE FOR DATA COLLECTION: Motion Gait Lab & Sport Hall, QMU 
(If not QMU state where) 
e.     APPROXIMATE DATES FOR DATA COLLECTION: 30/9/2014-31/7/2015 
 
All students should refer to Committee Response below and Comments overleaf 
 
COMMITTEE RESPONSE 
Decision  / X Date 
1. Project proposal and Ethical approval granted  1/10/14 
2. Proceed with minor modifications to the project 
proposal (as noted in response overleaf) 
  
3. Resubmit revised proposal by    
4. Resubmit revised ethics by (insert date ………)   
5. Submit for further ethics scrutiny (QMU / external)   
6. Project documentation incomplete    
7. Other …   
 
Please note – you cannot proceed to dissertation unless response box 1 and/or box 2 ticked () 
        
GENERAL AND SPECIFIC COMMENTS ARE PROVIDED OVERLEAF: 
Issues raised from original submission now addressed 
 
Note – disclosure received separate to Ethics application (email 19/08/2014) 
Please note – minor changes to stated methodology should be discussed with project 
supervisor.   
Any major changes to stated methodology must be notified to subject area DivREC 
representative and re-submitted to DivREC hubsite on the appropriate amendment form 
 
 
This form will only be signed by Head of Division once project and ethical approval granted 
 
Signature DiVREC member: ____Gillian Baer __derek Santos______________
 DATE__01/10/2014_______ 
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Appendix 9 Consent form 
 
 
Centre Number:  
Study Number: 
 
CONSENT FORM 
 
Study Title:The effects of exercise therapy on young people with cerebral palsy 
 
Name of Researcher: Asfarina Zanudin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 
          Please initial box 
 
1. I confirm that I have read and understand the information sheet dated Jan 2015 
(version 3) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
  
  
    
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights being 
affected. 
  
  
     
3. I understand that sections of my medical notes and data collected during the 
study may be looked at by responsible individuals from Queen Margaret 
University, from regulatory authorities or from the NHS Trust, where it is relevant 
to my taking part in this research. I give permission for these individuals to have 
access to my records. 
  
  
     
4. I agree to my GP being informed on my participation in the study  (optional)   
  
5. I agree to my picture and video being recorded for the purpose of this study   
  
6. I agree to take part in this study   
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________________________ ________________
 ____________________ 
Name of Patient Date Signature 
 
 
 
_________________________ ________________
 ____________________ 
Name of Person taking consent Date Signature 
 
 
 
When completed 1 for patient; 1 for researcher site file; 1 (original) to be kept in medical notes 
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Appendix 10 Data collection sheet 
Patient Identification Number:    Date: 
 
ActivPal Number: 
 
Date of Birth: 
 
Sex:   Male / Female 
 
GMFCS:  
 
Walking aids: 
 
 
 
 
 
 
 
Previous operations: 
 
 
 
 
 
 
 
 
 
 
Co-morbidities: 
 
 
 
 
 
 
 
 
 
Notes: 
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Did Canadian Occupational Performance Measure?  Yes / No 
 
 
TIMED UP AND GO (TUG) TEST 
 
Walking aid used?      Yes   No 
If yes, what aid was used?         
 
Attempt1     seconds 
Attempt2     seconds 
Attempt2     seconds   
 
Average    seconds 
 
 
 
RANGE OF MOTION 
 
 Left Right 
Hip flexion, knee flexed   
Popliteal angle, opp knee flexed    
Knee extension   
Knee flexion   
Dorsiflexion, knee flexed   
Plantarflexion, knee flexed   
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Hip Extension   
ANTHROPOMETRIC DATA: 
 
Height (mm):        
 
Weight: 
 
Limb Length (mm):  Right _______      Left_______ 
 
Knee Width (mm):    Right _______      Left_______ 
 
Malleolar Width (mm): Right _______      Left_______ 
 
Tibial Torsion: Right _______      Left_______ 
 
 
 
 
 
MUSCLE STRENGTH: 
 
Muscle Group Side 
Lever arm length 
(mm) 
Force  
Trial 1 Trial 2 Trial 3 
Hip Extensors 
 
Right     
Left     
Hip Abductors 
 
Right     
Left     
Knee 
Extensors 
 
Right     
Left     
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Vicon directory           
  
 
Comments/Walking aids etc        
  
           
  
 
GAIT ANALYSIS 
 
Trial # 
Left Force 
plate 
Right Force 
plate 
Processed Additional Info 
Static      
Static      
Static      
Balance 
Right 
     
Balance 
Right 
     
Balance 
Right 
     
Balance 
Right 
     
Balance Left      
Balance Left      
Balance Left      
Balance Left      
Walk      
Walk      
Walk      
Walk      
Walk      
Walk      
Walk      
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Walk      
Walk      
Walk      
Walk      
Walk      
Walk      
Walk      
Walk      
Walk      
Walk      
Walk      
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GROSS MOTOR FUNCTION MEASURE 
 
Evaluator’s Name      GMFCS Level:   
  
 
Testing Conditions (e.g.: room, clothing, time, others present):    
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Was this assessment indicative of this child’s ‘regular’ performance? Yes / No 
 
COMMENTS: 
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AEROBIC FITNESS 
 
GMFCS:  I II III 
 
Shuttle run test Level:           Shuttle:     
 
 
Level 0  12 3 4 5 6 78  
Level 1  12 3 4 5 6 78 9  
Level 2 12 3 4 5 6 78 9  
Level 3 12 3 4 5 6 78 9 10  
Level 4 12 3 4 5 6 78 9 10 
Level 5 12 3 4 5 6 78 9 10 
Level 6 12 3 4 5 6 78 9 10 11 
Level 7 12 3 4 5 6 78 9 10 11 
Level 8  12 3 4 5 6 78 9 10 11 12 
Level 9 12 3 4 5 6 78 9 10 11 12 
Level 10 12 3 4 5 6 78 9 10 11 12 
Level 11 12 3 4 5 6 78 9 10 11 12 13  
Level 12 12 3 4 5 6 78 9 10 11 12 13  
Level 13 12 3 4 5 6 78 9 10 11 12 13 14  
Level 14 12 3 4 5 6 78 9 10 11 12 13 14  
Level 15 12 3 4 5 6 78 9 10 11 12 13 14 15 
Level 16 12 3 4 5 6 78 9 10 11 12 13 14 15 
Level 17 12 3 4 5 6 78 9 10 11 12 13 14 15 
Level 18 12 3 4 5 6 78 9 10 11 12 13 14 15  
Level 19 12 3 4 5 6 78 9 10 11 12 13 14 15 16 
 
 
 
 
 
287 
 
 
 
Level 20 12 3 4 5 6 78 9 10 11 12 13 14 15 16     17 
Level 21 12 3 4 5 6 78 9 10 11 12 13 14 15 16     17     18 
Level 22 12 3 4 5 6 78 9 10 11 12 13 14 15 16     17     18 
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Appendix 11 ActivPAL instruction 
Thank you for wearing the activity monitor. It records how much of 
the day you are sitting, standing or walking. 
We would like you to wear it for at least seven days, you can take 
the monitor off your leg during the night, but this means attaching it 
to your thigh in the morning as soon as possible after you get up, 
and taking it off before you go to bed.  
The monitor only records for 10 days starting from the time you were 
given the monitor so please could you wear it next day of receiving it! 
After you have worn the monitor for seven days, could you please 
send it back to me in the self-addressed stamped envelope. We can 
then download the data from the monitor onto a computer and see 
how much of the day you spent either walking, standing or 
lying/sitting. 
 
Applying the activPAL (activity monitor) 
It is most comfortable to wear the monitor attached to the thigh (see 
picture). It should be positioned on the midline of the thigh, between 
the hip and the knee. However, it will function correctly if placed 
anywhere on the front of the thigh in the orientation indicated by the 
figure on the front panel. (the little man should be standing/UP 
pointing upwards) 
The monitoring device and the tape are not waterproof and they 
should be removed for bathing. The skin should be thoroughly dried 
after bathing to maximise the adherence of the tape/gel. 
 
Finally, please return the included form and note which days the 
monitor was attached to your thigh. 
 
 
 
Please contact me on 0131 4740000 if you have any questions 
regarding the monitor. 
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Thank you very much for helping with this study, 
 
Asfarina Zanudin 
PhD student 
Physiotherapy Division 
School of Health Sciences   
Queen Margaret University Drive 
Musselburgh    
EH21 6UU   
Email: AZanudin@qmu.ac.uk 
 
 
 Days& dates time 
Day 1   
Day 2   
Day 3   
Day 4   
Day 5   
Day 6   
Day 7   
 
 
 
Comments 
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______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
___________________________________ 
 
 
Please fill in the day and the times above and return with the monitor 
in the self-addressed stamped envelope
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Appendix 12 Feedback on the exercise programme questionnaire 
 
Feedback on the Exercise Programme 
 
1. Do you feel that the level of the exercise programme was appropriate for you?  
Choose best answer 
 
 Yes  No, much too easy 
    
 Usually, but sometimes too easy  No, much too difficult 
    
 Usually, but sometimes too difficult   
 
2. Would you find it more enjoyable to exercise in a group or individually?  
Choose best answer 
 
 Group 
  
 Alone 
  
 Makes no difference 
 
3. Do you feel that the length of the exercise session was: 
Choose best answer 
 
 Just right 
  
 Too long, it should have only been _________ minutes long 
  
 Too short, it should have been _________ minutes long 
 
4. How did you feel about the variety of exercises during each individual session? 
Choose best answer 
 
 Good variety of exercises 
  
 Not enough variety/I sometimes got bored 
  
 Too many different exercises 
  
 Other:  
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5. How do you feel about any alterations to the sessions over the course of the 24 week 
programme?Choose best answer 
 
 I liked how the sessions were altered as I got more used to the exercises 
  
 The sessions were altered, but I would have rather it stayed consistent 
  
 There were no alterations and I liked that 
 
 
 There were no alterations and I would have liked some changes 
  
 Other:  
   
 
 
6. Did you experience any muscle soreness/stiffness, pain, spasticity or similar adverse 
effects as a result of the exercise? Please describe briefly. 
 
 
 
 
 
7. Do you feel that the amount of supervision/instruction that was provided was: 
Choose best answer, add comments if you wish 
 
 Just right Comments:  
    
 Too much   
    
 Not enough   
 
8. How did you feel about the location of the exercise programme? Where would you 
rather be exercising? Choose best answer 
 
 Local leisure centre  
   
 Physiotherapy clinic  
   
 Other:  
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9. Did you notice any differences in your daily functioning since the start of the exercise 
programme? Please describe briefly. 
 
 
 
 
 
10. Would you consider continuing the exercise programme on your own now that the 
study is over? Choose best answer 
 
 Yes   No  
     
 Yes, but only for 1-2 sessions per week  Other:   
 
11. If you are considering continuing the exercise programme which components would you 
include? Check all that apply 
 
 Strength circuit  Stretching/flexibility 
    
 Aerobic component  All components  
 
 
 
12. If you are considering continuing the exercise programme where do you think you would 
be exercising? Choose best answer 
 
 I’d like to continue going to my local 
leisure centre 
 Don’t know 
  
    
 I will modify the programme to do as 
much as possible at home 
 Other:  
   
 
13. Please indicate any non-gym-based physical activities (from your initial exercise 
questionnaire) you plan to continue participating in? 
 
 Activity 1:   (to be filled in by researcher) 
   
 Activity 2:  (to be filled in by researcher) 
   
 Activity 3:  (to be filled in by researcher) 
 
  
 I was not participating in any other physical activities (Go to question 14)  
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If applicable, please state the reason you are no longer participating in the activity listed 
above: 
 
 
 
14. Have you started any new activities since the beginning of the exercise programme: 
 
 Yes:    No (Go to question 15) 
 
If yes, do you plan to continue participating in these activities? 
 
 Yes  No, - Why not?   
 
 
15. Please leave any additional comments you may have about the exercise programme , 
participation in other physical activities, and/or participation in this study.  
 
 
 
 
 
 
 
 
Thank you for your cooperation in the study! 
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Appendix 13 Participant information sheet 
 
 
 
Information sheet 
 
Part 1 
 
Study Title: The effects of a community exercise programme on young people with Cerebral 
Palsy. 
 
 
I am looking for volunteers to participate in this research study. This Information sheet is given 
to you because you have been invited to take part in the study. I feel it is quite important for 
you to know about the study before you decide. Please read this information sheet carefully 
and talk to others about the study if you wish. 
 Part 1 Explains the purpose of the study and what will happen if you decide to take part 
 Part 2 Gives you more detailed information about the conduct of the study 
 
If you have any questions, you can talk to us. Take your time to decide whether or not you wish 
to take part. 
 
What is the purpose of the study? 
We want to study how a community-based exercise programme will affect function, physical 
fitness, physical activity levels, self-esteem, and quality of life in young adults and adolescents 
who have Cerebral Palsy. 
 
Why have I been invited? 
You have been invited because you have Cerebral Palsy, are the right age (16-25 years), have 
been discharged from paediatric service, and are not currently regularly (i.e. twice a week or 
more) exercising in a gym. 
 
We need a group of people to either take part in the exercise programme or be part of the 
control group. Which group you will be part of is entirely decided by chance, (‘names out of a 
hat’). If you are assigned to the control group you won’t go through the exercise programme 
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initially, but we will compare your function, fitness, activity level, etc to people who have done 
the exercise training. This will allow us to determine the effects of exercise training. 
 
Do I have to take part? 
It is entirely up to you to decide whether or not to take part in this study. You are not required 
to give a reason if you decide not to take part. If you do decide to take part, you are free to 
withdraw from the study at any time without giving a reason. If you do withdraw from the 
study the data collected during any previous assessment visits will be retained. If you decide to 
take part, you will be asked to sign a consent form. 
 
What will happen if I take part? 
You will be assigned to either the group that is doing the exercise programme or the control 
group.  
 
If you are in the exercise group, you will take part in an 18-week exercise programme. The 
exercise training will take place at your local gym. For the first session and between 2-4 other 
sessions, an experienced physiotherapist will come to the gym with you and instruct you on the 
circuit exercise programme which will be adapted to your ability and needs. For the other 
sessions a fitness instructor from the gym will work with you to complete the circuit 
programme, which combines leg strength, core stability, endurance/aerobic, and flexibility 
exercises. For the first 6 weeks you will be expected to attend 3 supervised sessions per week. 
During weeks 7-12 you will attend 2 supervised sessions per week and will be encouraged to 
complete 1 more session on your own per week. In the last 6 weeks (13-18) there is no 
prescribed number of sessions but you will be encouraged to complete 3 sessions per week on 
your own. The times and day of the training sessions are entirely up to you, as long as the 
physiotherapist is able to accompany you to the gym on several occasions.   
 
If you are in the control group you will not take part in the exercise programme. You will, 
however, be given free leisure centre access for 5 months once the study is complete.  
 
Regardless of which group you are in, everyone who participates in the study will undergo four 
assessment sessions at the Queen Margaret University motion analysis laboratory on days and 
times which suit you. You will be reimbursed for travel to and from the University (which will 
include travel by taxi within Edinburgh). Each assessment will take about 1.5 to 2 hours to 
complete. These will take place before the first training session (or in the case of the control 
group shortly after you enter the study) and at 6, 12, and 18 weeks after the start of the study. 
 
You will be asked to wear shorts and a t-shirt for each assessment. During the assessment a 
number of different measures will be recorded. You will be asked to perform activities such as 
walking, picking items from the floor, getting up from sitting etc. Your muscle strength will be 
measured for a number of muscle groups in your legs. The flexibility of your ankle, knee and hip 
will be recorded. You will also undergo gait analysis. During this portion of the assessment, 
reflective balls (called markers) will be stuck to your legs and hips and you will be asked to walk 
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back and forth in the lab. The markers will allow us to record your movement patterns in three 
dimensions using multiple cameras linked to a computer. 
 
During the first and last assessment you will be asked to complete four short questionnaires. 
 
Before the exercise programme begins you will be given an activity monitor to wear for 7 days. 
The monitor is about the size of a credit card and is attached to the front of your thigh. It will 
record information about how many steps you take as well as the time you spend walking, 
standing, and sitting or lying down. 
 
Lastly, those in the exercise group will be asked to keep a log of your gym attendance and any 
muscle soreness or other discomfort you feel during or after your sessions. Although, some 
initial muscle soreness is normal for people when starting an exercise programme, you should 
inform your physiotherapist if this soreness continues or if you experience any other pain or 
discomfort as a result of the exercise programme and he/she will then modify your exercise 
programme appropriately. 
 
 
What are the possible disadvantages and risks of taking part? 
The assessment procedures involved are safe and common clinical assessments. However, 
there are minimal risks such as the possibility to fall, trip etc. The exercise programme will be 
tailored to your abilities and needs and will be supervised by a fitness instructor who has been 
instructed by an experienced physiotherapist so that risk of injury as a result of the exercise 
programme will be minimal.   
 
What are the possible benefits of taking part? 
By taking part in this study you will get to take part in a free supervised exercise programme 
either during the study if you are part of the exercise group or after the study has been 
completed if you are in the control group. During this time you will have unlimited access to 
your local community leisure centre.  
 
There are also indirect benefits for other young adults with CP. This study will help to develop 
an exercise programme to assist young adults in their transition from childhood to adult health 
care and hopefully help improve their daily function and quality of life. 
 
What if there is a problem? 
Any complaint about the study, the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. Detailed information is given in part 2. 
 
Will my taking part in the study be kept confidential? 
If you agree, your general practitioner will be made aware that you are participating in the 
study, but all information collected about you is kept strictly confidential; details are included 
in part 2. 
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Contact Details: 
Ms Asfarina Zanudin   Dr.  Marietta Van Der Linden 
PhD student    Senior Research Fellow - Physiotherapy 
Queen Margaret University  Queen Margaret University  
Queen Margaret University Drive  Queen Margaret University Drive 
Musselburgh   Musselburgh 
East Lothian     East Lothian 
EH21 6UU          EH21 6UU 
Tel: 0131 474 0000   Tel: 0131 474 0000 
E-mail: AZanudin@qmu.ac.uk  Email: mvanderlinden@qmu.ac.uk  
 
This completes Part 1 of the information sheet. 
If the information in Part 1 has interested you and you are considering the participation, 
please continue to read the additional information in Part 2 before making any decision. 
 
Part 2 
 
What if there is a problem? 
Any complaint about the study, the way you have been dealt with during the study or any 
possible harm you might suffer due to negligence will be addressed. Queen Margaret 
University has a liability insurance scheme for compensation as a result of harm caused due to 
the negligence on the part of the researcher in connection with the above mentioned study but 
no compensation arrangements are there for non-negligence harm. In the unlikely event that a 
participant loses capacity to consent during the study, this participant will be withdrawn from 
the study. Data collection during the previous assessment visits will be retained. 
 
Will my taking part in the study be kept confidential? 
Only your GP will be informed of your participation in the study, however this is not required. 
You can omit ticking the box in the consent from. If you do not want your GP to be informed 
the information collected about the participants will be kept strictly confidential. The data will 
be stored securely in locked cabinets or on a password protected network at Queen Margaret 
University. Every participant is given a code at the beginning of the study and only this code, 
not your name, is associated with any recorded data. Care is taken to remove any information 
that could identify you from any information presented, published or taken out of the 
university for any reason. 
 
The data will be accessed only by researchers involved in the study and the research committee 
responsible for monitoring the quality of research. 
 
What will happen to the results of the research study? 
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The results of the study will be submitted for publication in scientific journals. Care will be 
taken that the participants are not identifiable in any of the materials published and all the 
data collected will be kept for 10 years and will then be disposed of carefully. 
 
Who is organising and funding the research? 
The study is funded by The James and Grace Anderson Trust and ‘La Fondation Motrice’. 
Asfarina Zanudin is a PhD student at Queen Margaret University, will coordinate the study 
under the supervision of Dr Marietta van der Linden, a senior research fellow at Queen 
Margaret University. 
 
Who has reviewed the study? 
This study was given a favourable ethical opinion by the South East Scotland Research Ethical 
Committee and the Queen Margaret University Research Ethics Committee. 
 
 
Thank you for your valuable time. If you have any questions you are welcome to contact Ms 
Asfarina Zanudin during office hours (contact details above).   
 
 
If you want to talk to an independent advisor please contact Dr Frederike van Wijck for 
general information regarding taking part in a research study, andJacky Yirrell for information 
specific to this research. 
 
Independent Contacts: 
Frederike van Wijck Jacky Yirrell 
Reader in Neurological Rehabilitation Clinical Specialist Physiotherapist in  
Institute for Applied Health Research  Neuromuscular Disorders 
Glasgow Caledonian University  Department of Clinical Genetics 
Govan Mbeki Building, room A219  Western General Hospital 
Cowcaddens Road  Crewe Road 
Glasgow G4 0BA  Edinburgh EH4 2XU 
Tel: 0141 331 8967  Tel: 0131 537 1063 
Email:Frederike.vanWijck@gcu.ac.uk Email: jackyyirrell@nhs.net 
 
 
If you have any complaints before, during, or after the study please contact Kim Gilchrist, 
Senior Research Officer at Queen Margaret University during office hours. 
 
Kim Gilchrist 
Senior Research Officer 
Queen Margaret University 
Queen Margaret University Drive 
Musselburgh 
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Appendix 14 Craigalbert Leisure Centre (informal chatting) 
Focus Group with 3 young people; 
M -  aged nearly 15y (female) 
L age 18y (female) 
K 19y (male) 
The YP had been sent out the information sheets two weeks earlier and asked to read them and for their 
permission to take part in a round-table discussion about the study; 
The effects of exercise therapy on young adults with cerebral palsy that is being conducted by QMU. 
They were also given some time before the start of the meeting to read through the information sheet 
again. The meeting consisted of an informal style conversation between themselves and facilitated by Irene 
Croal, PLT at SCCMI, using the questionnaire provided by QMU. 
The questionnaires are enclosed, completed by each participant and additional notes provided here. 
 K commented that he was already a convert to exercise as he finds that flexibility exercises help to 
improve his ROM just as it does in able bodied people. He finds that when he does not do his 
training for a few weeks, he begins to lose his balance more when travelling on the bus, due to loss 
of core strength. 
 Sometimes K finds that with other commitments – he attends college 4 days a week that he is less 
inclined to attend the gym. This study might provide the added incentive that he needs 
 M said that because the information sheet mentions pain and discomfort that that might be enough 
to put some people off. 
 M said that she does experience pain after intense physiotherapy sessions, but it does not put her 
off as she knows it has been good for her 
 L said that she experiences quite a lot of back pain and she thinks that exercise can make it worse 
and it sometimes puts her off exercising 
 K said that attending QMU 4 times would put him off because he doesn’t know if it would mean 
taking time off college or how he would get there. Would the times be to suit him or at times that 
may co-incide with college. Because he would not know the answer to these questions, that he says 
might be enough to put him off responding. 
 M said that she would be worried about getting to QMU and they should say in the information 
sheet how you would get there and when exactly they would have to attend  
 K already does a lot of fitness training and was concerned that if he took part that he would have to 
stop his regular training 
 K and M discussed the description in the information sheet about the types of exercise and the 
measurements made and thought there was an over-emphasis on legs. They wanted to know if the 
upper limbs would be targeted more if they wanted them to be. 
 One participant , was very concerned by the fact that their participation on the trial would be shared 
with their GP. The concern was that as a recipient of disability living allowance, they are required to 
have a medical and so if the doctor thinks that they can take part in a 6 month exercise programme, 
then they should be able to work and have their DLA withdrawn. 
 
